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Summary
The RSN-2 strain of RS virus grown in BS-C-l cells was used 
for the isolation and characterisation of ts_ mutants.
RSN-2 strain growth was examined at different temperatures 
and the degree of cell-association of the virus calculated. The effect 
of DNA inhibitors such as actinomycin I) and mitomycin C as well as the 
effect of the concentration of phenylalanine, arginine and serum on RS 
virus was studied. Thin sections of RS virus infected cells were 
examined by electron microscopy. Infected cells were also examined 
under a scanning electron microscope.
Thirty-five _ts mutants of the RSN-2 strain were isolated from 
mutagenised virus and one ts mutant from non-mutagenised virus. A few 
ts mutants were ts_ at 37°C as well as the restrictive temperature (39°C). 
Some ts mutants must be affected in a cytolytic function since they grow 
but do not induce plaque formation at 39°C. An attempt was made to 
characterise the _ts mutants by genetic analysis. However, complementation 
could not be reproducibly detected in the cell system (BS-C-l cells) used. 
Therefore the ts_ mutants were classified on the basis of their growth 
and immunofluorescence pattern and thermolability at 39°C. Prom the 
immunofluorescence data the ts mutants were classified into three groups. 
Group I ts mutants have a reduced amount of antigen and a reduced number 
of fluorescing cells at 39°C compared to 31°C. Group III _ts mutants 
have a reduced amount of antigen at 39°C but the same number of 
fluorescing cells whereas Group II ts_ mutants have the same pattern at 
39°C as 31°C. Group I and III ts mutants are classified by lack of
growth at 39°C into Group A. Leak occurring duringgrowth of these 
ts mutants was less than 1%. Group II _ts mutants correspond to Group B. 
These mutants have greater than 10% leak at 39°C.
From the temperature-shift experiments the ts mutants 
examined from Group I and III appeared to have a defect in an early 
function. However the t£ mutant of Group II which was examined seemed 
to he required throughout the growth cycle and may he defective in a 
functional activity rather than synthesis. This tis mutant was heat—  
stable, the other _ts mutants examined were heat-labile.
The thermolability of ts mutants from each group was examined 
at 39°C. There was no correlation between heat-sensitivity and the 
classification of the jts mutants as both Group A (i and III) and Group B 
(il) ts mutants were heat-sensitive. Ts mutants from each group were 
assayed for virion-associated RNA-dependent ENA-polymerase activity. 
Although some activity could be detected it was difficult to assess as 
there was a high level of background activity in uninfected cells.
Section 1 
Introduction
1.1 Negative-Strand viruses
Negative-strand viruses are RNA viruses which have a single­
stranded RNA genome complementary in base sequence to m-RNA. These 
viruses also have a virus coded RNA-dependent RNA polymerase, which 
allows the transcription of m-RNA from the RNA genome. The group of 
negative-strand viruses includes the orthomyxoviruses, paramyxoviruses, 
rhabdoviruses and also possibly the metamyxoviruses (Mahy and Barry,
1975» Wunner et al., 1975)* The genome of the negative-strand viruses 
can be unsegmented (paramyxovirus, rhabdovirus) or segmented (ortho­
myxovirus). In viruses with a segmented genome, individual single­
stranded RNA molecules of the genome are each transcribed by a virion- 
associated RNA*1 dependent RNA polymerase to complementary RNA molecules 
which act as m-RNA (Fenner, 1974)* However, not all of the influenza 
virus subunits may be negative strands since the influenza virion RNA 
has been reported to have in vitro m-RNA activity (Siegert et al., 1973)*
N £ C A Tt </£- s -T/l fit NJ>
The genome of unoogmontedflviruses is transcribed by the virion-
norJoClST7*oW<C oF
associated RNA-dependent RNA polymerase into m-RNAj\ probably by diroet 
transcription rathor than by cleavage of transoribod RNA-into ohort- 
langthc, that is genomic rather than modificative control (Subak-Sharpe 
and Pringle, 1975)* The replication of the orthomyxoviruses (influenza 
virus type A, B and C) is sensitive in the early stages to the action of 
actinomycin D (Barry et al., 1962). However the replication of the 
paramyxoviruses (Newcastle disease virus (NDV) and the parainfluenza 
viruses) is not sensitive to actinomycin D (Barry et al., 1962). The 
properties of these groups are listed in Table 1 and compared with those 
of a proposed group, the metamyxoviruses (Melnick, 1971) which includes
human and bovine RS virus and pneumonia virus of mice (PVM). The three 
groups differ in the size of their nucleocapsid, that of the metamyxo- 
viruses (11-15 nm) (Berthiaume et al •, 1974) being intermediate in 
diameter between that of the orthomyxovirus (9 nm) and paramyxoviruses 
(17-18 nm). Both the ortho- and para-myxoviruses differ from the 
metamyxoviruses with the exception of PVM in having both haemagglutinin 
(Hirst, 1941) and neuraminidase (Gottschalk, 1957)* Morphologically 
the viruses from the three groups are similar. They are pleomorphic 
enveloped viruses with spikes on the membrane surface and they mature by 
budding from the cytoplasmic membrane.
The orthomyxoviruses and paramyxoviruses differ in their 
genetic interactions. Both complementation and "recombination” have 
been shown between ts mutant of influenza virus. The ts mutant can be 
grouped better on the basis of Recombination1 rather than complementation 
data. However the recombination frequencies (5-20%) obtained were 
higher than would be expected due to intramolecular recombination 
(Simpson and Hirst, 1968). Previous hypotheses suggested that high 
recombination frequencies obtained were due to the possibility of 
reassortment of a segmented genome (Burnet, 1959 and Hirst, 1962). It 
has now been shown that influenza virus nucleic acid resolves into 6 or 7 
single-stranded molecules (Bishop et al., 1971) and reassortment has been 
demonstrated between strains of influenza virus A (Kilbourae et al., 1967 
and Kilboume, 1968). Thus recombination in influenza virus is mainly 
due to genetic reassortment although some low frequency intramolecular 
recombination may occur (staiger, 1964). The "recombination" seen between 
ts mutants of NDV is thought to be due to the formation of particles with
more than one genome, if ts mutant genomes are involved complementing 
heterozygotes can occur which produce plaques at the restrictive 
temperature (Dahlberg and Simon, 1969a and Dahlberg and Simon, 1969b). 
Complementation (Gharpure £t al., 1969) and "recombination" (Wright 
et al., 1973) have been detected between jts mutants of RS virus (a 
metamyxovirus). However the "recombination" was due to complementing
heterozygotes and not true intramolecular recombination.
TABLE 1
(modified from Table 5-2 in Scholtissek et al., 1969)
Property Orthomyxovirus Paramyxovirus Me tamyxovirus
Particle size (nm) 80-120 150-250 100-350
Filamentous forms Common Unusual Common
Projections (nm) 10 12-15 12-17
Nucleocapsid (nm) 
(diameter) 9 17-18 11-15
Periodicity (nm) S'-t 4-6 6.5-7
Segmented
nucleocapsid Segmented single strand single strand
RNA sedimentation 
coefficient 
MW
38S 57S ND
6 6 4 x 10 daltons 6 x 10 daltons ND
Sensitivity to 
actinomycin D Sensitive Not sensitive Sensitive?
Eosinophilic
cytoplasmic
inclusions
- + +
RNA-RNA
polymerase + + +?
Haemagglut inin + +
X
N euramini das e + + —
XOnly P7M has haemagglutinin
1.2 Pneumonia virus of mice (PVM)
PVM as well as RS virus was proposed as a member of a new 
group, the metamyxoviruses (Melnick, 1971)* These viruses have 
nucleocapsids with diameters in the range of 11-15 nm (Bachi and Howe,
1973; Berthiaume et al., 1974> Norrby et al., 1970a). It has now 
been proposed to extend this group to include bovine RS virus, a virus 
morphologically and antigenically similar to human RS virus (ito et al•,
1973)* Some properties of these viruses are listed in Table 2.
The nucleocapsid of bovine RS virus is similar in diameter to 
that of human RS virus and FVM. The metamyxoviruses mature by budding 
and with the exception of PVM show no haemadsorption or haemagglutinating 
activity (inaba at al., 1970a and Richman et al., 1971)• PVM can 
agglutinate hamster and mouse erythrocytes and PVM infected cells can 
absorb to mouse erythrocytes (Compans et al., 1967). The centre-to-centre 
distance between projections of RS virus and PVM is thought to be 
related to their difference in haemagglutinating and haemadsorption 
properties. The distance between RS virus spikes is longer (10 nm) 
than that between PVM spikes (6 nm).
Human RS virus and FVM by complement-fixation and neutralisation 
tests have been found to be antigenically unrelated (Berthiaume et al.t
1974) whereas human RS virus and bovine RS virus have been found to be 
antigenically similar (Paccaud and Jacquier, 1970).
TABLE 2
Comparison of characteristics of Human and Bovine RS virus and FVM
(modified from table 1, p48 in Berthiaume _et al. , 1974)
Properties Human RS virus 
grown in HEp-2
Bovine RS virus 
grown in BK
PVM grown in 
Vero cells
Growth kinetics
Latent period 6 hours 24 hours 18 hours
Peak titre 24-48 hours 72 hours 43-96 hours
% Cell-associated 
virus 90 ND 90
Syncytium formation + in some cells + in some cells - 
(GBK)
Time for CPE to 
develop 3 days 3 days >11 days
Cytochemistry
Acidophilic + + +
Cytoplasmic 
inclusions 
Nuclear inclusions mm
Acridine orange yellow-green - yellow-green
staining of 
inclusions (other workers - )
Haemagglutination
Haemadsorption
+
+
TABLE 2 (contd.)
Properties Human RS virus 
grown in HEp-2 r
Bovine RS virus 
grown in BK
PVM grown in 
Vero cells
Immunofluorescence
Immunofluore scent 
AG detected (post- 
infection) 8 hours m 24 hours
cytoplasmic inclusions + + +
nuclear inclusions X - -
Electron microscopy
Spherical structure (diam) 100-350 nm 80-450 nm av 200 nm 100-200 nm
pleomorphoric forms + + +
filamentous forms (diam) 100 nm 100-130 nm 100 nm
length of envelope 
projections 12 nm 13-17 nm 12 nm
projection spacing 
(centre to centre) 10 nm 7-9 nm 6 nm
nucleocapsid (diam) 13*5 nm 11-15 nm 13*5 nm
nucleocapsid helex pitch 6.5 nm 7 nm 6.5 nm
cytoplasmic inclusions + + +
nuclear inclusions - - -
budding + + +
Nuclear inclusions can be detected in ts RS virus infected BS-C-l cells 
at 39°C
1.3 Bovine RS virus
In 1968, an inhibitor of human RS virus was found in bovine
sera. The level of this RS virus inhibitor increased with the age of
cattle from which it was obtained, being higher in older cattle. In
some cases increased levels of inhibitors were found in cattle with 
respiratory disease (Doggett et al.. 1968). Subsequently a virus was 
isolated from the nasal secretions of Swiss cattle with respiratory 
disease. The virus which was antigenically similar to human RS virus 
was shown to be the causative agent of the disease. Therefore this 
virus was termed Bovine- RS virus (Paccaud and Jacquier, 1970)• Bovine 
RS virus has also been isolated from cattle with respiratory disease in 
Belgium (Wellemans and Leunen, 1971; Wellemans et al.. 1970 and 
Wellemans et al., 1971)* Britain (Edington and Jacobs, 1970 and Jacobs 
and Edington, 1971)* Japan (inaba et al.. 1970a, b and Inaba et al.. 1972) 
and America (Rosenquist, 1974; Rossi and Kiesel, 1974 and Smith et ad.,
1975)* The symptoms of bovine RS virus disease axe slight fever, 
anorexia, depression, pyrexia, respiratory distress, coughing 
lachrymation and increased nasopharyngeal secretions (inaba et al., 1972).
The principal difference between bovine and human RS virus 
concerns their host range which is broader for bovine RS virus (Matumoto 
et al., 1974 and Paccaud and Jacquier, 1970). Bovine RS virus antibodies 
appear to be widespread in sheep; however the antibody level was lower 
(2-4-fold) than that in cattle (Smith et al.. 1975)* Berthiaume and his 
colleagues (1975) reported the prevalence of human RS virus complement- 
fixing (CF) antibody in sheep sera was high (81%) but low in the sera of 
cattle (14%) and horses (6%). Therefore it seems possible that sheep 
may have their own RS virus related to both human and bovine RS virus.
TABLE 3
Host range of Hovine and human RS virus
(modified from table 1 in Matumoto et al., 1974)
Cell culture Bovine RS virus Human RS virus
Growth CPE Growth CPE
Bovine kidney (BK) + + + +
Bovine testicle (BT) + + + +
Bovine thyroid + + - -
Bovine thymus + + + +
Bovine duodenum + + + +
Bovine rectum + + - -
Primary calf kidney
(eck) + + ND ND
Primary calf lung 
(ECL) + + ND ND
Maeiin-Darby bovine 
kidney (MDBK) + + NS ND ND
Bovine kidney (GBK) + + + +
neonatal calf lung + + NS ND ND
calf trachea + + NS ND ND
calf synovial + + NS ND ND
calf aorta + + NS ND ND
calf spleen + + NS ND ND
calf thyroid + + NS ND ND
Swine embryo kidney 
(ESK) + +
Hamster-lung 
Hm Lu-1 +
Hamster kidney 
BHK21-W12 X + X +
TABLE 5 (contd)
Cell culture Bovine RS virus Human RS virus
Growth CPE Growth CPE
Primary embryonic 
sheep kidney _ _ ND ND
Chick embryo - - - —
Chick kidney - - - -
Green monkey kidney 
(Vero) + + + +
o
2 rhesus monkey 
kidney - - + +
Human embryo lung 
(HEL) + + + +
Human embryo kidney
(hek) + + _ _
Human cancer (HeLa) X + - + +
Human cancer (Hep-2) 
KB
X +
—
+
A-
+
+
Human embryonic 
fibroblast - - ND ND
^Negative for Swiss strain of bovine RS virus 
NS - non-sycytial CPE 
ND - not done
1.4 Respiratory Syncytgal Virus
1.4*1 Clinical and epidemiological aspects of RS virus
Information on the clinical and epidemiological aspects of 
RS virus is widely scattered through the literature and has never been 
comprehensively reviewed. The first part of the RS virus review is an 
attempt to remedy this deficiency, although the medical aspects of RS 
virus and RS virus infection are not the main theme of this thesis.
RS virus is an important respiratory pathogen in infants. It
is a causative agent of upper and severe lower respiratory tract disease, 
especially bronchiolitis and pneumonia (Beem et al., 1962; Burton, 1964? 
Chanock et al.. 1962; Crone et al., 1964* Gardner et al.t 1975*
Hilleman et al., 1962; Lewis al** 1961; Peacock and Clarke, 1961; 
and Reilly et al•, 1961)•
Discovery and isolation of RS virus
In 1956, a virus was isolated from a chimpanzee with upper 
respiratory tract disease. It was termed chimpanzee coryza agent (CCA) 
and produced a degenerative effect in tissue culture. However no 
symptoms of disease developed in inoculated laboratory animals, only 
chimpanzees showed signs of disease. A laboratory worker in contact with 
the chimpanzees developed both serum neutralising and complement-fixing 
antibodies to CCA. Antibody to CCA was found in young adults (18 years) 
suggesting that they had prior infection (Morris et al.. 1956). In an 
attempt to recover virus from children with severe respiratory disease, 
two similar viruses were isolated, the Long and Synder viruses. These
viruses were serologically identical to CCA and not related to any 
other respiratory pathogens. They formed syncytia in KB cells (human 
epidermoid carcinoma) and in human liver cells as did CCA (Chanock 
et al., 1957)* The Long and Synder viruses and CCA were grouped 
together and termed "Respiratory Syncytial" virus (RS virus) as the 
virus has a syncytial cytopathic effect in some cell lines (Chanock and 
Finberg, 1957)* RS virus association with respiratory tract disease 
was confirmed by Beem and his colleagues (i960) by isolation of the 
virus from children with lower respiratory tract disease but not from 
control patients.
More RS virus infections can be detected serologically than 
by isolation (Homsleth, 1967 Moss et al., 1963). The complement- 
fixation test is used more frequently than the neutralisation test as it 
is simpler to use although not as sensitive. However, neither test is 
ideal since both are insensitive in detecting RS virus infection in 
infants ( <6 months old) (Beem et al., I960; Beem et al.. 1964*
Chanock and Finberg, 1957* Chanock et al.. 1961; Gardner et al., 1964* 
Parrott et al•, 1961 and Wulff et al., 1964a)• Immunofluorescence 
techniques can be used to screen clinical samples and infected cells 
(B*Alessio et al., 1970; Cradock-Watson ejt al., 1971* Gardner and 
McQuillin, 1968a; Hers et al., 1971* McQuillin and Gardner, 1968; 
MacWilliam and Herd, 1970; Nagahama et al.. 1970; Urquhart and Martin, 
1970; Urquhart and Walker, 1972 and Schieble et al., 1967)* The 
detection of RS virus in cough and nasal swabs is not as efficient as in 
nasopharyngeal secretions (McQuillin e^t al., 1970)• Some workers have 
claimed to get reliable diagnosis using smears of throat swabs (Gray 
et al., 1968). However Gardner and McQuillin (1968b) queried their
results since they had found examination of direct smears unsuitable 
due to the high amount of non-specific fluorescence detected and the 
low number of cells present.
Natural RS virus infection of children
Natural RS virus infection of children exhibits a number of 
characteristic features. RS virus is usually isolated during the 
winter but only when there is a RS virus epidemic in the area, the peak 
periods for bronchiolitis and pneumonia co-incide with the epidemic. 
Epidemics occur annually lasting 3-5 months. No other respiratory 
pathogen has this annual pattern (Chanock et al., 1961; Horn et al.. 
1975 and. Mufson et al., 1973)* Alternating long (13-16 months) and 
short (7-12 months) intervals have been found to occur between peaks of 
successive epidemics (Kim et; al., 1973a). RS virus illness usually 
occurs after 3-5 days incubation, in children its symptoms are cough, 
fever, rhinitis and sometimes pharyngitis and otitis media. However, 
in a high percentage of cases bronchiolitis and pneumonia occur 
especially in children infected during the first 6 months (Beem e_t al., 
1964; Berkovich and Taranko, 19649 Chanock and Parrott, 1965* Holzel 
et aL., 1963; Jacobs et al., 1971 and Sandiford and Spencer, 1962).
In a recent survey the association of RS virus with bronchio­
litis was further confirmed by RS virus being the only virus isolated 
from children ( <4 years) with the disease (Horn et a l,, 1975)* RS 
virus infection can result in death, especially in infants under 1 year 
old. Among children in hospital with RS virus lower respiratory tract 
disease the death rate can be as high as 2.4% (Adams ejt al., 1961a; 
Adams et al.. 1961b; Adams et al., 1963; Coates and Chanock, 1964*
Forbes et al., 1961; Holzel et al., 1963 and Lang et al., 1964)*
The incidence of severe respiratory disease in children decreases with 
age. Bronchiolitis was frequently found in children under 1 year old 
and rarely in older children whereas pneumonia was common up to the 
age of 2 years (Berglund, 1967 and Parott et al., 1973)* This age- 
related pattern is unique to RS virus and corresponds with the decrease 
in maternal serum antibody which disappears by the 4th to 6th month of 
life. Maternal serum antibody (igG) can be transmitted from mother to 
child. However its presence in infants ( < 3 months) does not protect 
them against RS virus infection and may be related to the severity of 
the disease symptoms in this age group. Nevertheless, it cannot be 
essential since older children (4-7 months) with no serum antibody 
develop RS bronchiolitis (Beardmore and Hebeka, 1967* Beem et al.« 1964*
Hambling, 1964a; Jacobs et al., 1971* Kapikian et al., 1961;
McClelland et al., I96I; Suto et al«f 1965 and Wright, 1965). The 
severity of RS virus disease could be related to the immunological 
response to infection. This response is absent in children under 4 
weeks old (Gardner ej; al., 1964) and could be the reason why these 
children do not develop severe symptoms on RS virus infection (Neligan 
et al.« 1970). From 4 weeks old onwards a higher percentage of children 
are capable of responding immunologically to RS virus, the maximum response 
being reached at 5 months of age. Immunological responsiveness in 
infants increases with age and is related to decrease in maternal serum 
antibody in their sera. Also, CF antibody response is inversely related 
to the level of maternal serum antibody as it is impaired in infants 1
to 3 months old (Gardner et al., 1964 and. Parrott et al., 1973). The
percentage of children with acquired RS virus serum antibody increases 
from 35% of children between 3-12 months old to 95% children of 5 years
of age (Gemez-Rieux et al., 1963; Hornsleth and Volkeit, 1964;
Moss et al., 1963 aJ^ d Parrot et al., 1961)•
In surveys done in Scotland a higher male to female ratio was 
found in children (under 1 year old) with RS virus lower respiratory 
tract disease. This ratio was nearly 2:1 for males suffering from RS 
virus infection as opposed to females (Ross et al.. 1971)*
American workers found that although RS virus was isolated 
from the same proportion of males and females with respiratory disease, 
there were significantly more male children admitted to hospital with RS 
virus infections (bronchiolitis and pneumonia) than female children 
(Parrott £t al., 1975 and Monto et al., 1974)• However male children 
generally show a greater tendency to develop infections than female 
children (Winter, 1972) which could result in the apparent male-association 
of RS virus infection.
RS virus association with upper respiratory tract disease
RS virus infection can also produce upper respiratory tract 
disease (Berglund, 1967; Chanock et al.. 1961; Hamparian et al., 1961 
and Horn et al., 1975)* However, nasopharyngeal symptoms and cough are 
commonly associated with most respiratory viruses and otitis media is 
associated with influenza B and adenovirus infections as well as RS virus 
infection (Horn et al., 1975)* Nevertheless otitis media is frequently 
associated with RS virus infections of young children (Berglund, 1967 
and Horn £t aL., 1975)* Guinea-pigs experimentally infected with RS 
virus by inoculation of their eardrums developed otitis media. RS virus 
could be recovered from the eardrums at least one week after infection.
Since RS virus is very labile at the temperature of guinea-pig middle 
ear it is unlikely to have survived there for a week. Therefore the 
virus probably reproduced in guinea-pig middle ear. Although it is not 
known if RS virus can grow in human middle ear epithelium the virus has 
been isolated from the tympanic mucus of infected children (Berglund,
1967).
Children who have had severe RS virus or adenovirus infection 
are more prone to develop asthma or chronic obstructive lung disease 
than children who had no respiratory infection caused by those viruses 
(strieder, 1974)*
Respiratory viruses including RS virus can be isolated from 
cases of whooping cough. However, it is not known if these viruses can 
cause whooping cough (Feldman and Cradock-Watson, 1972). RS virus has 
only rarely been isolated from croup (Beem e_t al., I960; Grauballe et 
al., 1974? Hamparian _et al., 1961 and Horn et al., 1975)* Croup , a 
middle respiratory tract disease, is usually associated with parainfluenza 
viruses (Horn et al., 1975)* A case of acute complete atrioventricular 
heart block was noted in association with RS virus infection. However, 
cardiac involvement in association with RS virus is rare (Bairan £t al.,
1974).
Sudden infant death syndrome (SIDS)
Viruses can be associated with sudden death in infants (Aherne 
et al., 1970; Johnstone and Lawy, 1966). The rate of virus isolation 
from SIDS cases was nine times the rate from normal infants clinically 
free of infectious disease. Among the viruses isolated.was RS virus
and other respiratory pathogens (Brandt et al., 1970)• RS virus has 
been suggested as a possible infectious cause of SIDS since a similar 
age distribution has been reported to occur with both SIDS and RS virus 
bronchiolitis. Also RS virus antigen has been detected in the lungs 
of some SIDS cases giving the same distribution pattern as seen in 
cases of RS virus bronchiolitis (Downham et al., 1975 and. Ferris et al., 
1973)* However, Foy and Ray (1973) found no correlation between SIDS 
cases and lower respiratory tract disease epidemics except that the 
incidence of both decreased in the summer.
Cross-infection and reinfection with RS virus
Cross-infection due to RS virus has occurred in hospitals 
(Chanock et al.. 1957; Chanock et al., 1961; Ditchbum et al.« 1971; 
Sterner, 1972 and Weightman et al•, 1974)* nurseries (Berkovich
and Taranko, 1964; Kapikian et al., 1961 and Sterner et ai,, 1966) and 
families (Berglund, 1967).
Natural reinfection with RS virus is very common in children. 
Several workers have detected RS virus by isolation or serological 
evidence from the same patients in different RS virus epidemics (Beem 
et al., 1967; Chanock et al., 1970 and Loda et al.. 1972). Reinfection 
with RS virus is less severe than initial infection (Beem, 1967 
and Horn et al., 1975) usually asymptomatic in adults but occasionally 
producing mild upper respiratory tract symptoms. Experimental 
reinfection shows the same pattern (Hamre and Procknow, 1961; Hamre 
et al.,1961; Johnson et al.. 1961; Johnson et al., 1962 and Kravetz 
et al., I96I). However, there is evidence that RS virus infection in 
adults over 50 years old results in more serious illness, i.e. bronchitis
and bronchopneumonia, perhaps due to a decrease fn immunity to the virus 
(Fransen et al., 1967 Sommerville e_t al., 1963)* Bronchiolitis and 
pneumonia can also occur in children ( < 4 years old) on reinfection with 
RS virus even if they have pre-existing serum neutralising antibody 
(Loda et al., 1972). This antibody does not protect against reinfection 
with RS virus. However RS virus nasal secretory antibody in trials, 
although not preventing reinfection, did modify the illness (Mills et al.t
1971).
Reinfection is not caused by antigenic variation as there is no 
significant difference between strains of RS virus causing successive 
infections (Mills et ai., 1971)*
Antigenic Variation
Although a common complement-fixing antigen is shared by 
different RS virus strains (Coates and Chanock, 1962; Coates et al.,
1963; Suto at al., 1965 and Wulff et al.. 1964a) some antigenic 
variation does occur between these strains and the prototype Long strain. 
This difference between strains was seen in cross-neutralisation tests 
using post-infection animal sera (ferret, guinea-pig, monkey, rabbit). 
However, when human sera was used in the test in place of animal sera 
no antigenic variation was seen between strains (Beem, 1967; Coates and 
Chanock, 1962; Coates et al., 19635 Doggett and Taylor-Robinson, 1965; 
Suto et al., 1965 and. Wulff et al.. 1964a). Animals (ferrets, guinea- 
pigs) develop homologous but not heterologous neutralising antibody in 
response to primary RS virus infection. However, children undergoing 
primary RS virus infection probably develop both homologous and hetero­
logous antibodies since an increase in neutralising antibody against
both the local and the prototype strain of RS virus occurs in their 
serum (Berglund, 1967; Wulff et ai., 1964a and Ross et al., 1964).
RS virus antigenic variation does not appear to be progressive 
since strains which differed from the prototype Long strain did not 
replace it and other similar RS virus strains in the population (Coates 
et al.. 1966).
Pathogenesis of RS virus disease
Several theories have been proposed to explain the pathogenic 
effect of RS virus infection in young children. RS virus disease seems 
to have an immunological component since children vaccinated with 
inactivated RS virus developed a severer response to natural infection 
than non-vaccinated children (Kim et al., 1969a).
One group of workers suggested that RS virus-induced severe 
lower respiratory tract disease is the result of a type II or III (Gell 
and Coombs, 1963) immunological response (see Figure l) (Brandt et al., 
1973 and. Chanock et al., 1970)* However, another group proposed that 
RS virus bronchiolitis is the result of a type I (Gell and Coombs, 1963) 
reaction but RS virus pneumonia has a different mechanism (Aherne £t al., 
1970; Gardner at al., 1970a and Urquhart and Gibson, 1970)• RS virus 
pneumonia was thought to result from direct virus damage to the lungs 
in the absence of local antibody.
Other theories have been put forward as explanations of severe 
RS virus illness; for example, that it results from lack of maternal 
antibody protection and immunological immaturity (Parrott et al•, 1973 
Ross et al., 1971) ox that it is related to the size of airways in young
children (Simpson et al., 1974a and Simpson et al., 1974"b)* It has 
also been suggested that RS virus disease could result due to delayed 
hypersensity (type IV reaction) (Chanock et al., 1970)* production
of interferon may be a factor in RS virus pathogenesis. Low levels of
interferon have been found in patients with RS virus disease (Ray et al.,
1967). However in vitro although RS virus is sensitive to interferon 
it is not a good inducer (Corbitt, 1971 and Gardner et al., 1970c). 
Moehring and Forsyth (1971) showed that the yield of interferon induced 
by RS virus in WI-38 cells was increased when 2% rather than 10% foetal 
calf serum was used in the medium and the multiplicity of infection (moi) 
wasO.Ol or 0.01 pfu/cell rather than 1.0 pfu/cell. The non-viral 
inducer of interferon polyl poly C when used at low levels (l or 10 |ig/ml) 
which did not induce detectable levels of interferon inhibited RS virus
growth (Hill et al., 1969 and Hill and Baron, 1969).
Figure 1 : Types of allergic reaction
The diagram is a modified version of figure 25*1 
from Coombs and Gell, 1971*
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Figure 1 : Types of allergic reaction
Type I reaction (Anaphylactic, reagin-dependent)
Antibodies (igE) are either associated with or adsorbed 
onto the membrane of tissue cells. A type I reaction results 
from the interaction of antigen with these passively sensitised 
cells. Histamine and other vasoactive substances are released 
by the sensitive cells.
Type II reaction (Cytotoxic or cell-stimulating)
The antibody (igG or I^l) reacts by means of its 
combining receptors with either an antigenic component of tissue 
cells or antigen which is closely associated with these cells. 
When complement is present, interaction between the antibodies 
and the surface antigenic components of cells can result in cell 
damage•
Type III reaction (Arthus-type, antigen-antibody complexes) 
Complexes are formed between antigen and antibody.
When antigen is present locally in moderate excess the complexes 
do not precipitate but remain soluble, causing local cell damage. 
This is an Arthus-type reaction.
Type IV reaction (belayed hypersensitivity)
Actively sensitised lymphocytes possibly of T (thymus 
derived) population respond specifically to antigen by releasing 
lymphokines and/or by the development of cytotoxicity.
1.4*2 Biological aspects of RS virus
RS virus infection of laboratory animals
RS virus can be recovered from the upper respiratory tract 
of infected ferrets (Pinto _et al., 1969), minks and marmosets 24 hrs 
after intranasal inoculation but not 7 days after infection. Serial 
passage of RS virus in ferrets did not increase its virulence. RS 
virus CF antibody was produced in a variety of experimentally infected 
animals (ferrets, mink, AKR mice, chinchillas) none of which developed 
RS virus disease (Coates and Chanock, 1962). However, guineapigs 
inoculated with RS virus through their eardrums developed RS virus 
otitis media. Only a low level of neutralising antibody developed in 
a few guinear-pigs* sera, about 2 weeks after inoculation. When guinea- 
pigs were given intranasal or intracardiac injections of RS virus most 
of them developed both CF and neutralising antibodies but no RS virus 
disease was produced (Berglund, 1967)* In RS virus infected guinea— 
pigs CF antibody decayed faster than serum neutralising antibody and was 
no longer detectable 8 weeks after inoculation (Berglund, 1967 and 
Hambling, 1966a).
RS virus in certain circumstances can be pathogenic for mice. 
It has been adapted to grow in the brain of suckling mice causing death 
between 6 to 14 days after inoculation (Cavallaro et ad., 1966). 
Encephalitis of infected suckling mice was associated with widespread 
necrosis and liquefaction of the brain. The adapted strain of RS virus 
is neuropathic; it only produces lesions in the nervous system of 
intracerebrally inoculated suckling mice.
Initially, it was found that this neuropathic strain could 
not "be passaged intracerebrally in adult mice, 3-4 weeks old. However 
it has now been shown to grow in the brain of 7 9 day old mice
(Cavallaro et al., 1967)* RS virus is not pathogenic for mice when 
intraperitoneal, intranasal or intrathoracic injections are given. No 
RS virus was recovered from the lungs of inoculated animals (Cavallaro 
et al., 1966).
RS virus growth in tissue culture 
Cells
RS virus cytopathic effect (c.P.E.) in tissue culture is 
dependent on the type of cell and composition of medium used. The 
characteristic CPE of RS virus infected cells is the formation of 
syncytia. However, not all RS virus infection of cells results in the 
production of syncytia, for example RS virus infected DMB cells round up 
rather than form syncytia. Syncytia are pronounced in RS virus infected
n>t
HEp-2 cells but minimal^KB and HeLa cells.
When maintenance medium with Scherers solution was used CPE 
was delayed and the development of syncytia was restricted. However, 
the yield of infectious virus was not altered by the type of CPE 
produced (Jordan, 1962). The sensitivity of cells to RS virus infection 
varies, human diploid cells such as WI-38, HeL-1 (human embryonic lung) 
(Anderson and Beem, 1966), L-4, L-49 (Dreizin et sd,, 19^7)> human 
embryonic lung fibroblasts (HLDC-1,-4,-6), human embryonic brain cells 
(HBC-1,-4) (Larionov and Soloneva, 1968) and HL cells (human heteroploid 
cells (Cavallaro and Monto, 1972) were more sensitive to RS virus than
HEp-2 cells. A continuous human amnion cell line (u) has also been 
reported to be more sensitive than HEp-2 cells, especially for initial 
isolation of RS virus (Young and Matthews, 1969)*
However, HEp-2 cells seem to be more sensitive for RS virus 
than HeLa, monkey kidney, human amnion and human kidney cell lines 
(Bennet and Hamre, 1962). One group of workers found unlike other 
groups (Bennet and Hamre, 1962; Chanock et al., 1962 and Lewis et al.. 
1961) that monkey kidney cells were much more sensitive to RS virus 
than HEp-2 cells (Wulff et al,, 1964b). Bovine testis cells appeared 
to be more sensitive to RS virus than HeLa cells (Caul et a l,, 1974)•
RS virus can grow well in suspensions of HEp-2 and MA-160 cells 
(human heteroploid cell line derived from benign prostate cells)• 
Suspension cultures would be a good method to use in the production of 
large quantities of RS virus (Richman and Tauraso, 1971)* Using the 
RSN-2 strain of RS virus I found that it grew in HeLa, HEp-2, WI-38,
Yero and CV-1 cells but not in BHK/C^ or ^ cells (Wunner et al,, 1975)*
RS virus plaque assay
In 19639 a plaque assay using HEp-2 cells was described for 
RS virus (Long strain). This method was found to be both reliable and 
sensitive. Infected cells were incubated at 36°C and plaques first 
appeared 9 days after infection. These plaques reached their maximum 
size (2 mm in diameter) 11 to 12 days after infection (Kisch and 
Johnson, 1963). Another plaque assay also using HEp-2 cells but a 
different RS virus strain (Randall strain) was developed about the same 
time. This assay differed from the above assay in the time required
o
for the development of RS virus CPE; it was much shorter, 3 days at 37 C,
as compared with 9 days at 36°C. However, this method had a longer 
adsorption period, 12 hours at 37°C as opposed to 2 hours at 36°C in 
the above assay and used liquid instead of agar overlay. A linear 
relationship existed between concentration of virus and the number of 
syncytia formed. Secondary plaques were not thought to develop before 
76 hr after inoculation as the distribution of syncytia was Poissonian 
until that time (Taylor-Robinson and Doggett, 1963).
Although RS virus antiserum added to the overlay medium 
prevented the formation of secondary syncytia it also reduced the size 
and number of primary syncytia produced. This suggested that syncytium 
formation was not solely due to intercellular spread of virus (Taylor- 
Robinson and Dogett, 1963).
Long strain of RS virus grown in HeLa cells forms macroscopic 
plaques under agar 5 - 6 days after infection (Levine and Hamilton, 1969)•
Overlay for RS virus infected cells
DEAE Lextran (Diethylaminoethyl dextran)
DEAE dextran added to either the virus inoculum or the
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maintenance medium hasrtreported to increase RS virus infectivity by 
various amounts. Some workers found that the addition of 15 pg/ml DEAE 
dextran to the maintenance medium of RS infected HEp-2 or HeLa cells 
increased infectivity of RS virus 100 fold (Nisevich et al., 1972) 
whereas another worker only found a 2-5 fold increase in RS virus 
infectivity when 30 jig/ml and 10 pg/ml of DEAE dextran was added to RS 
virus inoculum used in HEp-2 and AGHK (African green monkey kidney cells) 
cells respectively. DEAE dextran incubated with RS virus (30 pg/ml)
at 36°C for 2 hours before inoculation increased virus infectivity 
2-fold (Normura, 1968).
Protamine sulphate
Protamine sulphate at low concentrations (5 |ig/ml) in the 
virus inoculum marginally increased RS virus infectivity; however 
higher concentrations (60 |ig/ml) can cause as much as 50% inhibition 
of infectivity. Protamine sulphate incubated with RS virus for 2 hours 
at 36°C before inoculation increased RS virus infectivity as much as 
DEAE dextran (2-fold) (Normura, 1968).
Since protamine sulphate has a different effect to DEAE dextran 
when added to RS virus inoculum, ionic charge is not the main factor 
involved in the action of polycations in increasing RS virus infectivity. 
Probably DEAE dextran complexed with RS virus particles and increased 
their efficiency of attachment by binding to cell membrane. Protamine 
sulphate could in process of binding to the cell membrane block cellular 
receptors thus restricting the attachment of RS virus particles.
However, both DEAE dextran and protamine sulphate incubated with 
the virus before inoculation increase its infectivity. This could be 
due to these polycations having a stabilising effect on RS virus particle 
(Normura, 1968).
Dextran sulphate and Heparin
Dextran sulphate and heparin in low concentrations (5 (ig/ml) 
in the virus inoculum or incubated with the virus before inoculation for 
2 hours at 36°C have an inhibitory effect on RS virus growth in HEp-2 
cells (Normura, 1968).
RS virus can be grown in the absence of CO^ if L-15 medium 
overlay is used. There was no marked difference in the type of 
plaques formed or total virus yield compared with virus grown in the 
presence of CO^ using ordinary overlay medium (Potash and Gilbertson*
1967).
RS virus infected HEp-2 cells required Eagle!s M M  overlay 
medium to have at least 18 fig/ml glutamine otherwise syncytium formation 
was totally inhibited. When sufficient glutamine was added to infected 
cultures in glutamine-free medium RS virus CPE occurred after 2 days 
irrespective of the time infected cultures were in deficient medium.
When the normal concentration of glutamine (290 jxg/ml) in Eagles MEM 
medium was reduced to 72 (ig/ml RS virus CPE was delayed although no 
reduction in virus titre occurred (Marquez and Hsuing, 1967). These 
findings are in direct conflict with previous experiments, where the 
absence or presence of glutamine had no effect on the production of 
syncytia in RS virus infected HeLa, KB and HEp-2 cells (Jordan, 1962).
Haemagglutination test
No haemagglutinins have been detected in RS virus infected 
tissue culture fluids when human type 0, guinea-pig and chicken 
erythrocytes were used (Bennet and Hamre, 1962 and Chanock _et ad., 1957 
and Peacock and Clarke, 1961). Other workers using the supernatant of 
RS virus (Randall Str) infected HEp-2 culture fluid found no haemagglut­
ination of rooster, chicken and guinea-pig erythrocytes (Beem et al., 
I960).
A thorough attempt to demonstrate RS virus haemaggLutinin was 
carried out using RS virus (Burnett Str) grown in MA-104 (embryonic rhesus
monkey kidney), MA-160 (adult human prostate), WI-38 and HEp-2 cells.
The haemagglutination test was performed at various temperatures (4?
23°and 37°C) and at a pH range of 5*8 't0 7«4 using wide range of red 
"blood cells: human type 0, rhesus monkey, African green monkey, Hartley
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guinea—pig, NIH albino rabbit, golden Syran hamster, Swiss NIH random 
bred mouse strain, Sprague-Dawley albino rats, White Rock cockerel,
White Leghorn chickens (l day old), White Embden gander, Hampshire sheep, 
and Hampshire swine. The test was carried out for 30 to 90 mins 
depending upon temperature till control cells had sedimented. No 
haemagglutinin was detected in any of the experiments (Richman ejt ad.,
1971).
Haemadsorption test
Guinea pig, chicken and human type 0 erythrocytes did not 
adsorb to RS virus infected monkey kidney cells (Beem and Hamre, 1962) 
and rooster, chick and guinea-pig erythrocytes did not adsorb to RS virus 
infected HEp-2 cells (Beem et ad., i960). More recently an extensive 
search for haemadsorption has been carried out using RS virus infected 
MA-IO4 cells when CPE was well developed (25% to 58% of cell sheet 
involved). Red blood cells (RBC) from more than one animal of the same 
species were tested separately to avoid variation in sensitivity to RS 
virus infected cells which might occur between animals. The RBC’s used 
were from rhesus monkey, African green monkey, chimpanzee, gelada, guinea- 
pig, rat, hamster, Swiss NIH inbred strain mouse, NIH^- CFW white strain 
mouse, Pekin duck, goose, White King pigeon, cockerel and one-day old 
chickens (pooled). However haemadsorption could not be detected in any 
of the tests (Richman et al.. 1971)*
Neuraminidase
It has been reported that RS virus has no neuraminidase; 
however no experimental results in support of this claim have been 
presented (Waterson and Hobson, 1962).
Cell Fusion
Using various intravital stains such as janus green (for 
chondriome), neutral red (for vacuoles) and trypan blue (for dead cells) 
as well as phase contrast microscopy alterations in RS virus infected 
cell chondriome and vacuoles were followed.
Cell chondriome alteration was suggested to be induced by 
virus penetration of the cell. During the first 20 hours after infection 
cell chondriome became swollen, and later towards the end of the RS 
virus replication cycle disappeared as RS virus syncytia were formed. 
Syncytia can be seen as early as 16 hours after infection although most 
develop later. RS virus infection of cells does not destroy the nuclei 
(Wilczynski, 1971)- The nuclei stay on the periphery of RS virus 
syncytia (Kisch et al., 1962 and Wilczynski, 1971) whereas in measles 
virus syncytia the nucleus stay in the centre. (Klone et al., 1966). 
However the alterations in cell chondriome and vacuoles were similar to 
those occurring during myxovirus infection (Wilczynski, 1971)*
It has been reported that the formation of RS virus syncytia 
resulted in total inhibition of alkaline phosphatase activity in the 
cytoplasmic membrane and the complete loss of nuclear histones. An 
accumulation in the amount of phospholipids and a concentration of 
lysosomes in the middle of syncytia were also reported (Bonissol, 1966).
RS virus infection of cells can induce cell fusion. Polykaryocytes 
developed in HEp-2 cells 16-18 hours after RS virus infection. This 
was followed by lysosomal activation which preceeded cell fusion.
Pretreatment of cells with hydrocortisone hemisuccinate, a lysosome 
stabilising agent, reduced the amount of RS virus induced cell fusion. 
Polykaryocytes were still produced but they were smaller and had fewer 
nuclei (Greenham and Poste, 1971; Poste, 1971a and Poste, 1971b).
Physical properties of RS virus
Density of RS virus particle and complement-fixing antigen
Initially it was shown that RS virus infectious particles 
could be separated from soluble complement-fixing (CF) antigen by 
differential centrifugation (30,000 rpm/45 min). The CF antigen was 
recovered from the supernatant fluid while the pellet contained 90% of 
the recoverable infectivity (Chanock et al., 1957)* Further experiments 
were performed to separate and identify components of RS virus soluble 
CF antigen.
The tissue culture fluid from RS virus (Long and 1853^'Strains) 
infected cells (HEp-2, BEK) was concentrated by vacuum dialysis and used 
in the experiments. Most of the infectious RS virus (90%) from 
concentrated RS virus tissue culture fluid was recovered at a density of
1.22-1.24 g/ml after CsCl equilibrium centrifugation, whereas using 
unconcentrated RS virus fluid the infectivity was recovered at a higher 
density (1.25-1.27 g/ml). There was no difference in the density of 
virus particles between different strains of RS virus using this method. 
The complement-fixing (CF) antigen activity was detected in density range
1.23-1.37 g/ml in CsCl gradient (Coates et al., 1966).
Other workers have also reported similar results using 
concentrated RS virus material in CsCl equilibrium density gradients. 
Infectious particles had a density 1.21-1.23 g/ml and the CF antigen a 
density range 1.25-1.34 g/ml. Two populations of particles were found 
when RS virus concentrate of material was examined by discontinuous CsCl 
gradient. The rapidly sedimenting particles had most of the virus 
infectivity as well as 10% of the total CF activity associated with them, 
whereas the remaining CF antigen activity was associated with the slower 
sedimenting particles (Bloth and Norrby, 1966)•
Soluble CF antigenic material from RS virus infected tissue 
culture fluid can be separated by G200 Sephadex column chromatography 
into two fractions (A and B). Specific antibodies to A or B were 
produced in guinea-pigs inoculated with A or B respectively. Antigen A 
was found to have a density of 1.28-1.32 g/ml and Antigen B a density 
of 1.34-1*37 g/ml in a CsCl equilibrium density gradient. Guinea-pigs 
immunised with antigen A developed CF antibody to antigen A and neutral­
ising antibody, whereas those inoculated with antigen B only developed 
CF antibody to antigen B. There was no difference in density between 
antigen A and B when RS virus culture fluid was centrifuged to 
equilibrium through preformed sucrose gradient. Therefore the difference 
in density seen in CsCl gradients could be due to the difference in
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reaction to caleium ions rather than actual difference in density.
The density of antigen A in CsCl (1.28-1.32 g/ml) indicates 
that it could probably be the virion coat antigen. Antigen B is 
probably a component of the virion since it can be released from intact
particles by ether-Tween treatment. However, it is unlikely to be 
associated with the surface of the virion as it does not induce 
neutralising antibody. Human serum reacts equally well with Sephadex- 
purified antigens A and B; however the main distribution of CF antigen
activity reacting with human serum was found at a lower density (1*23 g/ml)
which suggests the presence of a third antigen (Coates et al., 1966 and 
Forsyth et ad., 1966). Tween 80-ether treatment of RS virus destroyed 
all virus infectivity but not complement-fixing activity (Bloth and 
Norrby, 1966). Antigen A was not sensitive to Tween-ether treatment 
whereas antigen B was very sensitive (Forsyth et al., 1966).
Identification of RS virus antigens by agar gel diffusion
and electrophoresis
Sephadex-purified antigens A and B each produced only one 
precipitin line when examined by agar gel diffusion. The serum of guinear- 
pigs inoculated with either antigen A or B only produced on precipitin 
line when tested. Concentrated (200 - fold) RS virus infected tissue 
culture fluid gave only two precipitin lines on agar gel diffusion 
(Forsyth, 1970)* However other workers on examination of serum from RS 
virus infected animals and RS virus material have detected three precipitin 
lines by agar gel diffusion (Berglund, 1967; Chanock and Parrott, 1965 
and Manyjarvi et al., 1967). Precipitin lines (A and B) produced by 
sera with antibodies to A and B have different electrophoretic mobilities. 
The precipitin line corresponding to antigen A moves towards the cathode 
whereas B remains close to the point of application. When human RS virus 
convalescent serum was examined by electrophoresis, only two antigens 
were detected, no third antigen was found (Forsyth, 1970)»
Factors affecting RS virus stability
Thermolabili ty
RS virus is very thermolabile. Hambling (1964b) reported that
it loses infectivity rapidly at 55°C, only 10% of the virus survived for 
5 minutes. Rechsteiner (1969a) using partially purified RS virus in 
distilled water showed a linear relationship between the logarithm of 
the inactivation rate constant and the reciprocal of the absolute 
temperature from 50°C to 37°C below this temperature there was no linear 
relationship. In earlier experiments with crude virus preparations 
(Beem £t al., i960; Bennet and Hamre, 1962 and Hambling, 1964b) the 
inactivation rates were lower probably due to the presence of stabilising 
agents in the tissue culture fluid used as a source of infectious virus 
(Rechsteiner, 1969a).
RS virus stored at -70°C or below is stable (Jordan, 1962; 
Rechsteiner, 1969a and Rowe and Michaels, i960). However RS virus 
stored at -20°C is inactivated more rapidly than at room temperature 
(Wulff et al., 1964b).
Sensitivity to freezing and thawing
It has been general experience that RS virus can more easily 
be isolated from fresh rather than frozen material as it is sensitive 
%o freezing-thawing especially if frozen slowly (Beem e t al., I960; 
Chanock et al., 1961; Hambling, 1964b and Holzel et al., 1963)*
However if RS virus is frozen rapidly and stored at -70°C or below, a 
single cycle of freeze-thawing may even enhance RS virus infectivity 
(Jordan, 1962 and Rechsteiner, 1969a).
The effect of serum concentration on the stability of RS virus
Hambling (1964b) found, that increasing the concentration of 
heat-inactivated rabbit serum from 5% to 45% in HS virus suspensions did 
not protect RS virus against loss of infectivity at 4°C or -65°C.
However, 45% serum showed a slight protective effect at -30°C.
The effect of pH
Jordan (1962) reported that RS virus growth was better in 
alkaline than acidic medium. Other experiments confirmed this finding 
as RS virus was found to be most stable at pH 7*5* If the deviated 
from this value RS virus lability increased especially if pH was lowered 
(Hambling, 1964b).
The effect of salt concentration
The concentration of different salts in RS virus suspensions 
affected the stability of the virus.
Partially purified RS virus in distilled water was protected 
against heat inactivation at 30°C* 20°C and 10°C by the addition of 
molar amounts of NaCl, MgSO^, NagSO^ and sodium phosphate. Protection 
decreased with decreasing molarity and no protection was given to RS 
virus by 0.1M solutions of these salts (Rechsteiner, 1969a).
Other experiments using RS virus in 0.1M tris buffer (pH 8) 
also showed that the addition of 1M NaCl protected RS virus against 
inactivation. The stabilising effect obtained by addition of 2M NaCl,
2M MgSO^ or 2M NagSO^ to RS virus suspension was similar to that obtained 
by addition of lM NaCl (Yamamoto, 1969). However, RS virus in distilled
water was not protected by addition of 1M MgClg (Rechsteiner, 1969a) 
whereas some protection was given to RS virus in 0.1M tris buffer by 
addition of MgCl^ (Yamamoto, 1969).
The effect of glucose and sucrose
Glucose (1M) had a similar effect to 1M NaCl in the protection 
of RS virus against heat inactivation except that its effectiveness was 
not reduced by decreasing the temperature to 0°C (Rechsteiner, 1969a).
Sucrose (44*5%) also had the same stabilising effect on RS 
virus suspensions as 1M NaCl (Yamamoto, 1969). It preserved RS virus 
infectivity for at least 2 years when the virus was stored at -70°C or 
below (Law and Hull, 1968).
The effect of lecithin
Lecithin enhanced RS virus inactivation at 10°C and 20°C as 
the virus in lecithin suspensions was inactivated more rapidly than the 
controls (Rechsteiner, 1969a).
The effect of skim milk
Bennet and Hamre (1962) reported that the addition of skim 
milk (20%) to RS virus culture fluids preserved the virus infectivity 
for at least 30 days at -40°C and longer at -60°C.
The survival of RS virus in aerosols
The inactivation of RS virus in aerosols has been studied at 
different relative humidities. Two inactivation mechanisms are 
possibly involved since two peak rates of inactivation occurred.
However, oxidation is not the cause of the inactivation since the same 
experiments in an atmosphere of pure Ng gave similar results (Rechsteiner 
and Winkler, 1969 and Rechsteiner, 1969b).
Cytochemical studies
Eosinophilic intracytoplasmic inclusions are more frequently 
found in syncytia than in single cells (Adams et al., 1961a; Bennet and 
Hamre, 1962 and Kisch £t al., 1962).
Acridine Orange
In one experiment acridine orange stained perinuclear RS virus
inclusions red (Levine et al., 1971)» in other experiments acridine
orange stained RS virus inclusions green (Berthiaume et al,, 1974»
Bonissol, 1966 and Corbitt and Beswick, 1972) whereas in yet other
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experiments no staining of inclusions occurred (Homoloth et al., 1969» 
Kisch et al., 1962 and Paccaud and Jacquier, 1971)• II single-stranded 
RNA was present in the inclusions acridine orange would stain them a 
bright orange-red colour. Green fluorescence with acridine orange 
staining indicates that the inclusions contain denaturated nucleoprotein 
(Bonissol, 1966), DNA or double-stranded RNA (Corbitt and Beswick, 1972). 
Enzyme digestion (RNase and DNase) did not remove the green coloration 
from the RS virus inclusions, neither did hot t r i o °acid (TCA) 
treatment. Therefore, the green fluorescence is probably due to acridine 
orange binding to protein (Corbitt and Beswick, 1972).
Methyl green-pyronin
When RS virus infected cells were treated with methyl green-
pyronin the inclusions stained deep pink. This suggested the presence 
of RNA especially since pretreatment of a fixed cell preparation with 
RNase before staining prevented coloration of the inclusions. DNase 
had no effect on the staining of the inclusions but hot TCA removed 
the stain. This indicated that RNA if present was mostly in the 
single-stranded form (Corbitt and Beswick, 1972). However, Bonissol 
(1966) using the methyl green-pyronin staining technique did not find 
RS virus inclusions stained, whereas parainfluenza types 2 and 3 
inclusions stained red.
Immunofluore scence
Levine and his colleagues (1971) detected RS virus specific 
immunofluorescence in infected HEp-2 cells from adsorption onwards; 
only 8-10 hours after infection could specific fluorescence be detected 
in the perinuclear inclusions. However, other workers did not detect 
RS virus specific antigen in HEp-2 cells to between 8 and 12 hours after 
infection (Bennet and Hamre, 1962; Berthiaume ejt al., 1974 an<l Kisch 
et al., 1962 and Nagahama et, al., 1974)•
Cytoplasmic inclusions which can be stained by haematoxylin and 
eosin have been reported to be both different from (Nagahama et al.,
1970 and Paccaud and Jacquier, 1970) and similar to (Bennet and Hamre,
1962 and Levine rt al., 1971) the inclusions detected by immunofluorescence.
Electron microscopic studies of RS virus
RS virus is very pleomorphic, both filamentous and spherical 
particles can be detected. The difference in size of particles seen is
outlined, in Table 4* The variation in size of the RS virus virion may 
be due to the different techniques used as the virion could be distorted 
as a result of osmotic pressure or centrifugation (Bloth et al., 1963). 
Incomplete virus particles, i.e. without a nucleocapsid, were predominant 
when concentrated RS virus culture fluid and thin sections of infected 
Vero cells were examined (Bachi and Howe, 1973)•
The RS virus nucleocapsid is fragile and has a tendency to 
unwind. Its diameter has been reported to be various sizes ranging from 
12 run (Bloth and Norrby, 1965) ^7 nm (Bloth and Norrby, 1967) (see
Table 4)* However, some workers found that by avoiding harsh treatments 
such as concentration of RS virus by centrifugation and dialysis, they 
could obtain reproducible results for the diameter of the RS virus 
nucleocapsid, 13.5 nm (Berthiaume et al,, 1974; Joncas et al., 1969 and 
Zakstelskaya £t al., 1967).
RS virus envelope projections have been reported to be of 
varying lengths, ranging from 10 nm (Bachi and Howe, 1973) to 17 nm (Bloth 
et al., 1963). Bloth and Norrby (1965) considered these projections to 
be similar in size and shape to the haemagglutinin spike of NDV. When 
RS virus is grown in the presence of 10 mM 2-deoxy-D-glucose (2dG) virions 
are produced in fewer numbers and without projections. This seems to 
indicate that 2dG inhibits the formation of RS virus projections (glyco­
proteins) (Hodes et al., 1975)*
No nuclear inclusions have been seen in thin sections of RS 
virus infected cells (Kalica et al., 1973* Kisch et al., 1963 and Norrby 
et al., 1970) with the exception of one report of nuclear inclusions in 
RS virus infected HeLa cells (Armstrong et al.. 1962). If the nucleus
is involved in RS virus infection, its role cannot be essential since 
RS virus grows in enucleate BSC-1 cells (Pollett et al., 1975)* Two 
types of cytoplasmic inclusion have been observed; the paranuclear 
fibrillar inclusions and denser, more granular inclusions (Armstrong 
et al., 1962; Berthiaume et al., 1974» Kalica et al., 1973 and- Norrby 
et al., 1970). RS virus buds from the cytoplasmic and vesicular 
membranes about 15 hours after infection. The RS virus particles 
usually contain 4-5 granules per particle. Inclusions are usually 
detected at the same time or a few hours earlier than budding (Bachi 
and Howe, 1973» Berthiaume et al.. 1970; Norrby et al.. 1970).
Some workers have reported that free RS virus nucleocapsids 
have a herring-bone pattern similar to that seen in the nucleocapsids 
of paramyxoviruses (Bachi and Howe, 1973 and Bloth and Norrby, 1967). 
However, Berthiaume and his colleagues (1974) have reported that RS virus 
nucleocapsids were arranged in straight parallel fibres in the virion. 
This is different from the superhelical arrangement seen for the nucleo­
capsids of the ortho- and para- myxoviruses.
TABLE 4
Electron microscopic studies of RS virus
Method of 
Preparation
Virion
Diameter
(nm)
Nucleocapsid
Diameter
(nm)
Projection
Length
(nm)
Reference
Sedimentation on 
sucrose*
Particle diameter 
estimated from 
formula*
Long strain used.
90-130 ND ND Chanock 
et al •, 
1957
Thin section 
RS virus (Long) 
infected HeLa 
cells.
Spherical 
particle 
65 nm
Filamentous 
particle 
60-70 nm
ND ND Armstrong 
et al,, 
1962
Negative Staining 
2% PTA
(1) Clarification 
virus material
(3>000 rpm for 
30 mins)*
(2) Concentration 
by forced dialysis
(3) Centrifugation 
on 30% sucrose
or centrifugation 
at 20,000 rpm for 
1 hour*
Long strain used.
Spherical and 
filamentous 
particles. 
90-860 
Average 340
ND Club-shaped
13-17.
width 4-7 
centre to 
centre 
distance
7-9
Bloth 
et al,, 
1963
Negative Staining Tween 80 and Free 12-16 
PTA ether treated nucleocapsid resembled
(1) PEG concentration virus - from dis- HA spikes
(2) Centrifugation Rosette-like rupted of NDV 
20,000 rpm/60 min particle particles and Sendai 
on CsCl density 5°-70 virus 
gradient average 60 10-12
(3) Material used pitch 7 
or treated Tween 80
and Ether
Long strain was used
Bloth and 
Norrby,
1965
TABLE 4 (contd)
Method of 
Preparation
Virion
Diameter
(nm)
Nucleocapsid
Diameter
(nm).
Projection
Length
(nm)
Reference
Negative Staining 
2% PTA
(1) Virus material 
frozen and thawed 
or homogenised
(2) Low speed 
centrifugation
(3) Concentration 
by ultra­
centrifugation 
41, 190 x g for 
30 min
Long strain used
spherical
particles
150
filamentous
particles
13-18 
nucleocapsid 
material 
from dis­
rupted 
particles
ND Eckert 
et al.,
1965
Negative Staining 
STS and PTA
(1) concentration 
by forced dialysis
(2) clarification 
low speed centri­
fugation
(3) centrifugation 
in discontinuous 
CsCl gradient 
Long strain used
ND 16-18 
estimated 
diameter of 
20 intact 
nucleocapsids 
Herring-bone 
like structure 
Pitch 7
ND Bloth and
Norrby,
1967
Negative Staining
(1) low speed 
centrifugation 
f3*000 rpm/5 min)
(2) cells kept and 
suspended in 
distilled water 
and allowed to 
disrupt.
Stain 3% PTA.
Long strain of RS 
virus was used.
80-100
spherical
and
filamentous
forms.
Rosettes
also
seen
Helix
herring-bone 
arrangement 
just seen -
13.5
15 Zaks tel skaya 
resemble et al., 
projections 1967 
of avian 
infectious 
bronchitis 
virus
TABLE 4 (contd)
Method of Virion Nucleocapsid Projection Reference
Preparation Diameter Diameter Length
(nm) (nm) (nm)
Negative Staining
(1) Centrifugation 
at low speed
(2) Sediment 
freeze-thawed or 
given hypotonic 
shock.
Stain 3% PTA
Supernate of 
high speed 
centrifugation
30,000 rpm/l hr 
also used.
Three newly isolated 
strains of RS virus 
were used
Spherical,
filamentous
and
pleomorphic
particles.
80-500
spherical
100-350
Nucleocapsid 
more delicate 
flexible and 
narrower than 
that of 
Parainfluenza 
type 2 
1%5
range
12.5-15
15 Joncas 
et al.,
1969
Thin Section 90-130 11-15 12-15 Norrby
RS virus (Long) et al.,
infected Vero Filamentous 1970
cells forms 100-130 
length 2 nm
Thin Section 
RS virus (Long) 
infected Vero cells
Negative Staining
(1) infected 
culture fluid 
centrifuged 
120,400g/60 min
at 4°C onto cushion 
of 55% sucrose
(2) sucrose 
removed by 
overnight dialysis 
Stain 2% PTA
Spherical 
particles 
Av. 150-250 
range 150-500 
Filamentous 
particles 
90-100
length 1-4 mp. 
some 10 mji 
seen
15
herring­
bone
pattern
10 Bachi and 
Howe,
1973
TABLE 4 (contd)
Method of 
Preparation
Virion
Diameter
(nm)
Nucleocapsid
Diameter
(nm)
Projection
Length
(nm)
Reference
THIN SECTION 
RS virus (A2) 
infected HeLa 
cells
Spherical and 
filamentous 
particles 
8O-I4O length 
of filaments
2 mji
11-15 11-120 Kalica 
et al• f
1973
THIN SECTION 
RS virus (Long) 
infected HEp-2 
cells
Negative
Staining
Spherical
particles
100-550
13.5
pitch 6.5 
centre to 
centre 
length 10
12
club-
shaped
Berthiaume 
et al,,
1974
Negative Staining 
Infected cells 
pelleted 450 g 
for 10 mins
Filamentous 
particles 
60-110 
Length 5 ni|i
Thin section 
12
Thin
Section
12
Pleomorphic
particles
80-500
Thin Section 
spherical or 
filamentous 
particles 
100 nm in 
diameter
1.4*3 RS virus nucleic acid
Intracellular RNA
Although on indirect evidence (e.g. ether sensitivity, 
resistance to mitomycin C, growth in enucleate cells) RS virus appears 
to be an RNA virus, the virion RNA has not yet been isolated,
3
In uninfected HeLa cells labelled with ^H-uridine the main 
species of RNA detected were 28S, 18S and 4S, whereas in RS virus 
infected cells cellular RNA synthesis was depressed and the major species 
detected was 4S RNA.
In experiments using actinomycin D (5 |ig/ml) the incorporation
3
of 'H-uridine into RS virus infected cells was poor. However, 
reproducible peaks of radioactivity could be detected. In RS virus 
infected HeLa cells, 24 hours after infection, a peak was detected at 
10S; 36 hours after infection when maximum incorporation of label
occurred two peaks were seen, one at 10S and one at 28S respectively.
No heavier RNA species was detected although the characteristic size of 
paramyxovirus virion RNA's is 50S. The nucleic acid detected in RS 
virus infected cells was mainly single-stranded RNA since most of the 
radioactivity of the sample disappeared on alkaline hydrolysis or N. Crassa 
nuclease treatment (Hodes e_t al., 1974b) •
3
The RNA in RS virus infected BS-C-1 cells labelled with ''R-
uridine in presence of actinomycin L (2.5 |ig/ml) was heterogeneous, with
the major species sedimenting at 16S and a minor species sedimenting at
3
approximately 50S. The main RNA species detected in ^H-uridine labelled 
partially purified RS virus were at 16s and 4S. When RS virus infected
3cells labelled in presence of actinomycin D with H-uridine were co­
extracted with "^C-uridine labelled uninfected cells using SDS-phenol 
method, the main species found in infected cells was 4S RNA with small 
amounts of I3-I6S, 25-28S and approximately 50S RNA (Wunner et al., 1975)•
Inhibition of viral RNA synthesis in RS virus infected cells
Indirect methods have been used to detect the period in the 
RS virus growth cycle when synthesis of viral RNA occurred. The uridine 
analogues, 6-azauridine (6-AU) and 2-thiouridine (2TU) prevent viral RNA 
synthesis. The effects of these inhibitors on RS virus growth was 
studied by their addition at different times after adsorption to RS virus 
infected cells. When 6-AU (10 |ig/ml) or 2TU (50 lag/ml) were added 2 
hours after adsorption no RS virus was produced. However if they were 
added any time between 5 and 18 hours post—infection some RS virus 
production occurred. Therefore, RS virus RNA must have accumulated in 
the cells during this period since it was available for virus production 
after the addition of inhibitors of RNA synthesis. The curves for 
virus production and viral RNA synthesis were parallel, the curve for 
viral RNA synthesis being 5 hours ahead (Levine and Hamilton, 1969 and 
Levine et al., 1971).
The data indicated that synthesis of RS virus RNA started 5 
hours after infection (Levine and Hamilton, 1969). This was supported 
by a fluorescent photometry experiment which reported an increase in RNA- 
content of RS virus infected cells 4 hours after RS virus infection.
An increase in the DNA-content of RS virus infected cells 10 hours after 
infection was also noted (Augusten, 1974)• In phenylalanine deficient
36
medium RNA synthesis in RS virus infected cells occurred at the same rate 
as in normal medium (Levine et al., 1971)
Inhibitors of DNA-dependent RNA synthesis
Actinomycin I)
Hornsleth (1969) found that low concentrations of actinomycin D 
(0.04 M-g/ml) did not inhibit RS virus replication when added together
with the virus or 1 hour before, 3 hours after or just after adsorption
of the virus. Pretreatment of the HEp-2 cells with actinomycin D 
(0.04 jig/ml) for 24 hours reduced the RS virus yield at 44 hours post 
infection but it also reduced the number of cells present by about 50%* 
Therefore, the effect of actinomycin D on the cells as well as the virus 
must be considered. Other workers found that actinomycin D (0.05 - 
0*5 Jig/ml) when added 1 hour before infection and present until the virus 
harvest reduced RS virus yield at 72 hours but enhanced it at 24 hours 
after infection (De Jong and Harmsen, 1973)* Formica and his colleagues 
(1969) found that RS virus replication was inhibited in the presence of 
0.1 to 2.0 (ig of actinomycin D/ml. Therefore the effect of actinomycin
D on RS virus growth appears to be variable.
Proflavine
Proflavine has been found to be more effective in inhibiting 
DNA polymerase activity than DNA—dependent RNA polymerase activity, 
unlike actinomycin D which has been found more effective in inhibiting 
DNA—dependent RNA synthesis (Hurwitz et al., 1962). Hornsleth (1966 ,^) 
reported that proflavine (0.05 - 2 |ig/ml) reduced the RS virus growth 
cycle in HEp-2 cells. The acceleration of virus growth on the addition
of proflavine was suggested to be the result of the inhibition of 
cellular RNA and protein synthesis by proflavine. Riboflavine (0.5 
5 (ig/ml) can reverse the effect of proflavine on the RS virus growth 
cycle.
1,4*4 RS virus proteins
Viral polypeptides
5
RS virus grown in HEp-2 cells and labelled with ^H-amino 
acid was purified and analysed by SDS-polyacrylamide gel electrophoresis 
(PAGE). Seven polypeptides ranging in molecular weight from 26,500 "to
90,000 were reported.
HEp-2 intracellular proteins from infected and uninfected 
cells were examined at 56 hours post infection. The number of newly 
synthesised proteins associated with the mitochondrial and microsomal 
subcellular fractions was markedly reduced in infected cells compared to 
uninfected cells. However most of the newly synthesised proteins 
produced by the infected cells which were associated with these fractions 
had similar electrophoretic mobilities to the virion polypeptides. The 
profile of proteins associated with the soluble fraction of infected and 
uninfected cells was similar and there was no relationship between these 
proteins and viral synthesis (Treuhaft and Beem, 1972)*
35When RS virus grown in BS-C-1 cells and labelled with ^S-
methionine was analysed by PAGE nine to ten polypeptides, six consistently,
could be detected. The same number and size of polypeptides could also
be detected using a discontinuous -SBS-PAGE system (Wunner and Pringle,
in preparation). In previous experiments using partially purified RS
virus (high speed centrifugation and isopycnic banding in sucrose gradient)
labelled in the presence of actinomycin D, five major and several minor
polypeptides were detected. The proteins extracted from cells simultan-
14 3eously labelled with ^C-leucine and 'H-arginine had a high ratio of
arginine to leucine incorporation. This could explain the requirement 
of arginine for RS virus production (Wunner et al.f 1975)* I*1 these
experiments the molecular weights of the viral polypeptides were 
calculated on the basis of comparison with vesicular stomatitis virus 
(VSV) structural protein markers. The molecular weights of the RS 
virus polypeptides ranged from 48,000 to 2^000daltons (see Table 5)*
Some of the polypeptides have been tentatively assigned 
functions, for example polypeptide VP48 (48,000 daltons) has been 
suggested as the glycosylated membrane protein. Nucleocapsids can be 
obtained by treatment of RS virus concentrated material with Triton X-100 
followed by centrifugation of this treated material in a metrizamide 
density gradient (15-45%)* Tbe nucleoprotein peak contained polypeptide 
VP^ and polypeptide VP^g and some small amounts of higher molecular 
weight polypeptides. The nucleocapsids banded in CsCl density gradient 
at 1.3 g/ml which is similar to the density of Pneumonia virus of mice 
(PVM) (Compans et al,, 19^7) and. paramyxovirus nucleocapsids (Wunner 
and Pringle, in preparation).
Other workers using polyethylene glycol (PEG) concentrated RS
virus have reported that on treatment of this material with SDS (0.5%)
followed by centrifugation on a sucrose gradient (30-70%) two bands are
detected. These bands had densities of 1.27 g/ml and 1.19 g/ml in 
3
sucrose. H-uridine was incorporated into the heavier of these bands
3
which was suggested to be composed of nucleoprotein, whereas 'H-lysine 
was incorporated into the band which was suggested to be composed of 
protein (Senterfit and Balridge, 1974)*
TABLE 5
Summary of data abstracted from Wunner and Pringle, in preparation
Poly­
peptide
Molecular 
weight 
(daltons)
Glycosyl-
ation
Function
*
VP48 48,000 + Major polypeptide probably
spike protein (g)
VP
41
41,000 - Major polypeptide probably
nucleocapsid protein (N), 
bands 1.22-1.38 g/ml in CsCl 
gradient
COK\
> 38,000 - Minor polypeptide associated
with nucleocapsid polypeptide
VP
31
31,000 - Major polypeptide function
not known
VP27 27,000 - Probably matrix polypeptide
(M)
VP25 25,000 - Minor polypeptide function
not known
p pr 2
p*p/ 3 4
> 48,000 *?
High molecular weight 
polypeptides present in 
small amounts - could be 
cellular
The effect of inhibitors of glycoprotein synthesis
The glucose analogue, 2-deoxy-D-glucose (2-dG) has been shown
to have an inhibitory effect on the growth of some enveloped viruses;
for example influenza A (fowl plague), Sindbis, Semlike Forest, and 
herpes simplex virus. Experiments have indicated that 2-dG appears to 
specifically inhibit the maturation of surface glycoproteins (Courtney 
et al., 1973» Kaluza e_t al., 1973 and. KLenk et al., 1972).
The replication and cytopathic effect (CPE) of RS virus as well
as parainfluenza virus type 3 (para 3) and measles virus was inhibited 
in the presence of 2-dG (l mM or higher concentration). However the 
effect of 2-dG was reversible. The inhibitory effect of 2-dG occurred 
from 12 hours post-infection onwards. Although the presence of 2-dG 
in virus cultures caused a reduction in the amount of complement-fixing 
antigen produced (4-fold) some antigens, for example the immunofluorescent 
antigen, were not inhibited. When 2-dG was removed from RS virus 
cultures in the middle of the virus cycle (17*5 hours), exponential 
growth of the virus occurred after 4 hours. This short latent period 
indicated that early virus products probably accumulated during the 2-dG 
block since mature virions were released more quickly than normal when 
the block was removed.
It is unlikely that 2-dG directly affects the cell surface 
since pretreatment of cells with 2-dG and treatment during the virus 
adsorption period did not inhibit virus multiplication or CPE. Electron 
microscopic studies with RS virus ts-2, showed that virions produced in 
the presence of 2-dG had no spike-like projections. This indicates that 
2-dG appears to act on RS virus by the inhibition of formation of surface
glycoproteins. Other workers have found this effect of 2-dG with 
different viruses, for example influenza A (fowl plague) (Klenk et al.,
1972 and Scholtissek, 1974)* However, not all enveloped viruses are 
inhibited by 2-dG, for example vesicular stomatitis virus (VSV) and 
Newcastle disease virus (NDV) replication were not affected. It has 
been suggested that this could be due to poor incorporation of 2-dG into 
VSV or NDV infected cells or that defects in the processing of viral 
glycoproteins in these viruses do not prevent the formation of infectious 
virus particles (Scholtissek, 1974)*
The effect of inhibitors of energy generating systems on
HS virus growth
Oxidative phosphorylation appears to be involved in RS virus 
replication as dinitrophenol (DNP), an uncoupling agent, causes marked 
inhibition of RS virus growth. However, the normal functioning of the 
TCA cycle does not seem to be essential for RS virus replication since 
sodium fluoroacetate and sodium malonate had no inhibitory effect.
Sodium fluoroacetate inhibits aconitase, an enzyme which catalyses the 
oxidation of citric acid and sodium malonate inhibits succinic dehydrogenase, 
an enzyme which catalyses the oxidation of succinic acid to fumaric acid 
in TCA cycle.
RS virus replication could involve glycolytic pathways since 
sodium iodoacetate inhibited RS virus production. However, since RS 
virus did not grow in HEp-2 cells in an atmosphere of 5% carbon dioxide 
and nitrogen, aerobic glycolysis rather than anaerobic glycolysis would 
seem to be involved (Hornsleth, 1966b).
1.4.5 Genetics of RS virus
Isolation of ts mutants of RS virus (Gharpure ejt al., 1969)
Four conditional-lethal ts mutants (ts Al, _ts A2, ts A3, .ts A4) 
of RS virus (a2 strain) on bovine kidney (BK) cells from plaque purified 
virus grown in the presence of 5“,Plur°uridine (10"”^ M). The frequency 
of isolation of these tjs mutants was low (0.8%) and their restrictive 
temperature was 39°C. Some of the jbs mutants did not produce infective 
virus at 39°C (ts Al, _ts A4) whereas other jts mutants (ts A2, ts A3) 
grew to a limited extent. The progeny obtained at 39°C did not produce 
plaques at that temperature and therefore represented "leakage'*. Ts A2 
was more "leaky" than t£3 A3 since its growth was only reduced 16-fold 
at 39°C in contrast to 100-fold for ts A3* None of the tsi mutants
produced plaques at 38°C and ts A2 and jts A4 did not produce plaques at
37°C. Ts Al and jbs A3 did produce plaques at 37°C although there was 
a 100-fold decrease of their plaquing efficiency at that temperature.
The plaques formed at 37°C were smaller, half the size, than plaques 
formed at 32°C.
It was suggested by Gharpure and her colleagues (1969) that 
spontaneous l^s mutants of RS virus were rare, since no jbs mutants were 
isolated from the survivors (249 plaques) of Nitrosoguanidine (NTG) 
treatment. Plaque purified RS virus was treated with NTG (100 (ig/ml) 
for 15 minutes at room temperature and NTG was then removed by dialysis.
Other t^ mutants of RS virus were isolated from different
treatments. Ts A5 and t£ A6 were isolated from the progeny of virus
•*2 Sgrown in the presence of 5-Pl^o^acil (10~ #^ M) whereas j^ s A7 was
isolated from virus exposed to ethylmethanesulphonate (EMS). Two of 
the new mutants (ts A6, _ts A7) resembled ts_ A3 in that they grew to a 
limited extent at 39°C whereas the other mutant, ts A7 did not grow 
at 39°C. One of the seven ts mutants (ts A2) did not produce 
characteristic syncytial plaques on BK and HeLa cells. This mutant 
produced non-syncytial plaques which consisted of an area of pyknotic 
cells. BK cell line was used for the isolation and initial growth of 
the jbs mutants since it was a suitable cell line for RS virus growth for 
vaccine production. However, RS virus produced very small irregular 
plaques on BK cells from which it was difficult to recover virus. 
Therefore, HeLa cells were used for characterisation of the ts mutants 
since they gave better CPE and grew to higher titre in these cells 
(Wright et al., 1973).
Whether the RS virus ts_ mutants isolated were the result of
single or double step mutation is not known. The low frequency of
isolation of the ts mutants (0.8%) coupled with the low concentration of
5-Fluorouridine used would suggest that single-step mutation was likely.
-5However, the in vitro stability, i.e. low reversion frequency 10 to
_7
10 , of the ts mutant might indicate that they have more than a single
change in the nucleotide sequence.
The method used for isolation of the ts mutants would favour 
the more stable mutants since virus from each plaque was grown in BK 
cells before screening for plaquing efficiency at permissive (32°C) and 
restrictive (39°C) temperatures. Therefore, if any single step mutants 
with high reversion frequencies occurred they would not be detected by 
this method since they would appear to be wild type on screening 
(Gharpure et al., 1969).
Complementation between ts mutant of RS virus
Yield complementation tests for RS virus jts mutants were 
performed in HeLa cells infected at 39°C with mixtures of RS virus ts 
mutants at a multiplicity of infection (moi) of 5-10 pfu/cell for each 
mutant. The seven _ts mutants examined were found to form three mutually 
exclusive complementation groups -
Definite complementation occurred between group A (ts Al, _ts A3, ts A4) 
ts mutants and the group C (ts A7) ts mutant. Ts A7 complemented each 
of the other ts mutants to give an increase (11 to 210-fold) in yield 
at 39°C.
In mixed infections between group B (ts A2) and other ts mutants, 
a significant increase (83-fold) in the yield of syncytial virus occurred. 
However, because _ts A2 was so "leaky" it was difficult to know if true 
complementation was occurring. If _ts A2 had the same genetic lesion as 
either or both of the other complementation group mutants, it could be 
"leaky" enough to allow the _ts mutants of these groups to grow at the 
restrictive temperature (39°C). Therefore a "plate complementation" 
test using HEp-2 cells was used, based on the principle that single 
infections of t£ mutants at 39°C produced no plaques, whereas if 
complementation occurred between two mutants at 39°C plaques would be 
produced. Using this system jbs A2 was found to complement with t£ mutants 
of group A and group C. Complementation also occurred between group A 
and. group C, but not between the ts mutants included in each group.
Although the seven _ts mutants formed three mutually exclusive 
complementation groups it was suggested that this does not necessarily
mean that these _ts mutants contained single genetic lesions since their 
stability would indicate the opposite to be the case (Wright et al*, 1973)*
Absence of recombination between _ts mutants of RS virus
Recombination tests were performed in HeLa cells infected with 
single its mutants and crosses of tsi mutants and incubated for 20 hours at 
32°C. The progeny virus was thenplated on HeLa cells and incubated at 
39°C and 32°C. "Recombination" was noted between ts A2 and te Al, ts A3 
and ts A4- However the frequency of recombination was found to be 
dependent on the temperature control of the plaque assay. Recombination 
frequency was higher (10.5 - 7*5%) when a hot air incubator was used and 
lower (0.1 - 3.0%) when a controlled temperature water-bath (39°C - 0.05°C) 
was used for the plaque assay. No "recombination" was seen between ts 
mutants of the same complementation groups.
Apparent recombination in animal viruses can occur as a result 
of several different mechanisms. For example, reassortment of genome 
segments can result in high frequency of "recombination" in reovirus and 
influenza A virus (Shatkin, 1971). Complementing heterozygotes can 
produce what appears to be "recombination" in Newcastle disease virus 
(Dahlberg and Simon, 1969a and b). However, in poliovirus, it has been 
suggested that the low levels of recombination detected could be due to 
true intra-molecular recombination (Cooper, 1969).
Examination of the progeny of mixed infections of RS virus ts 
mutants was performed by picking clones at 32°C and determining their 
phenotype. The clones were picked at the permissive temperature to reduce 
selective pressures. No true wild type recombinant plaques were found
among the progeny tested (68 plaques). Some of the clones (24%)
yielded progeny which were a mixture of ts Al and jts A2 (i.e. some ts Al
plaques and some jts A2 plaques). Ts Al clones were syncytial, .ts A2
clones were non-syncytial. The clones which yielded a mixture of
ts Al and ts A2 were probably formed by virus particles which contained 
both _ts genomes. Therefore, this data indicates that "recombination" 
detected between RS virus .ts mutants was due to complementing hetero- 
zygotes. It is unlikely that the apparent recombination was due to 
complementation occurring in virus aggregates, since sonication of the 
virus prior to plaque assay did not alter the "recombination" frequency. 
Also the frequency of "recombinant" plaques followed one hit kinetics 
during dilution. Mixtures of .ts. Al and _ts. A2 which were grown separately 
before mixing produce fewer (100-fold) "recombinant" plaques than the 
progeny of mixed infection.
The possibility that mixed progeny produced by some clones was 
due to cross-contamination was unlikely. Clones were picked from plates 
containing no more than 3 plaques and "clones" picked from areas where no 
virus CPE was seen did not yield virus (Wright et al.. 1973)•
Electron Microscopic study of RS virus .ts mutants
Thin sections of HeLa cells infected at permissive (32°C) and 
non-permissive (39°C) temperature with wild type RS virus and ts mutants 
of RS virus, were examined by electron microscopy. Growth of the ts
mutants and wild type RS virus was similar at 32°C. Dense cytoplasmic
inclusions but no nuclear inclusions were seen in infected cells. 
Maturation of the virions occurred by budding from the cytoplasmic or 
vesicular membranes. Various types of RS virus particle were seen,
spherical forms with diameters 80-140 nm and filamentous forms 
measuring 2 |im in length. The RS virus envelope projections measured 
11 to 20 nm and the internal components (nucleocapsid) had diameters of 
11 to 15 nm. Usually 6 to 12 of these internal components could he 
seen symmetrically arranged inside the virus particles. The same virus 
production was seen in cells infected with wild type RS virus at 39°C 
and 32°C.
At the restrictive temperature (39°C)» Group A _ts mutants 
(ts Al, _ts A4* ts A5) showed a marked decrease in the number of buds and 
filaments formed. However, there was no reduction in the number of 
cytoplasmic inclusions seen at this temperature, except in one jts mutant, 
ts A5. Only cytoplasmic inclusions could be seen in cells infected 
with jts A4 at 39°C, and only a reduced number of these in cells infected 
with _ts A5« The ts mutants of Group A appear to have a block in the 
process of transformation of the cytoplasmic membrane as this was limited 
at 39°C. It was suggested that Jbs A5 may have another defect as well 
since it shows a reduction in the number of inclusions produced at 39°C 
and initially grows poorly in bovine kidney cells at the permissive 
temperature.
Group B ts mutant (ts A2) showed virus production (buds, 
filaments, cytoplasmic inclusions) similar to that seen for wild type 
virus at the restrictive temperature. This was expected since this 
mutant is so "leaky" and immunofluorescence studies gave similar results. 
However, Group C ts mutant (ts A7) infected cells showed no evidence of 
virus growth, only more microvilli were seen in the infected cells 
compared with the uninfected cells. Therefore, it was suggested that
ts A7 has probably a defect which blocks nucleocapsid formation and 
aggregation. Membrane transformation would seem to be dependent on 
the aggregation of nucleocapsids in the cytoplasm near the membrane 
since no transformation occurred in their absence (Kalica et al.. 1975)*
1.4*6 RS virus vaccine
Inactivated RS virus vaccine
As RS virus is a major cause of severe lower respiratory 
tract disease in infancy (Berglund, 1967; Chanock £t al., 1961 and 
Gardner et al., 1975) a, method of protecting infants against this virus 
was needed. One feasible method was the production of an RS virus 
vaccine.
Initially a mixed vaccine containing inactivated RS virus as 
well as other respiratory pathogens was tested but this induced a very 
poor immunological response (Woodhour et al., 1966). Trials using 
inactivated RS virus vaccines which were highly antigenic were not 
successful. Although children vaccinated with these vaccines developed 
high levels of serum neutralising and CF antibodies they were not 
protected by the vaccine; developing severer symptoms than non-vaccinated 
children on natural infection with the virus (Chin et al., 1969;
Fulginiti, 1969; Kapikian et al.. 1961; Kapikian et al., 1969 and Kim 
et al., 1969b).
Low temperature-adapted RS virus vaccine
In other myxoviruses local respiratory tract antibody had been 
found to be associated with protection against infection (Chanock et al., 
1970; Smith _et al., 1966 and Waldman et al., 1968). Therefore since 
young children developed neutralising response to RS virus in their nasal 
secretions (Kim et al,, 1969b; Scott and Gardner, 1970 and Scott and 
Gardner, 1974) a, vaccine stimulating local respiratory tract antibody
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was proposed (Kim £t slL. , 1971)* An attenuated (low (26°C)—temperature- 
adapted) strain of RS virus was developed for use as a vaccine. The 
trial of this vaccine in adult volunteers was successful since they 
developed an immunological response to RS virus "but no RS virus 
associated illness (Friedwald et al., 1968). Therefore the vaccine 
was then tested in children. However, it was not suitable since 
vaccinated children who had not had RS virus infection developed mild 
respiratory tract disease (Kim et al., 1971)• As an alternative to a 
low-temperature-adapted RS virus vaccine a temperature-sensitive (ts) 
mutant vaccine was developed. Trials of the low (26°C)—temperature- 
adapted RS virus vaccine and the ts virus vaccine were undertaken in 
asthmatic children (McIntosh et al•, 1974)- The response of asthmatic 
children to these vaccines was similar to that of normal nonatopic
children. No excess wheezing occurred in any of the vaccinated children
which was in marked contrast to the response of asthmatic children to 
natural wild type RS virus infection (McIntosh _et al., 1973)*
Ts mutant RS virus vaccine
Ts mutants were isolated for use as a live vaccine based on the 
theory that they would grow at the temperature of the nasopharynx (32 -
34°C) and induce nasal secretory antibody, but they would not grow at the
temperature of the lower respiratory tract (37°C) (Wright et al., 1970)*
Four _t£ mutants of RS virus (A2 strain) were tested in vivo in 
hamsters. Hamsters are not ideal for evaluation of RS virus ts mutants 
because they do not develop symptoms of disease on RS virus infection. A 
non-specific inhibitor has been found in the lungs and nasal turbinates 
of hamsters. However, despite the lack of suitability some valuable
conclusions could be drawn from the RS virus tjs mutant tests as the 
temperatures of the upper and lower respiratory tracts in hamsters are 
similar to those in man. Ts Al was found to be the best mutant for use 
as a live vaccine since it replicated in hamster nasal turbinate but not 
in lungs (Wright et al*, 1970). Therefore _ts Al was tested in adult 
volunteers (Wright et al., 1971)* The mutant appeared to be attenuated 
in comparison to wild type as it produced less extensive infection and 
no illness. No revertants were isolated from the infected adults which 
agreed with the results of _ts Al infection of hamsters (Wright et al., 
1970). Ts Al did not induce a marked immunological response in adults 
since only one of the nine infected adults developed a rise in serum and 
nasal secretory antibody. Nevertheless, infection with the _ts Al vaccine 
induced resistance to challenge by wild type virus, 45 days after the 
initial inoculation. In this study the local secretory tract antibody 
did not seem to be the factor involved in the induction of resistance to 
RS virus. It was suggested that cell mediated immunity or interferon 
might be involved in the resistance to challenge by wild type virus.
Therefore, following the successful trial of the jts Al vaccine 
in adults (Wright et al., 1971) trials were undertaken of this vaccine on 
children (Kim a t al., 1973^; McIntosh a t al., 1974 and Parrott et al., 
1972). However, these trials were not successful since children who 
had no previous RS virus infection developed mild respiratory symptoms 
as a result of vaccination and otitis media developed in one of these 
patients. Ts Al appears to be communicable since it was isolated from 
people in contact with the vaccinated children (Kim et_ al., 1973^ and 
McIntosh et al.t 1974)* No challenge of Jts Al vaccinated children was 
reported to occur during the trials, therefore it was not possible to
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assess the effectiveness of the ts Al vaccine. Some revertants were 
Recovered* from the nasopharyngeal secretions of vaccinated children 
who shed virus during infection. However no correlation occurred 
between the age of the vaccinated children, their serum neutralising 
titre and the shedding of revertants. The revertants were less than 
0.1% of the total virus isolated from the respiratory tract at the peak 
of virus replication. It was not known whether this genetic change 
occurred in vivo in the infected children or in vitro during the growth 
of ts Al in HEp-2 cells at permissive temperature (Hodes et al., 1974)• 
Therefore to resolve this question ts Al was passaged twice in HEp-2 
cells (20 separate tubes); none of the progeny (20 populations) of the 
second passage had a different ts pattern from ts Al virus.
It was then suggested that the genetic change probably 
occurred in vivo in the infected children rather than through passage 
in vitro in HEp-2 cells. The revertant virus isolated from children 
was cloned. These clones showed various patterns of temperature 
sensitivity intermediate between ts Al and wild type RS virus, some of 
the clones had completely reverted to wild type.
Three possible explanations for this reversion pattern were 
proposed. Firstly, that ts^  Al could have undergone a change at more 
than one nucleotide site therefore reversion (back-mutation) occurring 
in one or more of these altered sites could result in a reduction in 
temperature sensitivity. This mechanism was thought unlikely since 
clones showing complete reversion to wild type were isolated quite 
frequently. If the suggested mechanism was correct, complete revertants 
would be rare as complete reversion would require simultaneous reversion
at several mutation sites.
Another possible explanation could be that a second mutation 
occurring at the same site as the first mutation might produce a less 
temperature sensitive gene product. However, this theory was also 
thought to be unlikely as different types of mutation would have to 
occur at the same site in order to explain the different intermediate 
patterns of temperature sensitivity. This might be possible if a 
locus with a very high tendency towards mutation existed in the RS virus 
genome (Hodes et al., 1974)*
A third explanation for the intermediate reversion pattern seen, 
is that a second (suppressor) mutation distinct from the original 
mutation could occur (Hodes et al,, 1974 and Kim et al., 1973)* This 
suppressor mutation could affect the original mutation by producing a 
gene product which could be used as a substitute for the original 
mutation product or it could open alternative pathways for the synthesis 
of viral products. A suppressor mutation could change the conditions 
in the host cell so that the original mutation*s defective product could 
be by-passed.
Intracistronic suppression could occur, that is, a second 
change in the same product, which would enable it to function almost 
normally. Another possibility which was suggested was that a change in 
the way genetic information is transformed into structural proteins 
could result in the intermediate. pattern of reversion.
At present, which of these possible mechanisms occurs in RS 
virus is not known (Hodes et al., 1974)*
Section 2 
Materials and Methods
Section 2 - Materials and Methods
2.1 Cell culture
2.1.1 African Green monkey kidney cells (BS-C-1)
BS-C-1 cells are epithelial African Green monkey kidney cells. 
(Hopps et al., 1963). They were maintained in continuous culture in 
rotating Winchester bottles (80 oz). The cells were grown in Eagles 
minimum essential medium (Glasgow modification) supplemented with 5 °r 
10% foetal calf serum (FCS).
Foetal calf serum was used in preference to ordinary calf 
serum as the latter contains antibodies to bovine respiratory syncytial 
virus (bovine RS virus) (Doggett £t al., 1968) which is antigenically 
similar to human respiratory syncytial virus (RS virus) (Paccaud and 
Jacquier, 1970). Antibodies if present in growth medium may become 
attached to the cells, therefore FCS was used in growth medium as well 
as in maintenance and overlay medium to avoid inhibition of RS virus by 
antibodies to bovine RS virus.
The BS-C-1 cells used were obtained at passage 75 from Dr. D. 
Bell, Biochemistry Department, University of Glasgow.
Production of BS-C-1 cell monolayers for growth and assay of RS virus
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BS-C-1 cells (12 x 10 cells/bottle) were seeded in medium 
(180 ml) in a Winchester bottle (80 oz) and gassed using 100% CO^ (100 ml). 
The bottles were rotated at 37°C for 3”4 days until confluent monolayers 
formed. Then, the cells were removed from the glass by washing twice 
with versene, once with trypsin, leaving 2 ml of trypsin in each bottle
and returning it to the rotating rack at 37°C for 5 ‘t0 10 minutes. The 
cells were centrifuged (1,000 rpm/5-10 mins), resuspended in growth 
medium (5 ml) and dispensed into Winchester bottles (80 oz) or used 
for plates or bottles (l oz),
BS-C-1 cells were passed every 3 to 4 days using the above 
procedure and could be propagated for 4 to 5 months 102 passages) 
before losing their sensitivity to RS virus or overgrowing on assay 
plates making it difficult to detect RS virus cytopathic effect. Low 
passage number (P76) BS-C-1 cells were revived routinely every three 
months or when required,
BS-C-1 cells, standard plating densities for confluence in 24 hours and
48 hours
Container No, of cells (24 hrs) (48 hrs)
Plate (35 mm) 7 x 105 3.5 x 105
Plate (50 mm) 1 x 106 5 x 105
Linbro well (6 mm) 1 x 105 5 x 104
Vial (12 mm) 2 x 105 1 x 105
Bottle (l oz) 1 x 106 5 x 105
The BS-C-1 cells were tested for Mycoplasma, however no mycoplasmal 
contamination could be detected,
2,1.2 African Green monkey kidney cells (CV-l)
CV-1 cells are adult African Green monkey kidney cells which 
unlike BS-C-1 cells are fibroblastic not epithelial in appearance. 
These cells were obtained from Dr. J. Williams of this department, who 
had earlier obtained them from the Cold Spring Harbour Laboratories.
The cells were propagated by the method used for BS-C-1 cells, and 
seeded at the same densities used for BS-C-1 cells.
2.1.3 African Green monkey kidney cells (Vero)
Vero cells are also an African Green monkey kidney cell line 
which like CV-1 cells are fibroblastic rather than epithelial. They 
were grown using the method detailed for BS-C-1 and seeded at the same 
densities. The Vero cells used were obtained from Plow Laboratories Ltd.
2.1.4 Human diploid lung cells (WI-38)
WI-38 cells (Hayflick, 1965) 3X6 fibroblastic human diploid
lung cells. They were grown using the method used for BS-C-1 cells.
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Plates (50 mm) were seeded at 2 x 10 cells/plate for confluence in 24 
hours. The cells were obtained from Dr. P. Perkins, National 
Institute for Biological Standards, Hawstead.
The WI-38 cells were tested for Mycoplasma and found to have 
M. arginini.
2.1.5 Human cervical carcinoma cells (HeLa)
HeLa cells (Gey et al., 1952) axe epithelial cells derived 
from a human cervical carcinoma. The cells were propagated in a similar 
manner to BS-C-1 cells. Plates (35 mm) seeded with 1.7 x 10^ cells 
were confluent in 24 hours. The HeLa cells were obtained from Dr. J. 
Williams of this department, who originally obtained them from Plow 
Laboratories Ltd.
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2.1.6 Human carcinoma cells (HEp-2)
HEp-2 cells are epidermoid cells derived from carcinoma of
the larynx (Toolan, 1954)• The cells were grown in the same way as
£
BS-C-1 cells. Plates (35 ^m) were seeded with 1.6 x 10 cells to form 
confluent monolayers in 24 hours. The HEp-2 cells were obtained from 
Plow Laboratories Ltd.
2.1.7 L cells (NCTC clone 929)
L cells (Earle, 1945) were derived from normal subcutaneous 
areolar and adipose mouse tissue. These cells axe fibroblastic in 
appearance and were grown in the same way as BS-C-1 cells. Plates 
(50 mm) seeded with 2 x 10^ cells were confluent in 24 hours. The L 
cells were obtained from Bio-cult Laboratories Ltd., Glasgow.
2.1.8 bh^21 c -^one 13
BHK^ C ^  c e l l line was derived from hamster kidney fibroblast 
cells (Macpherson and Stoker, 1962). The cells were grown in a 
similar manner to BS-C-1 cells except that the growth and maintenance 
medium used contains tryptose phosphate broth (10%) as well as PCS.
2.2 Storage of cells
The storage medium consisted of 4 parts of Eagles M M  
(Glasgow modification), 4 parts of PCS and 2 parts of glycerol (non­
toxic). The cells to be stored were removed from the Winchester 
bottle using trypsin as detailed earlier, then pelleted at 1,000 rpm 
for 5-10 min. Then, the cells were resuspended in 10 ml of Eagles 
MEM, and 1 ml of the cell suspension mixed with 1 ml of the storage 
medium and transferred to vials (5-6 x 10^ cells/vial).
The cells were stored at -195°C and revived by thawing 
quickly and then transferring the suspension to a bottle (l oz) with 
maintenance medium (5 ml).
2.3 Virus
2.3.1 Respiratory Syncytral virus (R.S. virus)
Long strain
The Long strain of RS virus (Chanock ejb al., 1957) was 
obtained from the American Type Culture Collection, Rockville, Maryland 
USA.
Before receipt the Long strain had been passaged six times in 
KB cells (Human epidermoid carcinoma of mouth) twice in Chang L cells 
(non-malignant human liver epithelial cells) and twice in HEp-2 cells. 
For experiments detailed in this thesis the Long strain was grown and 
assayed on BS-C-1 cells.
RSN-2 strain
The RSN-2 strain of RS virus was isolated from a five month 
old child with bronchitis by Dr. P.S. Gardner, Royal Victoria Infirmary 
Newcastle, in 1972. It was received from Dr. P.S. Gardner as an 
infected human diploid culture (MRC - 5 cells) and then passaged twice 
in BS-C-1 cells, before being cloned four times to ensure a genetically 
uniform stock. RSN-2 strain was grown and assayed on BS-C-1 cells.
Ag strain temperature sensitive (ts) mutants
The is, mutants (tsAl,A2,A7) were kindly supplied by Dr. R.M. 
Chanock, National Institute of Health, Bethesda. Before receipt the 
ts mutants had been passaged four times in HeLa cells and once in HEp 
cells. On receipt the mutants were passaged twice in BS-C-1 cells 
before being used in Complementation experiments.
2.3.2 Vesicular Stomatitis Virus (VSV)
The strain of VSV used was a triple cloned wild type stock of 
the Indiana - C strain obtained from Dr. C.R. Pringle of this department. 
This strain belongs to the Indiana serotype of VSV and was obtained 
originally from A.V.R.I. Pirbright by kind permission of the Director 
Dr. J.B. Brookesby. It had been attenuated by serial egg passage and 
was no longer virulent for cattle. VSV is an RNA virus which causes 
an animal disease of economic importance. It was used with the consent 
of the Animal Health Division of the Department of Agriculture, Scotland.
2.3.3 Pseudorabies virus (PSRV)
A cloned wild type stock of PSRV was obtained from Dr. C.R. 
Pringle. This wild type stock was a derivative of the Kaplan strain 
of PSRV and its characteristics have been described by Pringle, Howard 
and Hay (1973).
2.4 Virus stocks
2.4.1 Preparation of Virus stock
A confluent monolayer of BS-C-1 cells in a bottle (l oz) 
was inoculated with virus (0.2 ml) after the removal of growth medium.
The multiplicity of infection (moi) was less than 1 plaque forming unit 
per cell (pfu/cell). Adsorption was allowed for 1 hour at 31°C or 
room temperature then the maintenance medium (5 ml) was added.
The infected cells were incubated stationary at 31°C until 
the C.P.E. was well developed. Then, they were harvested by freeze- 
thawing in an alcohol-dry ice bath or by scraping using a Pasteur 
pipette bent at the tip. The virus stock (infected cells + medium) was 
stored either in a liquid nitrogen cylinder (-195°C) or in a low 
temperature storage cabinet (-70°C).
2.4*2 The concentration of virus using polyethylene glycol (PEG)
A Winchester bottle (80 oz) containing a confluent monolayer 
of BS-C-1 cells (60-70 x 10^ cells) was inoculated with virus (1-2 ml) 
in maintenance medium (8-9 ml). The moi was less than one. The bottle 
was rotated at 31°C for one hour to allow the virus to adsorb. Then, 
maintenance medium (60 ml) was added to the bottle and it was returned 
to 31°C until the CPE was just visible. The maintenance medium was 
removed and replaced by fresh maintenance medium (20 ml). After which 
the bottle was returned to 31°C and rotated until CPE was well developed. 
Then, the infected cells were harvested into the medium by scraping with 
a piece of silicone rubber on the end of a metal rod. The virus 
(infected cells + medium) was spun at 2,000 rpm for 20 minutes in a
refrigerated centrifuge (4°C). The cell pellet was discarded and the 
supernatant retained, PEG was added to the supernatant to give a 
final concentration of 6% PEG and the mixture was then placed at 4°C 
for 2 hours. During this time virus and proteins were precipitated.
Then the mixture was centrifuged (2,000 rpm/20 mins at 4°C) the super­
natant discarded and the pellet retained (precipitate). The centrifuge 
used was an MSE Mistral 6L. The pellet was resuspended in a small 
volume of 20 mM Tris HC1 (0.1 ml) pH 8.4* Usually, the virus pellets 
obtained from PEG treated virus suspensions from 5 Winchester bottles 
(80 oz) were pooled.
2.4*3 Virus for Immunofluorescence experiments
Bottles (20 oz) of confluent BS-C-1 cells were inoculated 
with 3-5 ml of virus, the moi was less than one. Adsorption was allowed 
for 1 hour at 31°C and then maintenance medium (20 ml) was added. The 
infected cells were incubated stationary at 31°C and harvested when 
the CPE was well developed by scraping infected cells into the medium 
using a piece of silicone rubber on the end of a glass rod. Then, the 
virus (infected cells + medium) was clarified by centrifugation (2,000 
rpm/20 mins at 4°C) and the supernatant retained and used as the virus 
inoculum.
2*5 RS virus assay and growth
2.5.1 RS virus plaque assay
BS-C-1 cell monolayers on plates (50 mm) were used for the RS
virus plaque assay. These cells were used in preference to the other
susceptible cell lines studied (HeLa, WI-38, HEp-2) because RS virus 
produced a clear distinctive cytopathic effect (CPE) in these cells.
RS virus formed foci of darker staining cells on BS-C-1 cell monolayers 
(plates 1, 2) whereas ,in WI-38 cells RS virus produced irregular 
syncytia (plate 3)*
Dilutions of RS virus (0.2 ml) in PBS/2.5% FCS were inoculated 
onto BS-C-1 cell monolayers. Then adsorption was allowed for one hour 
at 31°C or room temperature. After this time the agar overlay (5 ml) 
was added and the plates incubated for 6-7 days at 31°C or 5 days at 39°C.
The plates were fixed using formal saline (2 ml/plate), then the agar
was removed and the cell sheet stained with Giemsa Stain (2 ml) for 
5-10 minutes. Plaques were counted using a Watson dissecting 
microscope at magnification times 8.75*
2.5.2 Growth curves
Method (a) - Total virus
Bottles (l oz) containing confluent monolayers of BS-C-1 cells 
were inoculated with virus (0.2 ml). The moi was less than one. 
Adsorption was allowed for one hour at after which the monolayers
were washed twice with maintenance medium and a final volume of 5 ml 
added. Then, the infected cells were incubated at the appropriate
temperatures in waterbaths for various lengths of time. Samples were 
taken by removing duplicate bottles from the waterbaths and harvesting 
the infected cells into the medium by scraping or freeze-thawing. The 
virus sample (infected cells + medium) was stored at -70°C or below 
(-195°C) and titrated when BS-C-1 cells were available.
Method (b) - Total virus
This method was used for ts mutant growth curves. The 
smaller number of cells used enabled an increase in moi.
Confluent monolayers of BS-C-1 cells on plates (55 mm) were 
inoculated with virus (0.2 ml). The moi varied according to the &sl 
mutant used. Adsorption was allowed for one hour at 31°G or room 
temperature. Then, the plates were washed twice with maintenance 
medium and a final volume of 2 ml added. The plates were incubated 
in CC^-gassed incubators at 31°C and 39°C. Samples were taken by 
removing duplicate plates from the incubators at various times after 
adsorption. The infected cells were scraped into the medium using a 
piece of silicone rubber on the end of a glass rod. The virus sample 
(infected cells + medium) was stored at -70°C or -195°C and titrated on 
BS-C-1 cells at 31°C. The 39°C samples were also assayed at 39°C as 
well as 31°C to determine the amount of reversion as opposed to leak 
occurring at this temperature.
For temperature-shift experiments this method was modified.
As well as harvesting plates at various times after adsorption, plates 
were also transferred from 31°C to 39°C (upshift) and from 39°C to 31°C  
(downshift) at 12, 24, 36 and 48 hours after adsorption.
Method (c) - Cell-released and cell-associated virus
Monolayers of BS-C-1 cells on bottles (l oz) were inoculated 
with RS virus (0.2 ml). Adsorption was allowed for one hour at room 
temperature. Then the RS virus infected cell monolayers were washed 
twice with maintenance medium and a final volume of 5 ml added. The 
infected cells were incubated in a waterbath at 37°C. Samples were 
taken at various times from 0 hours to 48 hrs after adsorption by 
removing duplicate bottles from the waterbath. Then, the maintenance 
medium was removed from the infected cells and stored at -70°C before 
being assayed for RS virus (cell-released virus).
Fresh maintenance medium (2 ml) was added to the bottles (l oz) 
of infected cells. Then the cells were sonicated for 1 minute and 
after this scraped into the medium using a Pasteur pipette. The sample 
(infected cells + medium) was stored at -70°C and then titrated (cell- 
associated virus).
The titres of the samples were corrected for the difference in 
final volume between the cell-released (5 ml) and the cell-associated 
(2 ml) samples.
Plate 1 : RSN-2 strain plaque on BS-C-1 cells
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Plate 2 :
The cells were stained with giemsa.
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Enlarged view of a RSN-2 plaque on BS-C-1 cells
The cells were stained with giemsa.
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Plate 3 : RSN-2 Strain plaque on WI-58 cells
The cells were stained with giemsa. 
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2.6 Chemical agents
2.6.1 Mutagens
5-Elurouracil (5-FU)
This chemical was obtained from Koch-Light Laboratories Ltd., 
Buckinghamshire, England. Stock solutions were made by dissolving 
the chemical in sterile distilled water.
5-Azacytidine (5-ACR)
This chemical was obtained from Sigma Chemical Co., St. Louis, 
Mo., USA. Stock solutions were made by dissolving the chemical, in 
dissolved water.
Ethyl methanesulphonate (EMS)
M S  was obtained as a liquid from Sigma Chemical Co., St. Louis,
Mo., USA.
N-Methyl-N1-nitro-N-nitrosoguanidine (NTG)
NTG was obtained from Research Chemical, Ralph N. Emanual Ltd., 
Wembly, England.
2.6.2. Inhibitors
Actinomycin D
Actinomycin D was obtained as D-actinomycin MSD under the trade 
name Lyvac Cosmegen from Merk, Sharpe and Dohme Ltd., Hoddesdon, 
Hertfordshire. Each vial contained 0.5 mg of actinomycin D and 20 mg
of mannitol (inactive). Solutions of actinomycin D were made up with 
distilled water and used immediately.
Mitomycin C
Mitomycin C was obtained from Sigma Chemical Co., St. Louis, 
Mo., USA. Solutions of mitomycin C were made by the addition of 
distilled water to the chemical.
2.6.3 Amino acids
Arginine
Arginine was obtained from Koch Light Ltd. Stock solutions 
were prepared using sterile distilled water.
2.7 Complementation and Recombination 
2.7*1 Yield Complementation Method
Mixtures of ts mutants for use in complementation experiments 
were prepared and then inoculated onto BS-C-1 monolayers. Single-infection 
contained equal volumes of ts mutant and diluent (PBS) whereas mixed 
infecticncontained equal volumes of both ts mutants.
Virus (0.2 ml) inoculated onto BS-C-1 cell monolayers was 
allowed to adsorb for one hour at 4°C or 31°C* Then, the monolayers 
were washed twice with cold maintenance medium and a final volume of 
medium added. The monolayers were incubated at 39°C and then harvested 
and stored at -70°C. When BS-C-1 cells were available the samples 
were assayed at 31°C and 39°C.
The above method was used when HeLa and HEp-2 cells replaced 
BS-C-1 cells in some complementation experiments.
A complementation index (Cl) of 10 or above was taken as 
significant. This was a purely arbitrary figure.
CI = (A + B)31 - (A + B)39
A?10 + b^
A - ts mutant A 
B - ts mutant B
The different yield complementation methods used are detailed
below.
Method - 1
In this method the BS-C-1 cell monolayers used in the 
complementation experiments were in bottles (l oz). The incubation 
temperature was accurately controlled as an exact 39°C waterbath was 
used. Infected cells were harvested by freeze-thawing or scraping.
Method - 2
Blocks of Linbro wells (6 mm) obtained from Linbro Chemical 
Co. Ltd., were used in this method. BS-C-1 monolayers in these wells 
were inoculated with virus (20 ^ ) and after adsorption overlaid with 
maintenance medium (150 ^ ).
The blocks were incubated in a G0^ incubator at 39°C»
Infected cells were harvested 4 days after adsorption by freeze-thawing.
Method - 3
In this method BS-C-1 monolayers were grown on the bottom of 
vials (12 mm in diameter). The virus inoculum was 0.1 ml and after 
adsorption the cells were overlaid with maintenance medium (l ml).
Then the infected cells were incubated in an accurate waterbath at 39°C 
for 3 days before being harvested by freeze-thawing.
Method - 4
This method was the most efficient since BS-C-1 cell monolayers 
on plates (35 nim) can be easily harvested by scraping using a piece of 
silicone rubber on a glass rod. The incubation temperature was also 
accurate as an exact 39°C waterbath was used; the plates were placed in
a CC^-gassed. airtight jar which was immersed in the water.
The virus inoculum was 0.2 ml and after adsorption the 
infected cells were covered with maintenance medium (2 ml).
2.7*2 Recombination
Mixtures of ts. mutants were prepared and then inoculated onto 
BS-C-1 monolayers on plates (35 mm). The virus inoculum (0.2 ml) was 
allowed to adsorb for one hour at 31°C. Then, the monolayers were 
washed twice with maintenance medium and a final volume of 2 ml added.
The monolayers were incubated at 31°C for 4 days and then harvested by 
scraping the cells into the medium. Then the virus samples (infected 
cells + medium) were stored at -70°C until BS-C-1 cells were available 
for the assay. The virus samples were titrated at 31°C and 39°C and 
the recombination frequency was calculated using the formula given below.
% Recombination frequency
Virus titre at 59° (AB) Virus titre 39° AA Virus titre 39° BB
Virus titre at 31° (AB) Virus titre 31° AA Virus titre 31° EB
x 100
A ts mutant A
B ts mutant B
AA - self cross ts. A
BB self cross ts B
2.8 Thin sectioning technique
The following method was used to obtain sections of RS virus 
infected cells for examination by an electron microscope (Siemens, 101).
2.8,1 Preparation of RS virus infected cells
BS-C-1 cell monolayers on plates (50 mm) were inoculated with 
virus (0.2 ml). The virus was allowed to adsorb for one hour at 31°C . 
Then, maintenance medium (5 ml) was added to the plates and they were 
incubated at 31°C and 39°C in CO^-gassed incubators.
When RS virus CPE was just visible, 4-5 days after adsorption, 
the plates were removed from the incubators and the cell sheets fixed by 
the addition of 2.5% glutaraldehyde (4 ml/plate) for JO minutes. Then, 
the glutaraldehyde was removed and the cell sheet washed twice with PBS 
before the addition of 1% osmium tetroxide (10 drops/plate) for 15 minutes 
to stain the cells. After this the cell sheet was washed twice with 
PBS and a final volume of 2 ml of PBS was added to the plates. The 
infected cells were scraped into the PBS using a piece of silicone rubber 
on the end of a glass rod. Then the infected cell suspensions were 
placed in conical bottomed centrifuge tubes and centrifuged (4,000-5,000 
rpm/10 mins) using a MSE bench centrifuge. The supernatant was 
discarded and the pellet of infected cells retained. The cells were 
dehydrated in alcohol; the following percentages of alcohol 50, 5Q* 70,
90 were each successively added to the infected cells for 5 minutes and 
then removed. If required the infected cells can be left overnight 
in 70% alcohol.
After 90% alcohol treatment for 5 mins, the cells were given 
two 15 minute treatments with 100% alcohol. Then the alcohol was
removed and replaced with a 1:1 mixture of alcohol and propylene oxide
(P0) for 15 minutes. The mixture was removed and P0 added for 30
minutes, followed by the addition of a 1:1 mixture of P0 and Epon. At
this stage the cells can be left overnight if required.
The mixture of P0 and epon was removed and the cells were then 
immersed in epon for 1 hour. If the pellet was not compact, it was 
centrifuged before being layered on top of a little epon in a BEEM 
capsule. After the cells were placed in the capsules, the capsules 
were filled nearly to the top with epon. Then they were placed in an 
oven at 60°C for 48 hours to allow the epon to polymerise. When they 
were removed from the oven the embedded cells were ready for sectioning.
The LKB Ultromicrotome fitted with a glass knife was used to cut sections 
of the cells embedded in epon.
2.8.2 Staining thin sections for examination by an electron microscope
Thin sections cut using an LKB ultromicrotome were picked up 
on uncoated grids and left on the grids for 24 hours before staining.
Then, the grids were placed, section side down, on a drop of a saturated 
solution of uranyl acetate in methanol for 5 minutes. The grid (section 
side up) was then washed with distilled water and dried on a piece of 
filter paper. A drop of sodium hydroxide (0.1N) was placed on the grid 
(section side up) before it was placed on a drop of lead citrate for 5 
minutes. Then the grid was washed thoroughly with distilled water and 
dried on filter paper. The grid was examined using a Siemens, 101 electron 
microscope at magnifications between 4*000 and 8,000 and photographs taken.
2.9 In vitro assay for RNA polymerase of RS virus
The reaction mixtures (0.2 ml) were prepared in test tubes 
immersed in ice water. The same amount (0.1 ml) of sample (ts mutant, 
wild type RS virus or uninfected BS-C-1 cells) was added to each test 
tube. Then these solutions were added in the following order, 20 mM Tris 
HC1, pH 8, (0.04 ml), 70 mM dithiothreitol (0.01 ml) and reagent mixture 
(0.05 ml). The reagent mixture (l ml) contained 400 Eris HC1 buffer, 
(pH 8), 2.56 mM each of ATP, CTP and GTP, 256 pM of cold UTP and 0.24 
mCi/mole ^H -UTP. Therefore the final concentration of reagents in 
the reaction mixture (0.2 ml) was 104 mM Tris HC1 buffer (pH 8.0), 3*5 
dithiothreitol, 64O |iM each of ATP, CTP and GTP, 64 |iM of cold UTP and 
12 |iCi ^H -UTP. The 5»6 ^H -uridine 5*-triphosphate was obtained 
from the Radiochemical Centre, Amersham and had a specific activity of 
49 Ci/mmole in 5CP/0 ethanol. This ethanol was evaporated before the 
triphosphate was added to the reagent mixture.
The reaction mixtures were mixed using a Whirlimixer and zero 
time samples were taken. Then the mixtures were warmed to the 
incubation temperatures (31°C and 39°C) for 1 minute and then the reaction 
was started by the addition of 220 mM MgC^ (O.OO5 ml) with mixing. 
Incubation was continued and samples (0.02 ml) were taken at the following 
times 10, 20, 30, 60 and 90 minutes. The samples (0.02 ml) were placed 
on Whatman No. 1 filter paper discs and allowed to dry. Then the discs 
were washed 7 times with 5% trichloracetic acid containing 0.04M sodium 
pyrophosphate, 3 times in ethanol and once in diethyl ether. After 
drying the discs were placed in scintillation vials and a toluene based 
scintillant was added. The radioactivity was counted using an Inter­
technique SL30 liquid scintillation spectrometer.
2.10 Indirect Immunofluorescence Method of detecting RS antigen
in infected cells
This method involved staining coverslips of infected BS-C-1 
cells with specific absorbed antiserum (Bovine anti-bovine RS) and after 
washing with PBS (0.01M), staining the coverslips with rabbit anti-bovine 
antiserum conjugated with fluorescein isothyocyanate.
Only the internal and/or nuclear antigens could be detected 
as the infected cells were fixed by acetone. Surface antigens can be 
detected only if live cells are used. The indirect immunofluorescence 
method is more sensitive than the direct method but it can produce 
problems due to non-specific fluorescence.
2.10.1 Antisera
Bovine anti-bovine RS virus serum
Bovine anti-bovine RS virus serum was provided by Dr. J. Stott, 
Animal Disease Research Institute, Compton. The antiserum was absorbed 
with acetone treated uninfected BS-C-1 cells and its titre was estimated 
using the indirect immunofluorescent technique. It was used at a 
dilution of 1 in 50.
Human anti-RS virus serum
Two convalescent sera from children with RS virus infection 
were provided by Dr. J.H. Connolly, Virus Reference Laboratory,
Department of Microbiology and Immunobiology, Royal Victoria Hospital, 
Belfast. The sera were absorbed with acetone treated uninfected BS-C-1 
cells and used at a dilution of 1 in 10.
Rabbit anti-herpes serum
The rabbit anti-herpes simplex virus (ts 99) serum was kindly 
provided by Dr. Morag Timbury of this department. This antiserum was 
absorbed with acetone treated rat embryo cells and BS-C-1 cells. Using 
the indirect immunofluorescence technique the antibody titre in the 
serum was estimated. The titre of the anti-perum was 320. It was used 
at a dilution of 1 in 30*
Monkey anti-measles virus serum
The monkey anti-measles virus serum was provided by Dr. P.V. 
Shirodaria, Department of Microbiology and Immunobiology, The Queen's 
University of Belfast, Belfast. This antiserum was absorbed with acetone 
treated HEp-2 cells, Vero cells and BS-C-1 cells. Its titre was 
estimated by indirect immunofluorescence and it was used at a dilution 
of 1 in 50.
Rabbit anti-measles virus serum
The, rabbit anti-measles virus serum was provided by Dr. P.V. 
Shirodaria, Department of Microbiology and Immunobiology, The Queen's 
University of Belfast, Belfast. It was absorbed with rat liver powder, 
rat embryo cells and BS-C-1 cells. This antiserum was used at a 
dilution of 1 in 20.
2.10.2 Fluorescein Conjugates
Fluorescein isothiocyanate (FITC)-con.jugated rabbit anti-bovine globulin
This conjugate was a commercial preparation obtained from 
Nordic Pharmaceuticals and Diagnostics, London. The titre of the 
conjugate was 48* It was absorbed with acetone-treated BS-C-1 cells 
and used at a dilution of 1 in 15.
FITC-Conjugated sheep anti-human IgG.
Sheep anti-human IgG was obtained from Wellcome Reagents Ltd.
It was conjugated by Dr. P.V. Shirodaria with fluorescein isothiocyanate 
(FITC) obtained from Sigma Chemical Company. The conjugate was 
absorbed with acetone-treated mouse liver powder, HEp-2 cells and BS-C-1 
cells. Its titre was 1 in 160 and it was used at a dilution of 1 in 90*
FITC-conjugated rabbit anti-monkey globulin
The conjugate was a commercial preparation obtained from Nordic 
Diagnostics and Pharmaceuticals, London. Its titre was estimated by 
the indirect immunofluorescent technique. The conjugate was absorbed 
with acetone treated mouse liver powder, HEp-2 cells, Vero cells and 
BS-C-1 cells and it was used at a dilution of 1 in 15.
2.10.3 Absorption of antisera
Preparation of cells used to absorb antiserum
BS-C-1 cells in bottles (80 oz) were harvested into the medium 
by scraping using a piece of silicone rubber attached to the end of a 
metal rod. Then the cell suspension was centrifuged at 1,000 rpm for 
15 minutes and the cell pellet retained. The cells were resuspended in 
PBS (0.01M) and pelleted as before; this procedure was repeated three 
times. After, this treatment the cells were resuspended in acetone 
(10 times the volume of the cell pellet) for 5 minutes and then pelleted 
(2,000 rpm/15 mins). The acetone was discarded and the cells 
resuspended in PBS (0.01M) and then pelleted (2,000 rpm/15 mins). The
cells were resuspended in PBS (0.01M) and pelleted five times or until 
no trace of acetone remained. Then the cells suspended in PBS (0.01M) 
were stored at -20°C until required.
Other cell lines used for absorption were treated in the same 
way as BS-C-1 cells.
Absorption of antiserum or conjugate with uninfected BS-C-1 cells
The cells were treated with acetone as described earlier. 
Before use the cells were washed in PBS (0.01M) and pelleted (2,000 
rpm/15 mins).
Antiserum or conjugate was mixed with a third of its volume 
of acetone treated cells. The mixture was rotated for 48 hours at 4°C 
and then for a further 1 hour at 37°C. It was then centrifuged in a 
refrigerated centrifuge (10,000 rpm for 30-60 minutes) and the 
supernatant retained. The supernatant contained the absorbed antiserum 
which was clarified by filtration using a HA millipore filter (0.45 d)* 
This procedure was repeated between each adsorption when adsorptions 
with more than one type of cell were required.
2.10.4 Fixation and Fluorescent Staining
Preparation of virus infected cells
BS-C-1 cell monolayers on coverslips (13 mm) in plates (30 mm, 
50 mm) were inoculated with clarified virus suspensions (0.5 ml, 1 ml). 
Before inoculation the cell monolayers were washed with medium (Eagles 
MEM/l% FCS) containing a lower percentage of FCS than maintenance medium. 
The virus was allowed to adsorb for 1 hour at 3 1 °C and then the cell 
monolayers were washed with low serum supplemented Eagles MEM (l% FCS) 
and a final volume of this medium was added to the plates (2 ml, 5 ml). 
Then the infected cells were incubated in a CO^-gassed incubator at 31°C 
and at 39°C in either a CO^-gassed incubator or a COg-gassed airtight 
jar immersed in water in a 39°C waterbath. The 39°C waterbath was used 
to ensure greater temperature control. When the plates were incubated 
in the airtight jar in the waterbath the percentage of FCS had to be 
increased to 2.5% in order to prevent the cells from detaching from the 
coverslips.
Fixation of infected and uninfected cells
Maintenance medium was removed from the infected and 
uninfected cells and they were washed twice with serum free Eagle's 
medium. The coverslips were then washed twice in PBS (0.01M) and once 
in cold acetone (4°C) before being placed in a metal rack in a cold 
acetone bath (4°C) for 5 minutes. After treatment the coverslips were 
immediately removed from the acetone bath and allowed to dry in air 
(30-60 minutes). Then the coverslips were stored in plates (50 mm) 
with silica gel at -20°C.
Indirect immunofluorescence staining method
The coverslips to he stained were washed in PBS (0.01M) and 
arranged on rods in the staining box. Then the coverslips were 
covered without overflow with appropriate dilutions of non-conjugated 
antiserum (2-3 drops). The antiserum was allowed to react for 1 hour 
at 37°C. Each coverslip was removed and washed in PBS (0.01M) and 
then placed in the same order in a bath of PBS (0.01M) containing a 
magnetic stirrer. The washing was continued for 30 minutes. Then the 
coverslips were removed and their undersurfaces dried before they were 
placed on rods in the staining box. The appropriate conjugated 
globulin (anti-species globulin) was placed on each coverslip (2 drops) 
covering the whole surface without overflow. Staining was continued for 
45 minutes at 37°C. After this, the coverslips were washed with PBS 
(0.01M) as described above. Then the undersurfaces of the coverslips 
were dried and the coverslips mounted on slides (0.8 mm thick) in 
buffered glycerol-saline pH 8.3.
Specificity of staining
The specificity of bovine anti-bovine RS virus serum was 
established by the absence of staining with foetal bovine calf serum, 
rabbit anti-measles virus serum, rabbit anti-herpes simplex virus serum 
and monkey anti-measles virus serum. After adsorption of immune serum 
with RS virus infected BS-C-1 cells no staining was detected; this 
shows the specificity of RS virus staining.
2.10.5 Equipment
Microscopes used for fluorescence observations
Fluorescence observations were made using a Reichert 
fluropan fluorescent microscope under dark-field illumination with a 
Tungsten halogen lamp (G.E.C. 12 volts, 100 watts). A primary Baltzer 
filter and barrier filter 5 were used when necessary. Specimens 
were photographed in a Zeiss standard R.A. fluorescence photomicroscope 
using a U or I exciter filter and barrier filter 41*
Preparation of coverslips for tissue culture
Glass coverslips (Chance no. 1, 13 mm diameter) were cleaned 
prior to use by boiling in distilled water for 10 to 15 minutes. Then, 
the coverslips were allowed to cool (5 mins) and the procedure repeated 
three times. After washing, the coverslips were rinsed twice in 
absolute alcohol, and dried in air at 37°C. Then, each coverslip was 
polished with lens tissue. The coverslips were placed in glass Petri
dishes (8 coverslips per dish) and sterilised in a hot air oven at 180°C
for l-J hours.
The coverslips were obtained from Chance propper Ltd., Smethwick,
Warley, England.
Section 3 
Results
Section 5 - Results
3.1 General properties of RS virus
3.1.1 Growth of the RSN-2 strain in various cell lines
Several cell lines were examined in order to find a suitable 
cell system for assay and growth of the RSNr-2 strain of RS virus.
The RSN-2 strain did not grow in BHK/C^ or L cells.
However, it did grow in HeLa, HEp-2, WI-38, CV-1, Vero and BS-C-1 cells. 
As noted in section 2.5«1 BS-C-1 cells were chosen as the assay system 
for the RSN-2 strain because of the clear viral CPE produced in these 
cells (plates 1, 2). No clear plaques were seen when the RSN-2 strain 
was titrated on HeLa cells whereas irregular syncytia were formed in 
WI-38 cells (plate 3)«
Stocks of the RSN-2 strain cloned and grown in WI-38 cells 
and cloned and grown in BS-C-1 cells were titrated on both cell lines 
(Table 6). The plating efficiency of the RSN-2 strain on WI-38 cells 
was lower than on BS-C-1 cells. However, the RSN-2 strain which had 
been cloned and passed in WI-38 cells had a higher efficiency of 
plating on WI-38 cells than virus which had been grown in BS-C-1 cells.
Therefore the RSN-2 strain grows better and plates more 
efficiently on BS-C-1 cells than on WI-38 cells. However, the virus 
titre and plating efficiency can be improved if the RSN-2 strain is 
adapted by passage in the cell line used.
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3.1.2 Growth of RS virus (RSN-2 and Long strains) in BS-C-1 cells
The rate of growth of RS virus at different temperatures was 
examined to determine whether the rate of growth was dependent on 
temperature.
The Long strain of RS virus was grown in BS-C-1 cells at 
three different temperatures (31°» 37? 59°C). Stock of this strain was 
used as it was available at a higher titre than that of the RSN-2 strain. 
The growth cycle of the Long strain at these temperatures was different, 
the best yield and highest growth rate occurring at 39°C (Figure 2).
To determine whether the low titre of both strains of RS virus 
was due to RS virus remaining cell-associated, the levels of cell- 
associated and cell-released virus were measured throughout the growth 
cycles.
At 36 hours post adsorption 16 % of Long strain (Figure 3) was 
released whereas only 1% of RSN-2 (Figure 4) was released. Therefore 
both strains of RS virus are very cell-associated, however the Long 
strain is less cell-associated than the RSN-2 strain. This difference 
in cell association could account for the higher yield of Long strain 
compared with RSN-2 strain.
In these experiments the latent period of RS virus (RSN-2 and 
Long strains) in BS-C-1 was 10-12 hours and the exponential phase was 
20 hours or more. The entire RS virus growth cycle takes 36 to 48 hours 
in BS-C-1 cells.
Figure 2 s The growth of the Long strain of RS virus in
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3*1.3 Adsorption of the RSN-2 strain of RS virus to BS-C-1 cells
The efficiency of adsorption of the RSN-2 strain of RS virus 
to BS-C-1 cells was examined to determine whether poor adsorption of 
virus contributed to the low virus yield.
The percentage of RSN-2 strain adsorbed during 1 hour at room 
temperature (25°C) was 90%• This figure was the average of three 
separate experiments (24 samples) in which both wild type and ts mutant 
virus was used. The percentage of jts mutant virus adsorbed to BS-C-1 
cells is shown in Table 7» There was no difference in adsorption
is/s', tsH)
between wild type RSN-2 virus and ^ ts mutants*of This strain. However, 
loss of virus due to thermal inactivation during the adsorption period 
was not taken into account. The thermal inactivation rate of RSN-2 at 
25°C was considered to be low based on the results of experiments by 
other workers using the Long strain of RS virus. A suspension of 
partially purified Long strain virus in distilled water had an 
inactivation rate of 0.2 log pfu/hour (Rechsteiner, 1969a), whereas a 
suspension of the Long strain virus in culture medium, pH 7*8> was not 
inactivated during the first hour at 25°C (Hambling, 1964b).
In the above experiments the RSN-2 virus was suspended in tissue 
culture medium. If no or very little inactivation occurs at 25°C 
adsorption of the RSN-2 strain is very efficient. Thermal inactivation 
of _ts mutant virus may occur more readily at 25°C than that of wild type 
virus. Therefore infectivity lost due to thermal inactivation could 
result in an apparent increase in efficiency of adsorption.
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3.1*4 Treatment of RS virus infected BS-C-1 cells to release 
cell-associated virus
Since RSN-2 strain of RS virus is very cell-associated, 
methods of releasing cell-associated virus were used to try to increase 
virus yield (Table 8).
An initial experiment using sonication as a means of releasing 
cell-associated virus seemed promising. However, on further 
examination no correlation was found between time of sonication and 
increase in virus yield.
Another method used in an attempt to release cell-associated 
virus was trypsin-versene treatment. A solution of 5 nil of trypsin 
(0.25% w/v) and 20 ml versene was used. The RSN-2 virus infected BS-C-1 
cells were pelleted and resuspended in the trypsin-versene solution 
(2 ml) and then left in suspension for various lengths of time (5”30 
minutes). The action of the trypsin-versene solution was stopped by 
the addition of foetal calf serum (20%). Then the suspension of cells 
in trypsin-versene was centrifuged and the supernatant retained. The 
supernatant was assayed for RS virus infectivity.
There was no increase in virus yield due to trypsin-versene 
treatment. Therefore cell-associated virus was either not released by 
this treatment or if released, the virus must have been inactivated 
probably by the trypsin in the solution.
Other methods of increasing the titre of RSN-2 strain of RS 
virus were tried such as arcton and polyethylene glycol (PEG) treatment 
as well as the addition of the polycation polybrene (4 jig/ml) to the PBS
solution used to dilute the virus. PEG precipitation did increase 
the virus titre but axcton treatment drastically reduced it and 
polybrene had no effect.
TABLE 8
Treatment to release cell^associated RS virus (RSN-2 strain)
Method Titre
( i ^ ioM)
Increase in yield 
(LogiQ treatment
- Log^Q no treatment)
Experiment I - SONICATION
No treatment 6.78 /
Sonication (l min) 7.38 0.80
Frozen and thawed then
sonication (l min) 7.62 0.84
Experiment II - SONICATION
No treatment 5.15 /
Sonication (3O-3O sec)
interval of 1 minute 4.78 1.63
between sonication
Sonication (minutes)
0-5 5.40 0.25
1.0 5.26 0.11
1.5 5.15 0
2.0 4.78 1.63
2.5 5.26 0.11
3.0 5.48 0.33
3.5 5.15 Q.
4.0 5.04 1.89
Trypsin-versene treatment
Time (minutes)
0 5.66 /
5 5*66
10 5.61 I 95
20 5.59 £ 9 3 ■
30 5.31 1.65
Experiment I - Arcton
No treatment 6.78 /
Arcton (10 ml) 6.00 1.22
TABLE 8 continued
Method Titre Increase in yield 
(Logic treatment
- n0 treatment)
Experiment II - Arcton 
No treatment 5.15 /
Arcton (5 ml) 3.48 2.53
Arcton (10 ml) 3.30 2.15
Sonication (l min) + 
Arcton (10 min) 5.00 3.85
Experiment - Polvethvlene 
erlvcol (8%} treatment at 
4°C for 24 hours
No treatment 5.15 /
PEG 5.56 0.41
PEG 5.34 0.19
Experiment - Polybrene 
(4 ng/ml)
No treatment 5.15 /
Polybrene in diluent 5.18 0.05
5.2 Electron microscopic studies on the RSN-2 strain of RS virus 
infected BS-C-1 cells
3«2.1 Thin sectioning of RS virus infected BS-C-1 cells
RSN-2 virus-infected BS-C-1 cells were treated as described 
in the Material and Methods section. Thin sections of infected and 
uninfected cells (plates 4* 5> 6) which had been grown at J>1°C and 59°C 
were examined under the electron microscope.
The RSN-2 virus matures by budding from the cell membrane. 
Budding virus in various stages of development can be seen in Plates 
7, 8, 9, 10. In RSN-2 virus-infected cells typical dense cytoplasmic 
inclusions and marked margination of the chromatin could be seen which 
were not present in uninfected cells. Also in RSN-2 virus-infected 
cells there was a marked increase in the number and length of membrane 
processes (Plates 11, 12) compared with those in uninfected cells 
(Plates 4* 5> 6).
Thin sections of ts mutant infected cells (ts 15, ts 16, 
ts 25) were also examined but because of the number of particles seen 
at 51° in the sections, the absence of virus particles at 59°C could not 
be evaluated.
Plate 4 s Thin section of an uninfected BS-C-1 cell
The magnification of the photograph is 20,000 X. 
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Plate 5 s Thin section of an uninfected BS-C-1 cell
The magnification of the photograph is 20,000 X.
N O  M f t  R Q. f fsj f r ' f ' / 0  fsj 0 /=. - T H E  O hh g  O M
In  Th+e. m u c L e u s
PLATE 5
Plate 6 : Thin section of an uninfected BS-C-1 cell
The magnification of the photograph is 20,000 X. 
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Plates 7 and 8 s Thin sections of RSN-2 strain infected
BS-C-1 cell
RS virus particles can he seen in the first stages 
of budding from the cell membrane.
The magnification of the photographs is 20,000 X 
(Plate 7) and 16,250 X (Plate 8).
PLATE 8
Plates 9 and 10 s Thin sections of RSN-2 strain infected
BS-C-1 cells
RS virus particles can be seen in late stages of 
budding from the cell membrane and free in the 
cytoplasm.
The magnification of the photographs is 20,000 X 
(Plate 9) and 16,250 X (Plate 10)
PLATE 10
Plates 11 and 12 : Thin sections of RSN-2 strain infected
BS-C-1 cells
RS virus processes can be seen protruding from the 
cell membrane.
The magnification of the photographs is 16,250 X.
PLATE 12
5*2.2 Scanning electron microscope (EM) study of
virus-infected cells
Virus-infected and uninfected BS-C-1 cells grown on 
coverslips at 51°C were prepared for the Scanning EM as described in 
Appendix 2.
The microvilli present on the surface of uninfected BS-C-1 
cells are seen in plate 15* When the cells were infected with the 
RSN-2 strain the microvilli became longer and more numerous (Plates 14, 
15, 16, 17)* Studies using fluorescent antibodies by Dr. P. Shirodaria 
indicate that these processes.-carry virus antigen (personal 
communication)•
Mrs. P. McSevney prepared the samples for the Scanning EM 
and Dr. E. Follett took the photographs.
Plate 15 s . uninfected BS-C-1 cells
The magnification of the photograph is 2,000 X.
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PLATE 13
Plates 14 and 15 : RSN-2 strain infected BS-C-1 cells
The magnification of the photographs is 1,500 X
(Plate 14) and 10,000 X (Plate 15). 
ltsjp£c_r^t> o  ( M c u B f f r e b  H-~r 3  / °c  p o R  =j-2- H-ones.
r n e  r v i u M B E / e  l ^ ^ t h  o p c ^ u -^ p ^ o l e s -s c S
( R. E A-S & s  U/A^AJ C-&LL-S /aJ F E C T l ^ ^  uo > 1 
7?S. \f  tfctAS
?l~ A T E  I S'
EfiJL- FtGCrSI) V!E\aJ o P  -ThhES E  R/lo O£-SS& S .
PLATE 15
Plates 16 and 17 : RSN-2 strain infected BS-C-1 cells
The magnification of the photographs is 1,500 X 
(Plate 16) and 4,800 X (Plate 17).
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PLATE 16
PLATE 17
3*3 The effect of serum and amino acid concentration in
medium on RS virus growth
3.3*1 The effect of serum concentration on the growth of the 
RSN-2 strain of RS virus
The concentration of serum in Eagle fs medium was examined 
to determine the minimum percentage of foetal calf serum (FCS) required 
for the optimum growth of RS virus over 48 hours at 31°C.
RS virus growth occurred in the absence of FCS in the medium.
PoufZ
However, RS virus yield was increased almost We-fold by the addition 
of 1% FCS to the maintenance medium (Table 9).
The virus yield was not further increased until the serum 
concentration reached 10%.
Th
e 
ef
fe
ct
 
of 
se
ru
m 
co
nc
en
tr
at
io
n 
on 
th
e 
gr
ow
th
 
of 
RS
 
vi
ru
s
1
co
u&  MA
oo m 00 cs CM m< t O r*. CO co cs m'— • • • • •
4-1 4J o 1—1 T“ 1 1—1 t-^
d  d
TO o  Oi—1 i - 1 i—1
OJ 60 60
•H O  O
^  J  h-J
<D /—\
H r-l
a
•H
H  O rH VD OV CO CO vO
H St o O ov CM
C 00 • • « • •
d  o co uo m St m
QJ rH
a  ^
/~s
r—1cd
<U oo vO o  oo CS s t CO O  CM
H O vo s t o  <-• CO CTi CM CO
4-J I—1 • • • • • ■ • • • •
•H 00 CO CO s t m  <n in  s t St m  m
H  O
rHv -/
<u a
oo >h  3
d  d  h
4-1 4-1 (U
d a) co
<u o O  O o iH iH CN CM m o  o
Cl (44 <44 iH rH iH i—1
H rH
a) ih  d
p4 o  o
CO
a) m
S 3
•H O o  o 00 00 00 00 oo 00 00 00
H  rd St s t Si­ St St St S t Stv
3*3*2 The effect of arginine concentration on RS virus growth
The effect of arginine concentration in Eagle’s medium on the 
growth of two strains of RS virus, Long and RSN-2, in BS-C-1 cells was 
examined. The results for both strains were similar. Long strain 
growth was markedly reduced when no arginine was present in the 
maintenance medium (Figure 5)* However, the addition of arginine 
(42 |ig/ml) to arginine free medium 18 hours after adsorption reversed 
this effect. Therefore RS virus requires arginine for optimal growth.
This confirms earlier results of other workers using the Long strain of 
RS virus grown in HeLa cells (Levine et al.« 1971)•
Since RS virus required arginine for growth further experiments 
were undertaken to study the effect of increasing the arginine 
concentration in Eagle's medium. It was hoped that an increase in exginine 
concentration would result in higher RS virus yield. The addition of 
extra arginine (42 |ig/ml) to the maintenance medium of RSN-2 virus 
infected BS-C-1 cells at 12 hours and at 12 and 24 hours post adsorption 
only slightly increased the yield of RSN-2 virus at 48 hours.
Whereas increasing the concentration of arginine in the 
maintenance medium by 42 fig/ml immediately after adsorption resulted in 
an increase in RSN-2 virus yield (i log unit). However increasing the 
total concentration of arginine beyond this level (84 |ig/ml) did not 
result in any further increase in RSN-2 virus yield (Figure 6).
Figure 5 : The effect of arginine concentration on the
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Long strain of- RS virus
o
Temperature s 57 C
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Long strain grown in arginine free medium 
for 18 hours, then supplemented with 
arginine (42 jig/ml).
0   Long strain grown in arginine-free medium,
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Figure 6 : The effect of arginine concentration in medium
on RS (RSN-2 strain) virus yield
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Log^o yield at 0 hrs.
Infectivity is measured as Log^/ml.
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3.3*5 The effect of methionine concentration on growth of
the RSN-2 strain of RS virus
If RS virus could be grown and labelled in methionine free 
55medium more ^S-methionine label would be incorporated into viral 
55polypeptides as "^S-methionine would be the only source of methionine 
in the medium apart from serum.
The effect of methionine concentration on RS virus growth 
55was examined because S-methionine is used as a radioactive label for
virus polypeptides. RS virus was grown in Eagle’s medium containing
various concentrations of methionine (15 fig/ml, 7*5 M-g/ml9 0 jig/ml).
Eagle's medium (Glasgow modification) contains 15 |ig/ml of methionine.
There was no reduction in RS virus yield when the virus was grown in
Eagle's medium without methionine (Table 10). Therefore methionine-
free medium can be used when RS virus polypeptides axe labelled using 
55•^S-methionine.
TABLE 10
The effect of methionine concentration on RS virus; growth
Time 
(hours )
Methionine
Hg/ml
Titre
(log10M )
Mean
Titre
^ield
0 0 3.60 3.50
/0 0 3.40
48 0 4.84 5.10 1.60
48 0 5.36
48 7.5 4.90 5.08 1.58
48 7.5 5.26
48 15 5.30 4.92 1.42
48 15 4.54
’‘Yield is taken as the difference in value between titre at 
48 hours (log^/ml) and 0 hr (log^/ml).
5*4 The effect of inhibitors of nucleic acid and protein synthesis
3.4.I The effect of actinomycin D on the growth of RS virus 
(RSN-2 strain)
Actinomycin D is a polypeptide antibiotic which at the level 
of 1-5 M-g/ml almost completely inhibits (95%) DNA-dependent RNA synthesis. 
However, RNA synthesis which does not require cellular or viral DNA is 
not affected by these levels. Actinomycin I) also inhibits the transport 
of RNA from the nucleus to the cytoplasm (Reich and Goldberg, 1964)*
In vivo and in vitro actinomycin acts by binding to the guanine residues 
of helical, deoxypolynucleotides containing guanine (Reich, 1966). The 
replication of DNA and some RNA viruses (fowl plague, Rous sarcoma virus, 
reovirus) is inhibited by actinomycin D.
The effect of actinomycin D on RS virus was examined to 
determine whether RS virus replication was inhibited like that of the 
orthomyxoviruses or unaffected like that of the paramyxoviruses by the 
presence of actinomycin D.
Initially the yield of RS virus in the presence of 5 |JLg 
actinomycin/ml and 10 jig of actinomycin D/ml was examined (Table 11).
At 24 hours and 48 hours there was no decrease in RS virus titre in the 
presence of 5 fig of actinomycin D/ml. However, in the presence of 10 |ig 
of actinomycin D/ml at these there was a decrease in RS virus titre 
(lj log units at 48 hours). Since high concentrations of actinomycin D 
are toxic to cells the effect of 10 jig/ml could be non-specific.
To confirm these findings RS virus and vesicular stomatitis 
virus (V.S.V.) were grown in the presence of 5 Hg/ml of actinomycin D.
TABLE 11
The effect of actinomycin 3) on RS virus growth
Experiment Time 
(hours)
ACTINOMYCIN D
NONE 5 |ig/ml 10 \ig /m l
1 0 3.94 3.87 3.87
5 3.49 3.56 3.09
10 3.39 2.45 2.91
24 4.34 4.43 4.15
48 5.15 5.16 3.78
2 0 3.83 3.85 ND
72 5.90 4.77 ND
ND - not done
Titre of virus given as log^/ml
In this experiment RS virus yield in the presence of 5 |ig of 
actinomycin D/ml was reduced; 1-jjr and 2-J- log units at 57 and. 48 hours 
respectively (Figure 7)« This result was in contrast to the previous 
finding that there was no decrease in RS virus titre at 48 hours. VSV 
also showed a reduction in yield (l log unit at 14 hours) but not at 
57 hours. The effect of actinomycin D on VSV was presumed to be non­
specific.
Since these experiments with RS virus gave contradictory 
results further experiments to examine the effect of actinomycin D 
concentration on RS virus yield were performed. In two similar 
experiments, one using Pseudorabies virus, a DNA virus, for comparison 
with RS virus there was no correlation between concentration of 
actinomycin D and the degree of reduction in virus yield (Figure 8).
The cells were pretreated for 2 hours before infection with 
the concentration of actinomycin D which was added after adsorption. 
Pseudorabies virus was completely inhibited by even the lowest concen­
tration of actinomycin D (0.1 (ig/ml) and by pretreatment of cells with 
actinomycin D (10 jig/ml). The cells were washed twice with medium 
without actinomycin D before infection and no further actinomycin D 
was added to the samples to show the effect of pretreatment alone.
RS virus yield was reduced by pretreatment of the cells with
actinomycin D but not as much as by the addition of various concentrations 
of actinomycin D after adsorption. In the presence of actinomycin D
(5 |ig/ml) RS virus yield was reduced (about 1 log unit). This reduction
was smaller than that found in a previous experiment (Figure 7) with no 
pretreatment of cells. The results were calculated as percentage
resistance to actinomycin D (Figure 8). RS virus yield was reduced 
80-90% in the presence of actinomycin D whereas Pseudorabies virus was 
reduced 99%*
The effect of actinomycin D on RS virus yield can be variable, 
since RS virus yield has been reduced (Figures 7* 8) as well as not 
affected (Table 11) by the presence of 5 lig/ml of actinomycin D.
A variability in response to actinomycin D has also been 
reported for poliovirus. Several factors were reported to affect 
poliovirus resistance to actinomycin D; the strain of virus used and 
the age of the cells, but the main factor seemed to be the presence of a 
substance in serum which induced an actinomycin-resistant state. The 
substance was nondialysable and heat stable and was considered to be a 
hormone. Experiments showed that the hormone insulin even in low 
concentration (0.004 pg/ml) had a similar effect to the substance present 
in serum. Pretreatment of cells with insulin had no effect on 
poliovirus growth in the absence of actinomycin D. However, when 
actinomycin D was present insulin pretreatment of cells produced an 
increase in resistance to actinomycin D. This effect was not seen when 
insulin was added after adsorption to cells which had not been pretreated 
(Cooper, 1966).
Therefore an experiment based on the poliovirus findings was 
undertaken. The effect of pretreatment of cells with Eagle’s medium 
alone or supplemented with either FCS (5%)» bovine serum albumin, BSA 
(fraction V) 1 mg/ml, insulin (4 |ig/ml) or combinations of insulin and 
FCS or BSA before infection was examined (Table 12). Cells which had 
been pretreated for 25 hours with any one of the media described above
Figure 7 : The effect of actinomycin D (5 ug/ml) on the
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Figure 8 : % Resistance of RS virus (RSN-2 strain) to
actinomycin D
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were infected with RS virus. After adsorption the same type of 
medium was used as maintenance medium and in one set of duplicate 
cultures it was supplemented with 5 Hg actinomycin D/ml. Cultures 
pretreated with medium containing insulin (4 i^g/ml) were slightly less 
sensitive to actinomycin D than those pretreated with medium containing 
no serum, FCS and BSA (fraction V). The combination of insulin with 
BSA resulted in an increase in sensitivity to actinomycin D. This must 
be due to the action of BSA since insulin in combination with FCS did 
not show the same effect. The combination of insulin and BSA in medium 
resulted in the best RS virus yield in the absence of actinomycin D. 
Therefore since the percentage yield was calculated on the difference 
between virus yield in the absence and presence of actinomycin D, the 
sensitivity of the virus to actinomycin D would appear to be higher 
than in the other examples. The results show that insulin did not 
markedly influence RS virus resistance to actinomycin D. An interesting 
feature was that insulin (4 |ig/ml) and BSA (l mg/ml) or BSA (l mg/ml) 
alone could substitute for FCS in Eagle’s medium. RS virus grown:in 
iiuadium supplemented with these factors gave the best yields.
Following a personal communication from Dr. Meera Gharpure 
that RS virus like influenza virus was only sensitive to actinomycin D 
if added during the early part of the growth cycle, an experiment was 
undertaken to study the effect of addition of actinomycin D at various 
times after adsorption (Table 13)*
Actinomycin D (l x^g/ml) was added to maintenance medium at 
various times after adsorption. The effect of actinomycin D was most 
marked when it was added directly after adsorption virus yield being
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reduced 99*5%* However, as the actinomycin D was added later in the 
growth cycle its effect decreased progressively.
The addition of actinomycin D to medium 8 hours post
adsorption resulted in only a 76% reduction in RS virus yield.
Therefore, actinomycin D appears to affect RS virus growth at an early 
stage in the growth cycle.
3-*4*2 The effect of mitomycin C on RS virus (RSN-2 strain) growth
High concentrations of mitomycin inhibit cellular but not viral 
RNA synthesis and DNA synthesis by combining with the cellular DNA and 
inactivating it. Actinomycin inhibits DNA dependent RNA synthesis but 
does not destroy the genes controlling it since cellular DNA synthesis 
is not inhibited. The effect of mitomycin C (10 (ig/ml, 5 dg/11!) on 
RS virus growth was examined.
The presence of 10 jig of mitomycin c/ml reduced RS virus
yield at 48 hours by 41% and. completely inhibited the growth of PSRV, a
DNA virus (Table 14)* Therefore RS virus did not appear to require 
cellular DNA or DNA synthesis for replication. The reduction in RS 
virus yield was probably due to the non-specific effect of mitomycin C 
on the cells.
.c
4-»
&o
Vi
CO
(0
P
Vi
•rl
>
CO
Pi
c
o
c
•rl
cj
s*.
So4-J
•H
0
n-l
o
4->
OVM-l
m
0)
qjrC
H
QJ
oo
cdXJ4-1I— l
e 0)a)•rl
o So
ViQJ
Pi*
a•H
a
i
4-1
•r4
a)
6•H
H
to
P
M♦H
>
4J
e
<u
0
•rl
Vi<D
CU
X
W
CO
3.
CO
p.
m
QJ
ao
2
m  cr»
O  vO vO fO (J\ 
oo <r o  lo oo
co co co co <r
CT\ CTi <r Cl 
o> • *  CO CO H
co co co <r m
m o  <too 
h  m  <r
CN
I
ZCO
Pi
o
CT\
o00
CO o 
oo cn
co m
O cn 
r^.
CN
I
!3co
Pi
CN
oo
o
v
o  o o
r-.co
o o <r
O  <r oo cn <r
CO CO
QJ QJ
•rl •rl
-P -Pcd co cd co
P P Vi P
O Vi O ViX* *rl XJ *rl
P > P >QJ QJCO CO
Pi Pi
co m  i-i 
i—l o  o 
o  o  o 
• • •
o  o o
00 00 O  O  00I-" O  CO O  !—I
N1 •tf CO CO CN
00
o
o  cn
CN CO
-d- -*r r-
O  O  <r vo co 
i- l CN CO Nf
CO
a)o
c
qjco
■8
•rl
xJ
I— l
QJ•rlSo
a)oo
«d
4J
cs
QJ
Ouaj
Pi
CO
cd
x>QJCO
CO
QJ
VI
CU
QJ
00P.
a•H
O
oV)
•H
B
ipo
QJOpiQJCO
QJ
V4Pi
QJ • 
M O
4J
QJ
•rl
S*•K
a
•rlO
r
4-1
•rl
0
3.5 The isolation and growth properties of RS virus ts mutants
3.5,1 Mutagenisation of the RSN-2 strain of RS virus
RS virus was cloned four times to obtain a homogeneous stock 
before mutagenisation* Then RS virus was mutagenised using various 
concentrations of different mutagens. The virus was grown in the 
presence of 5-f‘luz'O‘uz‘acil (5-FU), N-methyl-N’-nitro-N-nitrosoguanidine 
(NTG) or 5-azacytidine (ACR) to induce mutations during replication.
It was also exposed to ethyl methane sulphonate (EMS) a mutagen which 
acts by causing direct chemical modification of the viral nucleic acid.
Clonally related mutants may occur when the virus is mutagenised 
during replication. To avoid isolating a large number of clonally 
related mutants, mutants were isolated fromAindependently treated clones 
of virus.
5-Flurouracil ( 5-FU)
5-FU is an analogue of uracil and acts by replacing uracil in 
RNA during replication. Miscoding occurs in RNA viruses grown in the 
presence of 5-FU because halogenated uracils are more likely than uracil 
to undergo tautomeric change. When this happens uracil resembles 
cytosine in pairing with its complementary base guanine during nucleic 
acid replication. 5-FU present during replication is a good mutagen 
for RNA viruses, for example poliovirus (Cooper, 1964).
RS virus was grown in the presence of concentrations of 5-FU 
from 5 to 200 fig/ml at 31°C (Experiment l). The infectivity of virus 
grown in the presence of 200 pg/ml of 5-FU was reduced by 2^ log units
fL fiQ u C 'S
(Figure 9). Closes were picked from RS virus treated with 5* 10* 25*
50, 75, 100 and 200 |ig/ml of 5-FU.
In another experiment (Experiment 2) RS virus was grown in
the presence of concentrations of 5-FU from 5 to 100 jig/ml at 31°C and
39°G. The infectivity of RS virus grown in the presence of 100 |ig/ml
PLftQ ueS
of 5 -FU was reduced by 32 l°g "units (Figure 10). Ginn as were picked 
from RS virus grown in the presence of 50 ng/ml of 5-FU as the greatest 
difference in plating efficiency between virus grown in the presence 
of 5-FU at 31°C and 39°C occurred at this concentration. The smallest
difference in plating efficiency occurred when virus was grown in the
. PLttGueS
presence of 100 |ig/ml of 5-FU; olonee- were also picked from this virus.
Clones of RS virus were grown in the presence of 50 Hg/ml of 5-FU and
«i©»es were picked from this virus (Experiments 3 and 4).
N-methyl-N1 -nitro-N-nitrosoguanidine (NTG)
NTG is an effective mutagen for RNA viruses in vitro. It is 
also a mutagen for DNA viruses in vitro and in vivo (Fenner, 1974)*
In earlier experiments other workers had found that treatment 
of RS virus with NTG in vitro, exposure to 100 |ig/ml NTG for 15 minutes, 
was not an effective means of inducing ts mutants (Gharpure et al., 1969). 
Therefore in this experiment RS virus growth in presence of varying 
concentrations of NTG (0-10 fig/ml) was examined. The infectivity of 
RS virus grown in the presence of 10 fig/ml of NTG was reduced by 4 l°g 
units (Figure 11).
Pl a q u e
Olonec were picked from RS virus grown in the presence of 0.1, 
0.25, 0.5, 2.5 and 10 |ig/ml NTG.
The reduction in titre of RS virus in the presence of NTG
was probably due to the effect of NTG on the cells rather than NTG
affecting RNA virus replication.
Ethylmethane sulphonate (MS)
EMS has been used in vitro as a mutagen for both RNA and DNA 
viruses. It appears to affect the guanine bases in DNA and RNA.
In this experiment the concentration of EMS was constant, only 
the time of exposure of the virus to EMS varied. RS virus was treated
in vitro with EMS (4 ml virus + O.O4 ml EMS) for various lengths of time.
When required samples were taken and transferred into vials containing 
a solution of PBS and 2% thiosulphate which neutralised the EMS in the 
sample.
When RS virus w^s treated with EMS for 30 minutes 71% of the
Pl p q u c s
virus infectivity was lost due to inactivation (Figure 12). Qlones were 
picked from RS virus treated with M S  for 10, 15 and 20 minutes.
5-azacytidine (5-ACR)
A clone of RS virus was grown Ain the presence of 50 fig/ml of 
0 Pulques
5-ACR at 31 C. Clones were picked from the progeny virus. i s
M 3S )^ lA/aS /SoLftT F-R.OM THI S
Figure 9 : The effect of 5-Flurouracil (5-FtO on
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3• 5• 2 Isolation of temperature-sensitive (ts) mutants of the
RSN-2 strain of RS virus
0
Mutants were isolated by two procedures. The first was a 
conventional procedure (method i) of random isolation of clones 
followed by screening at two temperatures. This procedure had certain 
disadvantages which necessitated the development of a second improved 
procedure (method 2).
Method-I
Various dilutions of mutagenised virus were plated on BS-C-1 
cells and incubated at 31°C for 6 to 7 days. Then clones were picked 
from plates containing a few well separated plaques. The clones were 
picked using Pasteur pipettes which were inserted into the agar overlay 
above the plaques, removing a plug of agar and infected cells. Then 
the plug of agar and infected cells was placed into medium (2 ml) in a 
vial (12 mm). The vials were frozen and thawed before the contents 
were titrated at 31°C (permissive temperature) and 39°C (non-permissive 
temperature).
This method was not suitable for the isolation of RS virus 
ts mutants because of the poor recovery of infectivity per clone (20-200 
pfu/clone). About a thousand clones were screened using this method, 
however no jbs mutants were isolated. To reduce the possibility of 
picking aggregated virus particles clones which had been screened were 
recloned. However, no ts mutants were isolated from this recloned virus 
(231 clones). Since freeze-thawing was an important cause of poor 
recovery of infectivity method 2 was devised to eliminate the necessity 
of freeze-thawing.
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A  p la q u e  o f  v i r u s  w a s  p i c k e d  u s i n g  a  T h e  P a s t e u r  p ip e t t e  c
P a s t e u r  p ip e t t e  f r o m  a  p la t e  c o n t a in in g  a w a s  u s e d  to  s ta b  t h r o 1
f e w  w e l l  s e p a r a t e d  R S  v i r u s  p la q u e s .  ' a g a r  (2  m l )  c o v e r i n g
B S C -1  c e l l  m o n o l a y e r ,  
d i v i d e d  i n t o  4  s e g m e n t  
th e  b o t t o m  o f  the  p l a t  
T h e  s a m e  a r e a  i n  a d 
a l s o  s ta b b e d  a n d  s e ra ;  
p i p e t t e .
3.
7i i J-.
—  h j b C r * / ?
■ n —  irf ■
/'
c g q  t n o i \ ig Yt? A.
4 .
3i°c
tS VldUS, Q U C  ■
T h e  v i r u s  w a s  a l l o w e d  to  a d s o r b  f o r  1 h o u r  
a t  31° C a n d  th e n  the  p l a t e s  w e r e  o v e r l a i d  
w i t h  a g a r  (5 m l ) .
One o f  th e  p l a t e s  w a s  in c u b a t e d  a t  31 °C  a n d  
the  o t h e r  p la t e  w a s  in c u b a t e d  a t  3 9 ° C .
A f t e r  5 d a y s  i n c u b a t i o  
p l a t e s  w e r e  f i x e d  a n d  
m e n t s  w i t h  ia n d  w i t h o u  
n o te d .  A f t e r  6 - 7  day* 
p l a t e s  a t  31 °C  w e r e  sc 
p i c k e d  f r o m  p la q u e s  i i  
a t  3 9 ° C h a d  n o  v i r a l  (
T h e  c lo n e  w a s  t r a n s fe :  
c o n t a in i n g  a B S - C - 1  ce 
g r o w n  a t  31 °G .  T h e n  
w a s  t i t r a t e d  a t  31 °C  a]
before the plates were overlaid with more agar (5 ml)* One of 
duplicate plates was incubated at 39°C f°r 5 days and the othei 
for 7 days. The 39°C plates were fixed, stained and scored, 1 
were picked from the sectors at 31°C whose duplicate sectors af 
showed no plaque formation. These clones were transferred to 
of BS-C-l cells in bottles (l oz) and the virus was allowed to 
before maintenance medium (5 ml) was added.
The infected cells were incubated at 31°C until CPE w 
100%, then they were harvested by freeze-thawing or scraping, 
(infected cells + medium) was titrated at 31°C and 39°C to dete 
whether the virus was temperature sensitive.
This method represents a considerable improvement on 
The recovery of virus from clones was much better and _ts mutant 
isolated. However, method-2 still had some disadvantages, abou 
(23%) of the clones picked had no detectable virus and most of 
(96%) which appeared to be _ts in the first screening on growth 
further screening proved to be wild type rather than ts.
A total of 35 is mutants of RS virus were isolated fr 
treated with different mutagens and one tis mutant, t£ 24, was i 
from non-mutagenised virus (Table 15)* Fifteen mutants (ts
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ts 15 - 17» ts 27 - 34, ts 36) were isolated from virus grown in 
various concentrations of 5-FU (25, 50, 200 |ig/ml). The overall 
frequency of isolation of ts mutants was low (1.3%) • However, the 
frequency of isolation of its mutants from virus grown in the presence 
of 50 |!g/ml of 5-FU in Experiment 1 and 4 (clone 15) was higher.
There was no correlation between concentration of 5-FU and the 
frequency of isolation of ts mutants.
Two ts mutants (ts 19, ts 20) were isolated from virus 
grown in the presence of NTG (2.5 fig/ml). The frequency of isolation 
of ts mutants from virus grown in the presence of NTG- was no higher 
than that for virus grown in the presence of 5-FU. There was also 
no correlation between concentration of mutagen and the frequency of 
isolation of ts mutants.
A jts mutant (ts 18) was isolated from virus treated with EMS 
for 10 minutes. There was no correlation between time of treatment 
and the frequency of isolation of ts mutants.
The frequency of isolation of the spontaneous ts mutant was
low (0.25%). However there was no significant difference between this
frequency and the frequency of isolation of ts mutants from most of the
3t
mutagen treatments as can be seen from the/f values (Table 15)* The 
values were calculated by comparing the number of clones screened to 
isolate ts mutants in a particular treatment with the number of plaques 
screened to isolate the single spontaneous ts mutant.
Since most of the frequencies of isolation of ts mutants from
different treatments are not significant and there is no correlation 
between frequency of isolation and concentration or time of mutagen 
treatment, it is possible that most of the ts mutants isolated are 
spontaneous rather than mutagen induced.
3*5*3 Selection procedure for early _ts mutants of RSN-2 
strain of RS virus
An attempt was made to isolate early tss mutants and also to 
increase the frequency of isolation of ts mutants using the following 
selection procedure.
Virus previously treated with 5-FU (10 or 50 ing/ml) was 
inoculated onto BS-C-1 cell monolayers in bottles (l oz) and allowed to 
adsorb for 1 hr at 31°C. Then the cell sheets were washed twice and a 
final volume of 5 ml of maintenance medium added. The infected cells 
were incubated at 39°C for 5 hours. Then the maintenance medium was 
replaced with medium containing 50 |ig 5-Azacytidine (5-ACR)/ml and the 
bottles retained at 39°C for 18 hours.
5-ACR when incorporated into the virus genome inactivates it.
It was assumed that early _ts mutants would not replicate at 39°C and 
therefore 5-ACR would only be incorporated into the RNA of wild type virus 
and late function ts mutants with lethal effect. After 18 hours 
incubation of the bottles at 39°C the medium containing 5-ACR was removed 
and the monolayers were washed twice and covered with maintenance medium 
containing no 5-ACR. The bottles were transferred to °C and incubated 
until the CPE was nearly 100%. The samples (infected cells + medium) 
were harvested by scraping and titrated at 31°C* Since 5-ACR inactivated
104
the genome of wild type virus and late function ts mutants a greater 
percentage than usual of the virus grown at 31°C was expected to be _ts 
in an early function. Clones were picked from this virus and screened 
using the sector-plating method (method-2).
Fourteen ts mutants (ts 4-14♦ ts 21-23) were obtained using 
this procedure. The frequency of isolation of the selected ts mutants 
was 2% which was higher than the overall frequency of isolation of 
unselected mutants.
A modification of this selection procedure was also used. A 
clone of wild type RS virus was grown at 37°C for 3 hours and then 5-ACR 
was added to the maintenance medium. The virus was grown in the 
presence of 5-ACR for 18 hours and then the medium containing 5-ACR was 
removed. Following this the cell sheet was washed twice with medium 
containing no 5-ACR and a final volume of 5 ml added. The infected cells 
were transferred to 31°C until the CPE was nearly 100% and then they 
were harvested by scraping. The virus sample (infected cells + medium) 
was titrated at 31°C and clones picked from this virus. It was hoped 
that using this method early function ts mutants with a lower restrictive 
temperature (37°C) would be isolated. Two ^ s mutants (ts 20, ts 26) 
were obtained using this procedure. However the growth of these mutants 
was not restricted at 37°C. The frequency of isolation of these ts 
mutants was lower than that for the other selected ts mutants.
3*6 Growth and efficiency of plating of RS virus ts mutants
The growth and plating efficiency of RS virus ts mutants at
31°C, 37°C and 39°C was examined (Table 16). Some of the jbs mutants
grow at 39°C but do not plate at that temperature while a few ts mutants
revert on passage at the permissive temperature (31°C). Most of the
o .
ts mutants grow and plate at 37 C; however some tjs mutants (ts 5» is 15
ts 16, ts 18) although they grow at that temperature do not form plaques
A few trS mutants (ts 2, jts 6, jts 19) seem to be tis at 37°C as well as
39°C, since they do not grow or form plaques at both temperatures.
In the growth experiment at the three different temperatures 
(31°C, 37°C, 39°C) a few of the ts mutants had low yields. This was 
due to low moi and in some cases perhaps to individual mutants having 
longer growth cycles than wild type virus.
Work using RS virus has three main problems, the low titres of 
virus, thermolability and the sensitivity of RS virus to freeze-thawing. 
These problems are equally applicable to work with RS virus tsi mutants. 
RS virus must be stored at -70°C or below since infectivity is rapidly 
lost at higher temperatures. At -20°C 65% of RS virus infectivity was 
lost in 10 days. Virus stock could not be freeze-thawed more than 
twice, since a high proportion of virus infectivity was lost at each 
freeze-thawing. Some of the ts mutants are more sensitive to freeze- 
thawing than wild type virus.
TABLE 16
ts mutants Grown at 31* 37* 39°c Grown at 31°C r\
code Assayed at 31°0 
Titre (pfu/ml)
Assayed at 31* 36, 
Titre (pfu/ml)
39 c
31 37 39 31 36 39
1 3*4xl04
oCNJ• 3 7.0xl06 2.7xl06 0
2 8.0xl05 5.0x10 5.0X101 3*5xl06 7.5xl05 0
3 2.5xl05 2.4x10^ +0 2.1xl06 2.0xl06 3.5X101
4 3.5xl05 l.OxlO5 +0 1.4xl05 4.2xl04 5.0
5 1.5xl05 4*7xl05 l.OxlO1 1.6xl07 0 0
6 1.6xl06 1.5X101 5.0X101 4.8xl06 0 0
7 3*9xl05 9.0xl05 5-OxlO1 3.3xl06 1.7xl06 0
8 1.5xl05 9.0xl05 4*3xl05 2.2xl06 1.2xl06 0
9 1.5xl05 l.OxlO4 5.0X101 1.5xl05 9.5xl04 0
10 ND ND ND 5.4xl05 5.5xl05 0
11 5.5xl04 2.0xl05 3.0xl05 4.0xl05 l.lxlO5 0
12 1.7xl04 1.9xl05 0 3.0xl05 5.0xl04 0
13 8.0xl05 j—
1 
• £ o -
P* 1.3xl05 3.5xl05 ND 0
14 7.5xl04 3.2xl04 2.1xl02 3.0xl05 ND 0
15 7.0xl05 2.5xl05 0 l.OxlO8 +0 0
16 1.5xl06 5.0xl04 0 8.5xl06 0 0
17 3.8xl05 8.0xl05 5.0 7.5xl06 4.0X101 5.0
18 2.2xl06 1.8xl04 0 5.9xl07 0 0
19 1.7xl04 l.OxlO1 0 7.0xl07 1.5xl02 5.0
20 ND ND ND 1.5xl05 ND 0
21 2.2xl05 8.5xl02 l.OxlO1 l.OxlO6 9.0xl05 0
22 2.0xl05 l.OxlO1 4.0X101 3.0xl06 2.0xl06 0
23 1.5xl05 2.1xl05 7.5X101 4.0xl08 4.0xl07 0
24 1.7xl05 9.0xl02 l.OxlO1 4.0xl05 ND 0
25 4«4xl04 2.2xl04 2.5X101 l.lxlO6✓ ND 0
26 5.5xl04 l,lxl05 0 1.1x10 ND 0
27 3.0xl05 1.7xl02 0 l.OxlO5 ND 0
28 3.5xl04 1.5xl05 0 4.4xl06 ND 5.0
29 1.7xl05 1.4xl04 2.7xl02 2.6xl06 ND 5.0
TABLE 16 continued
ts mutants Grown at 31* 37* 3?°c Grown at Cl
code Assayed at 31°C Assayed at 31* 36, 59 C
Titre (pfu/ml) Titre (pfu/ml)
31 37 39 31 36 39
30 ND ND ND 3.1xl04 ND 0
31 1.3xl04 1.3xl02 0 1.5X105 ND l.OxlO1
32 l.OxlO5 2.5xl05 l.OxlO5 1.1x10 ND 2.0X101
33 4.5xl02 3*9xl02 0 1.2xl06 ND 2.0X101
34 ND ND ND 4 xlO4 ND 0
35 5.0xl05 4*3xl04 5*Qxl05 1.5xl06 ND 1.5X101
36 6.5xl02 8.0X101 0 3*0xl04 ND 0
wild type 
virus 3.7xl05 4#0xl05 1.2xl05 2.4xl05 2.3xl05 2.2xl05
+ indicates cell change but has no plaque formation
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3*7 Genetic studies using RS virus ts mutants
3#7*1 Complementation experiments using jts mutants of the
RSN-2 strain of RS virus
Ts mutants of the RSN-2 strain were examined using the yield 
complementation test in an attempt to identify mutants affecting 
different genome functions.
Unless otherwise stated BS-C-1 cells were used in the yield 
complementation experiments. The complementation indices for each 
experiment were calculated using the highest titre of each single 
infection in that experiment. Complementation indices above the value 
of 10, an arbitrary figure, were considered to indicate complementation.
A difficulty in work with RS virus is the low titres of virus obtained. 
Therefore, in order to obtain reasonable multiplicities of infection 
small numbers of cells had to be used.
Linbro wells (6 mm) were used in complementation experiments 
because fewer cells were required (l x 10^ cells/well) compared with 
other methods and consequently high ratios of pfu to cells could be 
obtained. The recovery of virus from Linbro wells was good but there 
was marked variation in yield between duplicate crosses in the same and 
different blocks. Yield complementation experiments using Linbro wells 
gave indications of complementation (Table 17> 18). However, since 
variation occurred between duplicate mixed and single infections it was 
difficult to interpret these results. Blocks of Linbro wells were 
incubated at 39°C in a CO^-gassed incubator. In an attempt to have more 
accurate temperature control complementation methods 1, 3 and. 4 using an
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accurate 39°C waterbath were used (section 2.7*1)•
Complementation using vials, 12 mm in diameter, (method 3) 
had greater temperature control than that using Linbro wells (method 2) 
but viral recovery was poor. Only one mixed infection (ts 5 and ts 9) 
had a reasonable complementation index (i.e. above 10) (Table 19a)*
The complementation experiments using bottles (method l)
suffered from the disadvantage of low moi due to the high number of cells 
£
used (1 x 10 cells/bottle). Some mixed infections which'had high 
complementation indices in an earlier experiment (Table 17) now had 
lower complementation indices e.g. ts 4 and ts 6, ts 6 and ts 17* 
Experiments using three different methods (plates, vials and Linbro wells) 
were simultaneously performed. The plate method (method 4) seemed to be 
the best as infected cells could be removed efficiently by scraping with 
a piece of silicone whereas it was more difficult to harvest cells from 
vials. Also variation did not occur between duplicate mixed and single 
infections using this method unlike that using Linbro wells.
All of the complementation experiments irrespective of method
used, were hampered by the leak yield of some of the ts mutants. This
leak varied between experiments. Whether a mixed infection appeared to
have a high complementation index (Cl), depended often on the degree of
rtiy&b 1 pJ^ isCT iq r/
leak of the ts_ mutants involved. For example, the croosAbetween ts 1 
and ts 7 (Table 18) had a high complementation index value because in 
this experiment ts 7 bad a lower leak value than in the other experiment 
using Linbro wells (Table 17)* In the complementation experiment using 
vials, the complementation index between ts 5 and ts 9 was above 10 since 
the leak of ts 9 was lower in this experiment (Table 19a) than in previous
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experiments using Linbro wells (Tables 17, 18). The mixed infection 
between _ts 1 and ts 20 and _ts 1 and ts 6 in the same experiment (Table 
19a) had low complementation indices which were contrary to the results 
in previous experiments (Table 17, 18).
Higher titres of virus had to be used in complementation 
experiments using plates, in order to obtain higher multiplicities of 
infection without altering the number of cells. The titre of the ts 
mutants used was increased by concentrating large volumes of stock (100 
ml) using the PEG precipitation method (section 2.4#2). Although the 
moi was increased in these experiments (Table 20) there was no increase 
in the value of the complementation indices. Therefore lack of 
complementation in BS-C-1 cells did not seem to be due to the moi of 
infection of the jts mutants being too low. It is possible that the ts 
mutants tested were affected in the same genome function, which would 
result in them being unable to complement and the positive value obtained 
in these experiments being spurious. Another possibility is that the 
cell system used did not allow the detection of complementation. 
Complementation might be masked by the high leak of some ts_ mutants in 
these cells.
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3*7*2 Complementation between ts mutants of the and
the RSN-2 strains of RS virus
To test whether lack of complementation between ts mutants of 
of RSN-2 strain was due to the mutants or to the cell system used, 
mutants of k^ strain which complement in HeLa cells (Wright et al.t 1973) 
were compared with these jts mutants in BS-C-1 cells. Before being used 
in complementation experiments they were passaged twice in BS-C-1 cells 
and their titres increased by concentration using the PEG precipitation 
method. .
In the complementation experiment in BS-C-1 cells (Table 21a) 
using the ts mutants of the A.2 and the RSN-2 strains of RS virus no 
complementation indices above 10 were obtained. Complementation indices 
above 1 were obtained in three mixed infections, ts A7 and ts 23, ts A7 
and ts 15 and ts 19 and ts 15* These ts mutants had the same moi, 
approximately 3 pfu/cell, which was higher than those of the other ts 
mutants used. No complementation occurred between ts Al, t^s A2, ts A7* 
This could be due to the cell system used (BS-C-1 cells) or to the low 
moi of _ts A2 (0.14 pfu/cell) and ts_ Al (1*4 pfu/cell) compared with t_s A7 
(3.3 pfu/cell).
To test whether the lack of complementation between the ts 
mutants was related to the cell system used, complementation experiments 
using the same ts mutants (ts Al, ts A2, ts A7> ts 15, ts 19> ts 23) were 
performed in HEp-2 (Table 21b) and HeLa cells (Table 21c). The moi of 
ts mutants in these cells was lower with the exception of ts A2 than those 
used in BS-C-1 cell experiment (Table 21a). Only one mixed infection in
TABLE 21
Complementation using different cell monolayers in Petri dishes 
(35 mm), Ts mutant infected cells incubated in a waterbath at 39 C
for 48 hours
Table 21a
BS-C-1 cells used in complementation experiment
moi 1.40 0.14 3.30 3.20 1.50 3.30
Ts mutant Al A2 A7 15 19 23
Al (3.4xl05) 0.1 0.9 < 0.1 < 0.1 < 0.2
A2 (6xl04) 0.4 < 0.1 < 0.1 < 0.1
A7 (l.5xl04) 2.2 0.3 4.5
15 (7.5x10 )< 0.1 2.0
19 £ 5x10°) 0.5
23 (3.4xl05)
Table 21b
HEp-2 cells used in complementation
moi 0.20 0.49 3.10 0.12 0.13 0.17
Ts mutant Al A2 A7 15 19 23
Al (2.1xl05) 2.0 9.6 0.3 0.7 <0.1
A2 (4.3xl04) 0.7 3.0 0.5 0.3
A7 (9xl04) 1.2 0.2 <0.1
15 (2.4xl02) Lull <0.1
19 (2.2x10 ) <0.1
23 (4.5xl05 )
Table 21c
HeLa cells used in complementation experiment
moi 0*19 O .46 2.90 0.11 0.12 0.16
Ts mutant Al A2 A7 15 19 23
Al (1.5X101) 4*3 0.2 0.3 0.9 0.8
A2 (1.5x10 ) jjj} <0.1 0.5 6.3
A7 (3.9x10 ) 0.7 0.4 2.7
15 (l.6xl02) no m)
19 (6x10^) m  2
23 (1.5x10
( \ g-irurlg infpntion ti t/rp (-nfia/ml^ - moi - multiplicity Of infection
HEp-2 cells had a complementation index above 10 (i.e. ts 15 and _ts 19)• 
However, the mixed infection between ts_ Al and ts; A2 had a Cl of 2 and 
between ts Al and jts A7 had a CXiof 9*6. The Cl of the mixed infection 
between ts A2 and ts A7 was low (0.7)•
Mixed infections of ts mutants at the same moi in HeLa and 
HEp-2 cells had higher complementation indices in HeLa cells. Comple­
mentation indices above 10 in HeLa cells could be detected for mixed 
infections between _ts A2 and _ts A7» ts 15 and ts_ 19f ts 15 and. _ts 23 and 
ts 19 and ts 23. The Cl of the mixed infection between jts Al and ts A2 
was 4.3 and that between tis Al and A7 was 0.2 which was very low.
Complementation should have occurred between ts Al, ts A2 and 
ts A7 in HeLa cells, the variation in complementation indices between 
these mixed infections is perhaps due to the low moi of ts Al (0.19 pfu/ 
cell) and its A2 (0.46 pfu/cell) compared with that of ^ ts A7 (2.9 pfu/cell). 
In earlier experiments performed in HeLa cells by other workers 
complementation occurred between these jts mutants (Wright et al., 1973) 
each jts mutant had a moi of 5* Multiplicities of 5 pfu/cell could not 
be obtained with the number of cells used and the stock available in 
this experiment.
The difference in complementation indices obtained using the 
different cell systems could be due to the higher leak of _ts mutants on 
HEp-2 and BS-C-1 cells than on HeLa cells (Figure 21c). However, this is 
not true for all combinations, the leak of ts 15 and ts 19 was no higher 
in BS-C-1 cells than in HEp-2 or HeLa cells.
Complementation was detected in HeLa and HEp-2 cells and not 
in BS-C-1 cells even although moi was higher in BS-C-1 cells. Therefore
there could he some type of interference or suppression of complementation 
in BS-C-1 cells. HeLa cells seem to be the best cell system for 
complementation experiments as the leak in these cells was generally 
lower than in BS-C-1 or HEp-2 cells (Figure 13)* However, it will be 
necessary to confirm these findings by future work.
The yield from two complementation mixed infections, one with 
a Cl above 10, was examined (Table 22). All the viable clones 
recovered from both yields of virus were Jts as expected if the increased 
yield was due to complementation. There was no indication of reversion 
or recombination.
3.7*3 Test for recombination between _ts mutants of RS virus
A recombination experiment was performed using BS-C-1 cell 
monolayers on plates (35 and. PEG concentrated virus as described in 
section 2.4*2. The percentage of ts+ virus recovered from the crosses 
was less than 0.05% (Table 23). However the percentage o'E ts+ virus 
from the cross ts 1 and ts 5 was about 5 times greater than the sum of 
the self-crosses, suggesting low frequency recombination. A similar 
phenomenon was observed by Wright and his colleagues (1973)» which on 
analysis of the progeny proved to be due to complementing heterozygotes.
Figure 13 5 Complementation and leak in relationship 
to host cells
x and y are individual ts mutants of 
RS virus.
-♦---- *—  ts mutants grown in HeLa cells.
0 ____ q  ts mutants, grown in HEp-2 cells.
■ —  -0-----0  1 ■—  ts mutants grown in BS-C-1 cells.
Infectivity is measured as log^^/ml. 
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TABLE 22
Analysis of complementation yield
The complementation indices of the mixed infections examined are
given in Table 19a
Mixed
Infection
No. of clones 
isolated
No. of 
viable 
clones
No. of 
which
clones 
grew at
°/o
ts
3i°c 39°C
ts 2 x ts 9 40 34 34 0 100
ts 5 x ts 9 40 27 27 0 100
Cross ts 2 x ts 9
Frequency of ts+ clones ^ 2.9%
Cross ts 5 x ts 9
Frequency of ts* clones ^ 5*3%
TABLE 25
Recombination Experiment
CROSS 
of ts 
mutants
Titre (pfu/ml)
3l°c
Titre (pfu/ml) 
39°c
Percentage 
of ts+ virus
1 x 0 5.9 x 105 5.0 x 101 0.008
5 x 0 3.3 x 106 2.5 x 10° < 0.001
19 x 0 6.5 x lo5 1.5 x 101 0.002
1 x 5 6.1 x 106 2.7 x i05 0.044
1 x 19 2.7 x 106 2.8 x 101 < 0.001
5 x 19 2.2 x 106 0 0.001
3.8 Grouping of ts mutants of RSN-2 strain by
immunofluorescence pattern
Since the ts mutants could not be grouped using genetic 
analysis other methods of classification had to be used. The ts mutants 
were grouped on the basis of their immunofluorescence pattern at 39°C 
(Table 24a, 24b). This work was a joint project with Dr. P. Shirodaria, 
Department of Microbiology and Immunobiology, The Queen* s University of 
Belfast.
On the basis of number of fluorescing cells and amount of 
antigen present at 39°C as compared to 31°C, the ts mutants studied can 
be divided into 3 groups.
Group I
Mutants in this group show a marked reduction in the number of 
fluorescing cells at 39°C as compared to 31°C (Plates 18, 19)* The 
amount of antigen in cells at 39°C is also reduced. Group I can be 
subdivided: Us) Fluorescing cells which have no processes at 39°C;
t(b) Fluorescing cells which have processes at 39°C.
Sixteen ts mutants are classified in Group I (Table 24a).
Group II
Mutants in this group have a similar pattern of fluorescence at 
39°C to that at 31°C and resemble wild type virus (Plates 20-23). 
Inclusions and processes were present at both temperatures. The number 
of fluorescing cells at 39°C was only slightly reduced (Table 24a) and 
there was no reduction in the amount of antigen present. Fifteen ts 
mutants belong to this group.
Group III
Mutants in this group have a marked reduction in the amount 
of antigen present at 39°C but only a slight reduction in the number of 
fluorescing cells (Plates 24,25)*No processes are detected at 39°C but 
inclusions are present. Three _ts mutants belong to this group. (Table 24a)
Nuclear antigen can be detected in cells infected with many
of the jts mutants. This antigen is only seen when bovine anti-bovine
RS virus serum and not human RS virus convalescent serum is used to stain
the infected cells. This is probably a consequence of the high titre
of antibody in convalescent calf serum. Nuclear antigen had not
previously been detected in RS virus infected cells. (Berthiaume et al•,
1974; Kisch et al., 1962; Levine et al.. 1971; Nagahama et al..
1970 and Shedden and Emery, 1965)•
Table 24a
o
Ts mutants grouped according to immunofluorescence pattern at 39 C
Group I Group II Group III
a b
ts 4 ts 12 ts 1 ts 3
ts 5 ts 17 ts 2 ts 15
ts 16 ts 21 ts 6 ts 33
ts 18 ts 22 ts 7
ts 19 ts 27 ts 8
ts 25 ts 28 ts 9
ts 31 ts 29 ts 10
ts 35 ts 36 ts 11
ts 13 
ts 14 
ts 23 
ts 24 
ts 26 
ts 30 
ts 32
Total 8 
Nb.of 
ts Mutants
8 15
TABLE 24b
Quantitative immunofluorescence data supplied by Dr. P. Shirodaria, 
Department of Microbiology and Immunobiology, The Queen*s University
of Belfast.
GROUP ts mutant Number of fluorescing cells
51°C 59°C
la ts 4 104 cells/45 fields 4 cells/coverslip
ts 18 > 50 cells/field 67 cells/40 fields
ts 19 580 cells/17 fields 8 cells/17 fields
ts 55 40 cells/field 1 cell/17 fields
lb ts 5^ I65 cells/17 fields 5 cells/coverslip
II ts 6 15 cells/65 fields 4 cells/29 fields
ts 14 105 cells/8 fields 80 cells/8 fields
III ts 5 > 50 cells/field slight reduction
Plates 18 and 19 s BS-C-1 cells infected with a Group I
ts mutant (ts 18)
The ts mutant infected cells were stained with bovine 
anti-bovine RS virus serum.
Plate 18 shows the Group I Its mutant infected 
BS-C-1 cells at 31°C.
Plate 19 shows the Group I t£ mutant infected 
BS-C-1 cells at 59°C.
The magnification of these photographs was 480 X.
Plate 18
A  large number of processes can be seen.
Plate 19
RS virus antigen can be seen in the nucleus. No viral processes 
were detected and there was a marked reduction in the number of fluores- 
cing cells and amount of antigen detected.
PLATE
PLATE
Plates 20 and 21 : BS-C-1 cells infected with a Group II
ts mutant (ts 8)
The _ts mutant infected cells were stained with bovine 
anti-bovine RS virus serum.
Plate 20 shows the Group II ts mutant infected
BS-C-1 cells at 31°C. A o*=
P/L O C.£S S  ts  S \aJ  (S a. £ : .
Plate 21 shows the Group II ts mutant infected
BS-C-1 cells at 39°C. Wo ^ePucTic/s, /w t h s
o f  P r o c e s s e s  a w d  a-Mo u n t  o f=- r t r v r i G r C
DeretTeD.
The magnification of these photographs was 480 X.
PLATE 20
PLATE 21
Plates 22 and 25 : BS-C-1 cells infected with a Group II
ts mutant (ts 14) and stained with
human RS virus antiserum
The ts mutant infected cells were stained with 
convalescent sera from children with RS virus 
infection,
Plate 22 shows the Group II ts mutant infected 
BS-C-1 cells at 31°C.
Plate 23 shows the Group II ts mutant infected 
BS-C-1 cells at 39°C. ^  induction thc
O F  F L U o  C £ L L 5  / H V / D  pr^OU rsi^T O F- A w T I G - E M
DcrecrtfD.
The magnification of these photographs was 480 X.
PLATE 22
V  .
i
PLATE 23
Plates 24 and 25 : BS-C-1 cells infected with a Group III
mutant 5)
The ts mutant infected cells were stained with bovine 
anti-bovine RS virus serum.
Plate 24 shows the Group III _ts mutant infected 
BS-C-1 cells at 31°C . This ts mutant produces a 
large number of viral processes at the permissive 
temperature •
Plate 25 shows the Group III ts mutant infected
BS-C-1 cells at 39°C. RS virus -antigen oan bo seen 
fvj 0 P r o c e s s e s  k/e DeT(?cT6j).iwN'thia miffHaua 
The magnification of these photographs was 4®0 X.
PLATE 24
PLATE 25
3.9 Physiological properties of RS virus ts mutants
The physiological properties of RS virus ts mutants were 
studied at the biological rather than the biochemical level because of 
the difficulties involved in biochemical studies of wild type RS virus.
For example the nucleic acid of RS virus has not yet been isolated and 
classification of mutants into RNA -ve and RNA +ve phenotypes would be 
premature•
3.9.1 Growth properties of jts mutants at 31°C and 39°C
The growth properties of wild type RS virus (Figure 14) and 
thirteen jts mutants of RS virus have been examined and found to fall 
into two main groups (Table 25).
Group A
This group includes those _ts mutants which have no or very 
little (<2%) leak over 48 hrs at 39°C (Figure 15-21, 29a).
Group B
The ts mutants in this group have a high level of leak at 39°C 
(^10%) and their growth pattern at 39°C is similar to that at 31°C  
(Figure 22-25, 26a). The plating efficiency of these t£ mutants at 
39°C is low which suggests that they are defective in a cytolytic function.
The division of these thirteen ts mutants into groups based 
on growth pattern at 39°C corresponds very well with the immunofluorescence 
classification for these mutants. Group I and III ts mutants form Group A 
and Group II _ts mutants form Group B. However, there is one exception 
ts 25 which although classified as a Group I ts mutant has the growth 
pattern at 39°C of a Group B ts mutant.
TABLE 25
Classification of _ts mutants based, on their growth at 39°C
Group A Group B
Poor or no growth at 39°C Growth at 39°C
ts 3 ts 1
ts 5 ts 2
ts 15 ts 9
ts 16 ts
rr\
CM
ts 17 ts 25
ts 18
ts 19
Different stocks of _ts 25 were used in the immunofluorescence 
and growth cycle experiments. However, the difference in behaviour 
of ts 25 in these experiments was not due to reversion occurring during 
the growth cycle since this was less than 1%.
The effect of altering the moi of jts virus is shown in 
figures 23a, b and 24a, b. There is no difference in the yield of 
ts 23 in the two experiments although the moi is 2-fold higher in the 
first experiment (figure 24a). However, the yield increment of ts 2 
is low (0.5 log units) in the experiment (Figure 23a) where the moi is 
high (4*8) and higher (1.5 log unit) when moi is low (O.48) (Figure 23b). 
Therefore, there appears to be multiplicity-associated interference of 
RS virus replication. This has also been noted by other workers (Beem 
and Treuhaft, 1972).
In some viruses (e.g. influenza, VSV) multiplicity associated 
interference is due to the replication of defective particles in 
multiply-infected cells.
Figure 14 : The growth of the RSN-2 strain of RS virus
at 31°C and 39°C
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Figure 15 : The growth of _ts 3 (Group III)
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Figure 16 : The growth of ts 5 (Group I)
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Figure 17 : The growth of ts 15 (Group III)
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Figure 18 : Growth of ts 16 (Group i)
o
q , ,i .— q  Growth of _ts mutant at J1 C
-q   Growth of jts mutant at 39°C
tAOV ‘ 0*19 PPlA | CELL.
"I" 1M6 M O U H  ToSr-/Vl>S6RprioN
1IAI 
H3d 
Odd 
301
39°-
HOURS
Figure 19 : The growth of ts 17 (Group i)
q  q  Growth of ti. mutant at 31°C
Growth of jbs mutant at 39°C
MO ( !
I H - O U & S  Po s t - /M S o & P T i O/V/ .
lo
g 
pf
u 
pe
r 
m
l
39
7040 50
HOURS
Figu**© 20 s The growth of Jbs 18 (Group I)
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Figure 21 : Growth of ts 33 (Group III)
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Figure 22 : The growth of ts 1 (Group II)
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Figure 23a : The growth of _ts 2 (Group II)
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Figure 23b s The growth of ts 2 (Group II)
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Figure 24a : The growth of _ts 23 (Group II)
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Figure 24"b : The growth of ts 23 (Group II)
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Figure 25 : The growth of jbs 25 (Group II)
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3*9*2 Temperature-shift experiments
Four ts mutants, three from Group A and one from Group B were 
studied by temperature-shift experiments (section 2.5*2, method 6) to 
determine whether their ts mutation affected a function which occurred 
early or late in the RS virus growth cycle.
1. Ts 9 (Group B)
Ts 9 is a very leaky ts mutant. For this reason these results 
axe difficult to interpret. However, in the upshift (31°C to 39°C) 
experiment (Figure 26a) virus growth appears to be inhibited at all times 
during the growth cycle except at 60 hours. In the downshift experiment 
(39°C to 31°c) at 12, 24, 36, 48 and 60 hours there is immediate synthesis 
of ts 9 but a final reduction in yield at 36 and 48 hrs (Figure 26b).
o oVirus growth appears to be inhibited at 39 C but not at 31 C.
This suggests that the mutated gene product in _ts 9 infected cells is 
required throughout the growth cycle, and that its functional activity 
rather than its synthesis is temperature-sensitive.
2. Ts 15 (Group A)
In the upshift experiment (Figure 27a) the growth of jts 15 was 
inhibited when the virus was shifted-up at 12, 24 and 36 hours. However, 
no inhibition occurred at 48 and 60 hours. When ts 15 was shifted-down 
at 12 and 24 hours, virus growth was not inhibited whereas at 36 and 60
hours virus the yield was reduced (Figure 27b).
From these data it appears that ts 15 affects an early step in
the RS virus growth cycle probably during the first 12 hours. The
affected gene product is required for at least 36 hours, as shift-up 
during that time results in inhibition of virus growth. Physiological 
factors may be responsible for the reduction in yield at 36 and 60 hours 
on shiftdown. It would appear that t_s 15 kept for 36 hours or longer 
at 39°G is unable to recover when returned to the permissive 
temperature (31°C). This is probably partly due to the fact that jts 15 
is very heat-labile (see Table 26).
3* Ts 16 (Group A)
When ts 16 was shifted-up to 39°C at 12 and 24 hours after 
infection, virus growth was inhibited (Figure 28a). However, when 
ts 16 was shifted-up after 24 hours there was no inhibition in virus 
growth. On downshift (Figure 28b) at 12 and 24 hours there was a slight 
reduction in virus yield which became marked at 36, 48 and 60 hours.
Ts 16 probably also affects a step in the RS virus growth cycle 
which occurs at or before 12 hours, and is required for at least 24 hours. 
The reduction in virus yield on downshift may indicate that ts 16 is 
unable to recover after incubation at 39°C. It is interesting to note 
that although on virus growth was not inhibited by upshift at 36 hours, 
there was a marked reduction in final yield of virus.
4. Ts 19 (Group A)
On upshift at 12 hour the yield of ^ ts 19 was reduced and its 
growth delayed (Figure 29a). However, there was an enhancement of the 
yield on upshift at 24, 36, 48 and 60 hours. When ts 19 was shifted- 
down at 12, 24 or 36 hours there was no reduction in the final virus
yield (Figure 29b). A marked reduction in virus yield occurred when 
ts 19 was shifted-down at 48 and 60 hours,
Ts 19 probably affects a very early step in the RS virus 
growth cycle which occurs before 12 hours post-adsorption and is not 
required beyond 12 hours. The reduction in virus yield which occurs 
on shiftdown at 48 and 60 hours was probably due to inability of the 
virus to recover after exposure at 39°C, since ts^  19 is very heat labile 
at 39°C (see Table 26).
The patterns exhibited by ts 15, ts 16 and Jbs 19 were similar. 
These Group A jts mutants appeared to affect early functions in the RS 
virus growth cycle, whereas ts >5, the group B Ite mutant, appeared to 
affect a function required throughout the growth cycle. The jts 9 lesion 
may involve the functional activity rather than the synthesis of a gene 
product.
Figure 26a : Upshift growth curves of ts 9 (Group II)
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Figure 26b s Downshift growth curves of jts 9 (Group II)
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Figure 27a : Upshift growth curves of ts 15 (Group III)
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Figure 27b : Downshift growth curves of ts 15 (Group III)
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Figure 28a : Upshift growth curves of jts 16 (Group i)
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Figure 28b : Downshift growth curves of jts 16 (Group I)
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Figure 29a : Upshift growth curves of ts 19 (Group i)
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Figure : Downshift growth curves of jts 19 (Group i)
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3.10 The heat stability of ts mutants of RS virus
The heat stability of the _ts mutants was examined to 
determine whether the gene functions affected by the mutations were 
heat sensitive. If the ts lesion affects a structural protein the 
virion may be heat sensitive whereas if it involves a non-structural 
protein the virion is not expected to be heat sensitive.
The heat stability of some ts_ mutants (ts A2, t£ A7, ts 9, 
ts 15, ts 16, Jbs 19* ts 23) was examined over a period of 2 hours at 
39°C (Figure 30) and calculated as percentage of residual virus (Table 
26). Ts A2 had a percentage of residual virus (58%) similar to that of
wild type virus (52%) whereas ts A7 had a lower value (26%). These
results are similar to those found by other workers (Kalica et al.. 1973) 
for these ts mutants taking into account differences in experimental 
conditions.
The other ts mutants tested (ts 15, .ts 19, ts 23) were very 
heat sensitive with the exception of ^ ts 9 and ts 16. Ts 9 was a heat 
stable as wild type virus whereas ts 16 was more heat sensitive than 
wild type virus, although not as heat sensitive as the other ts_ mutants.
The jts mutants studied fall into three groups. In the first
group are the _ts mutants (ts 15, ts 19, ts 23) which are very heat
sensitive at 39°C. Therefore the ts phenotype of these mutants could 
be due to their thermolability at 39°C. In the second group are those 
ts mutants (ts 16, ts A7) whose heat sensitivity at 39°C is intermediate 
between the level of heat sensitivity of wild type virus and the very 
sensitive group of ts mutants. The third group of ts mutants (ts A2,
TABLE 26
Heat stability of ts mutants of RS virus
ts mutant Percentage residual 
virus after 2 hr at 
39°C
ts A2 58
ts A7 26
ts 9 50
ts 15 0.6
ts 16 18
ts 19 1.5
ts 23 3.6
RSN-2 wild type virus 52
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5.11 Polymerase activity associated with ts mutants of
RS virus (RSN-2 strain)
It has been suggested that RS virus may have viral associated 
RNA-polymerase activity (Szilagyi and Pringle, in preparation).
Experiments undertaken with wild type RS virus and jts mutants 
to detect polymerase activity were hampered by the high background 
activity found in uninfected BS-C-1 cells (Figure 5l)* Ts mutants 
tsl,ts2, t s 5 * i £ 5  and. jts 19 were assayed for polymerase activity 
by Dr. J. Szilagyi, and ts 15, ts 16, ts 17, ts 19» ts 25 wild type 
virus and uninfected BS*KJ-1 cells by myself. The level of polymerase 
activity in the uninfected BS-C-1 cells studied was similar to that found 
associated with the wild type RS virus sample (Figure 51)* However in 
some of the _ts mutant samples the level of polymerase activity was 
2-fold higher than that found associated with uninfected BS-C-1 cells.
The polymerase activity was higher at 51°C than at 59°C in the ts^  15 and 
ts 16 samples (Figure 51) and it declined more rapidly at 59°C than at 
51°C. In the samples ^ 2 ,  t s 5 * its>5 and ts 17 (Figure 52) the 
polymerase activity was also 2-fold greater than in uninfected BS-C-1 
cells but higher at 59°C than 51°C, declining more rapidly at 59°C. No 
polymerase activity above the background level was detected in the samples 
of Ijs 1, ts 18, jts 19 and ts 25 which were tested.
There was no correlation between enzyme activity and virus 
infectivity of the sample tested. The mutants with no polymerase 
activity above background level had the same (e.g. ts l) and higher 
(e.g. ts 18, ts 19, ts 25) titres than those with greater polymerase 
activity. It is possible that cellular rather than viral polymerase
activity was measured since the virus preparations used were not pure 
but crude PEG precipitate suspensions.
Figure 51 s RNA-dependent RNA-polymerase assay
  . —  Polymerase activity at 31°C
(counts per minute x 10^).
| ^ - ■ Polymerase activity at 39°C
(counts per minute x 10^). ,
Infectivity (pfu) of polymerase 
sample (0*1 ml)
5
wild type virus s 8*0 x 10 
ts 15 : 7.0 x 105 
ts 16 : 8*5 x io5.
wild type RSN-2 virusuninfected BS-C-I cells
IsIBts15
MINUTES
Figure 52 : ENA-dependent KNA—polymerase assay
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Discussion
Section 4 - Discussion
4.1 The biology of RS virus in BS-C-1 cells
In this discussion the biological properties of the RSN-2 
strain of RS virus will be compared with those of other strains of RS 
virus in different cell lines.
The RS virus growth cycle is relatively long, 30 - 60 hours 
or longer depending on the host cell used. In BS-C-1 cells the 
latent period of the RSN-2 strain and the Long strain is similar (10 - 
12 hours) and their growth cycles take 36 - 48 hours (see Figures 3 
and 4). Levine and Hamilton (l967f 1969) found that the latent 
period of the Long strain in HeLa cells is similar to that in BS-C-1 
cells but shorter than that in HEp-2 cells (12 - 16 hours).
In BS-C-1 cells the RS virus (RSN-2 and Long strain) growth 
cycle is longer than in HeLa cells (20 - 30 hours) but shorter than in 
HEp-2 cells (48 60 hours) (Bennet and Hamre, 1962; Richman and
Tauraso, 1971> and Vilcyznski, 1971)* Therefore the length of the RS 
virus growth cycle depends on the host cell used in the experiment.
The titre of RS virus is very poor irrespective of the cell
n
line used, since it does not usually exceed 2 x 10 pfu/ml. This is 
probably due to the fact that the virus is very cell-associated. For 
example as much as 84% of the Long strain and 99% of "the RSN-2 strain 
of the virus remain cell-associated in BS-C-1 cells. Levine and 
Hamilton (1967» 1969) also found the Long strain very cell-associated,
90% in HeLa cells and 96% in HEp-2 cells, although Jordan (1962) only 
found 50% of the Long strain cell-associated in HEp-2 cells. The degree
of cell-association of RS virus appears to depend on both the strain of 
virus and host cell used.
A wide variation in the rate of adsorption of RS virus to 
cells has been reported. This variation also appears to be related to 
the strain of virus and host cell used. Adsorption of the RSN-2 strain 
to BS-C-1 cell monolayers seems to be more efficient than that of the 
Long strain to HEp-2 or HeLa cell monolayers (see Table 27). However, 
these results are not directly comparable since the methods and RS 
virus strains used were different. It is known that variation in RS 
virus adsorption can occur between strains of RS virus. For example 
the Long and 18537 strains adsorbed more efficiently to HEp-2 cell mono­
layers (Coates et al., 1966) than the Randall strain (Bennet and Hamre, 
1962). Adsorption to cells in suspension seems to be much faster than 
to cell monolayers, for example, the Long strain adsorbed faster to HeLa 
cells in suspension than to monolayers (see Table 27). However, the 
adsorption of the Burnett strain to HEp-2 cells in suspension (Richman 
and Tauraso, 1971) was slower than that of the Long strain to HEp-2 cell 
monolayers. This variation was probably due to the different virus 
strain used but may also be related to cell type as the Burnett strain 
adsorbed much faster to MA-160 cells (a continuous human heteroploid line 
derived from benign prostate) in suspension than to HEp-2 cells in 
suspension (Table 27).
The data presented for RS virus (RSN-2 strain) adsorption to 
BS-C-1 cells (l hour at 25°c) was not adjusted for thermal inactivation 
as this was presumed to be negligible based on the results of earlier 
experiments (Hambling, 1964b; and Rechsteiner, 1969a). Thermal
inactivation of RS virus was taken into account in their data for the 
Burnett strain by Richman and Tauraso (l97l)« This data was adjusted 
for a 10-fold reduction in RS virus titre over 24 hours at 37°C based 
on earlier inactivation experiments by other workers (Beem £t al•, i960; 
and Hambling, 1964b). However, the data for the adsorption of the Long 
strain to HeLa and HEp-2 cells at 37°C were not adjusted since between 
91 and 113% of the original virus could be accounted for; thermal 
inactivation over 2 hours at 37°C was considered negligible (Levine and 
Hamilton, 1969).
Following adsorption (2 hours at 37°C) 45 minutes incubation 
was required for complete penetration of the Long strain inoculum into 
HeLa cells. Most of the cell-associated virus (90%) was neutralised 
by the addition of specific antisera therefore it was suggested that 
this virus was attached to the external surfaces of the cells (Levine 
and Hamilton, 1969).
The type of RS virus CPE depends on the host cell and medium 
used (Jordan, 1962). RS virus infected BS-C-1 cells under agar do not 
produce syncytia but dark-staining foci of heaped cells (plate l). When 
examined using a scanning electron microscope uninfected BS-C-1 cells 
were seen to have some microvilli (plate 13)» However, in RS virus 
infected cells the number and length of these processes increased 
markedly, as can be seen from the scanning electron microscope photo­
graphs, plates 14 - 17« These processes could correspond to the viral 
processes seen in thin sections of RS virus infected cells (plates 11, 12) 
and in RS virus infected cells (plate 22).
RS virus infection does not necessarily result in cell death 
since ts mutant infected cells can produce virus without visible CPE 
at the restrictive temperature (39°C). These t^s mutants are probably 
defective in some cytolytic function since they grow but do not plaque 
at 39°C.
Multiplicity-associated interference was detected in experiments
tx r J ib
using _ts mutants of RS virus (Figure 2 %)• A similar type of interference 
was noted in an earlier experiment by Beem and Treuhaft (1972) using 
HEp-2 cells infected with wild type virus at various multiplicities.
The yield per cell of RS virus from these cells was low (0.2 pfu/cell) 
when a high moi (moi 7) was used but high ( 25 pfu/cell) when a lower 
moi (moi 0.02) was used. This interfering activity was not due to the 
action of interferon since it could be sedimented (30,000 rpm for 15 
minuteq) and was sensitive to acid and ether treatment. Therefore it is 
possible that defective RS virus particles are responsible for inter­
ference of RS virus replication.
Defective interfering particles usually contain normal viral 
structural protein but only part of the viral genome. Replication of 
these particles only occurs in the presence of normal virus. The 
interference of normal virus replication by defective interfering 
particles results in an inhibition or reduction in yield. If undiluted 
virus is passaged the proportion of defective particles in the progeny 
increases (Huang and Baltimore, 1970)*
Host factors may be involved in RS virus growth since 
complementation between mixed infections of ts mutants (ts 15 and ts 23,
ts 19 and jts 23 and _ts 15 and _ts 23) could not be detected in BS-C-1 
cells (Table 21a) but could be detected in HeLa cells (Table 21c). 
However, the requirement for these factors or factor may be variable 
since complementation may occur in BS-C-1 cells. The low frequency 
"recombination11 detected between _ts 1 and ts 5 (Table 23) is probably 
not true recombination but complementation. Aggregated virus 
particles or heterozygotes could complement at 39°C giving rise to virus 
with apparent ts+ phenotype.
Nuclear antigen can be detected in ts RS virus infected cells 
at 39°C. The detection of RS virus specific material in the nucleus 
is interesting since it could possibly be related to the existence of 
a RS virus proviral BNA which has been recently reported (Simpson and 
Iintuna, 1975)* This BNA was isolated from bovine embryonic kidney 
(BEK) cells which had been infected with a ts mutant of RS virus and 
passed at the non-permissive temperature (39°C) for more iiian 80 cell 
generations. No viral CPE was detected during the passage of these 
infected cells but infectious virus could be recovered from the cells by 
co-cultivation at the permissive temperature (31°C) or by treatment with 
halogenated pyrimidines. The DNA but not RNA extracted from the 
infected cells produced RS virus plaques when titrated on HEp-2 cells. 
When this extracted DNA was treated with DNase it lost its infectivity 
but not when it was treated with RNase. The DNA did not produce 
plaques in cells which had been pre-treated with actinomycin D or 
mitomycin C. RS virus proviral DNA was also recovered from HEp-2 cells 
persistently infected with RS wild type virus.
DNA intermediates have also been reported in cells persistently
infected with other RNA viruses (measles, feck borne encephalitis virus
ZtfD AivW
(TBE), Sindbis virus) (Zhadanov, 1975)• More work needs to be done in 
this area in order to confirm these findings and to extend the search 
for proviral DNA to other RNA viruses. If RNA viruses have a DNA 
intermediate it cannot be essential for viral replication at least in 
the case of RS virus since it grows in enucleate cells. However the 
existence of proviral DNA in these RNA viruses would alter the present 
concept of replication and function of RNA viruses since only RNA tumour 
viruses were thought to have a DNA intermediate.
The inhibitory effect of actinomycin D on RS virus growth 
could be related to the existence of a proviral DNA. However, it could 
be due simply to the declining ability of BS-C-1 cells treated with 
actinomycin D to support RS virus growth. This is possible since the 
yield of VSV in the presence of actinomycin D was also reduced at 14 
hours (Figure 7)» Actinomycin D does not inhibit VSV virus replication 
directly (Hummeler, 1971)* The reduction in yield is probably due to 
the effect of actinomycin D on the cells. Although RS virus growth is 
reduced in the presence of actinomycin D it is not affected to the same 
extent as PSRV (a DNA virus), which is completely inhibited. This was 
to be expected since RS virus does not require the presence of an intact 
nucleus for growth since it can grow in enucleate cells (Follet et al., 
1975)* However, the yield of RS virus from enucleate cells is only 
40?6 of that from nucleate cells at 31°C since the enucleate cells 
deteriorate markedly before completion of the RS virus growth cycle.
Actinomycin D reduced the yield of RS virus when added 
immediately or a short time after adsorption (Table 13)* This effect
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RS virus yield is reduced in the presence of mitomycin C 
(10 |ig/ml) to 59% whereas the yield of PSRV is less than 0*02% in the 
same concentration. Therefore RS virus does not require DNA replication. 
The reduction in RS virus yield could be due to a deterioration in the 
cell*s ability to support virus growth due to the effect of mitomycin C.
RS virus protein synthesis can be inhibited by the removal 
of specific amino acids (i.e. arginine or phenylalanine) from the 
maintenance medium or by the addition of cycloheximide to the maintenance 
medium.
The growth of both the RSN-2 and the Long strains of RS virus 
is inhibited in arginine deficient medium. However, the addition of 
arginine reverses this effect (Figure 5)* There is a maximum concen­
tration of arginine (84 (ig/ml) beyond which the addition of more arginine 
will not enhance virus growth (Figure 6). These results confirmed the 
findings of Levine and his colleagues (1971) who found that the growth 
of the Long strain of RS virus was inhibited in HeLa cells in phenyl­
alanine (PA) or arginine deficient maintenance medium. In PA deficient 
medium (l fig/ml PA) protein synthesis occurred at the normal rate for 6 
hours and then the rate markedly decreased. This time was not long 
enough for the completion of the RS virus latent period therefore no 
RS virus was produced. However, RS virus production occurred within 
2 hours of the addition of PA (5 jj.g/ml) to the maintenance medium of the 
infected cells which had been in deficient medium for 18 hours. This 
short latent period (2 hours) suggested that early events in the RS virus 
growth cycle had been completed during the time in PA deficient medium.
PA was not a specific requirement since arginine depletion had a similar
effect on RS virus growth. It was suggested that at least one
OSLUS
structural component was not made in RS virus infected/\in PA or
arginine deficient medium. Also suggested was that the amino acid
deficiency could block migration of RS virus antigen from the site of
synthesis to the cell membrane (Levine et al., 1971) • However, we
14 3found that the ratio of incorporation of ^C-arginine to 'H-leucine was 
high for all of the five RS virus polypeptides which were detected by 
PAGE. It was suggested that exogeneous arginine was a limiting factor 
because it was required for incorporation into RS virus polypeptides 
(Wunner et al., 1975)-
Not all amino acids are essential for RS virus growth, 
however, since the virus grows well in methionine-free medium. However, 
1% serum is required for good RS virus growth and at least 10% for 
optimal growth.
Cycloheximide (25 ng/ml) has been used by Levine and Hamilton
(1969) to study RS virus protein synthesis. It inhibited RS virus 
production when added any time after infection. Therefore RS virus 
protein synthesis appears to be required throughout the growth cycle.
It was suggested that continuous protein synthesis was required because 
there was no accumulation of RS virus structural proteins in the 
infected cells and that protein synthesis is essential for maturation of 
the RS virion, perhaps required in the budding process.
Evidence has been presented to suggest that RS virus is a 
negative strand virus (Wunner et al., 1975) based on the presence of a 
fast sedimenting RNA component (50S) and low molecular weight RNA (4S)
in the cytoplasm of infected cells. However, RS virus ENA has not yet
"been extracted and characterised. Therefore whether this RNA is
3
complementary to m-RNA and non-infectious is not known. H-thymidine
is incorporated similarly into both RS virus-infected and uninfected
cells indicating the virus did not contain DNA. Also incorporation of 
3
vH-uridine into virus specific RNA could be detected in the presence of 
actinomycin D (2.5 |ig/ml) which was added late. The other feature of 
negative strand viruses is the possession of a virion associated RNA*" 
dependent RNA-polymerase (transcriptase). RS virus may have a virion 
associated RNA-dependent RNA-polymerase (Szilagyi and Pringle, in 
preparation) but evidence for the existence of this polymerase in 
experiments detailed in this thesis is not conclusive. It is possible 
that the polymerase detected in these experiments (Figures 51 $ 52) 
was cellular rather than viral. RS virus is morphologically similar 
to the ortho- and para-myxoviruses, which are negative strand viruses.
Its nucleocapsid is similar in structure and intermediate in width between 
that of the orthomyxoviruses and the paramyxoviruses. The evidence 
available at present favours the idea that RS virus is a negative-strand 
virus.
4*2 The temperature-sensitive mutants of RS virus
The ts mutants of the RSN-2 strain were classified and 
compared with the ts mutants of the strain of RS virus.
The RSN-2 jts mutants were isolated from virus treated with or 
grown in the presence of various mutagens. However, the overall 
frequency of isolation of these _ts mutants was low and not significantly 
different from the frequency of isolation of the spontaneous jts mutant 
(Table 15)• In "two instances the frequency of isolation was signifi­
cantly greater than the spontaneous frequency. In both cases the virus 
was grown in the presence of 50 M-g/ml of 5-FU. The increased number of 
ts mutants may have been picked due to chance or due to effective 
mutagenisation increasing the proportion of jbs mutants in the virus 
population. The lattoa? explanation is most probable as an increase in 
the proportion of jbs mutants due to mutagenisation is unlikely since 
there is no relationship between concentration of mutagen and frequency 
of isolation of _ts mutants. Therefore it must be presumed that all of 
the jbs mutants isolated were spontaneous rather than induced.
Genetic analysis of the RSN-2 strain of jbs mutants could not 
e<=<-t.s
be undertaken in BS-C-l^since complementation between ts mutants was not 
reproducible. However, complementation could be detected in mixed 
infections of _ts mutants in HeLa cells. BS-C-1 cells may be unsuitable 
for use in complementation analysis because they are large cells and 
RS virus particles may not complement unless in close proximity. From 
the data obtained from mixed infections in HeLa cells there appear to be 
at least three different complementation groups (Table 28) which 
correspond to Groups I, II and III of the immunofluorescence classification.
TABLE 28
Complementation between ts mutants representing
Groups I, II and III
BS-C-1 HeLa
GROUP ts mutant ts 19 ts 25 ts 15 ts 19 ts 25 jbs 15
I ts 19 - - + +
II ts 25 - +
III ts 15
+ Complementation index above 10 
- Complementation index below 10.
Since genetic analysis using BS-C-1 cells was not feasible
other methods of analysis were attempted. The results of the analyses
are summarised in Table 29* The jt£ mutants can be classified into
three groups by indirect immunofluorescence based on their growth
pattern in BS-C-1 cells at 39°C (Table 24). The A2 strain jts mutants
can also be divided into three groups (Gharpure et al •, 19&9) > however
these groups do not correspond exactly to those of the RSN-2 strain.
Ts A2 produced more antigen than wild type RS virus at 24 hours and
about the same amount at 48 hours after infection at 39°C. This ts
mutant shows the same pattern at 39°C as RSN-2 ts mutants belonging to
Group II. Ts A4 produced no antigen in infected cells at 39°C. This
ts mutant does not correspond to any RSN-2 strain ts mutant. The other
ts mutants, ts Al and tsi A3 produced reduced amounts of viral antigen at
39°C. These mutants could correspond to those RSN-2 ts mutants
belonging to Group III or I depending on whether the number of infected
cells was also reduced as well as viral antigen. The pattern of
complement-fixing (CF) antigen development at 39°C in individual ts
mutants of A^ strain was similar to that of their immunofluorescent
o
antigen. For example, ts A2 produced as much CF antigen at 39 C as 
did wild type virus (Gharpure et; al., 1969)*
RS virus specific-staining was seen in the nucleus of some 
RSN-2 ts mutant infected cells at 39°C. Nuclear fluorescence had not 
previously been detected in any immunofluorescent experiments. No 
nuclear antigen was detected in cells infected with the ts mutants of 
the A2 strain of RS virus. However, this is probably explained by the 
fact that these jbs mutants were only stained with human anti-RS virus 
serum which does not have antibodies or have them in too low a
TABLE 29
Physiological classification of ts mutants
Method GROUPS
Fluorescence I III II
Growth at 39°C A A B
Temperature-
shift
experiment
"Early” function 
affected
(ts 16, ts 19)
"Early"
function
affected
(ts 15)
Function required 
throughout growth 
cycle• Functional 
activity rather 
than synthesis ts
(ts 9)
Thermolability labile labile labile/stable
(ts 16, ts 19) (ts 15) (ts 23) (ts 9)
concentration to detect nuclear antigen. Nuclear antigen could only 
be detected when bovine anti-bovine BS virus serum. was used to stain 
RSN-2 ts; mutant infected cells, not when human anti-RS virus serum 
was used.
The high antibody titre of bovine convalescent serum is the 
result of a good immunological response in calves to parenteral 
inoculation. Human convalescent sera has a lower titre as natural 
infection does not evoke such a good response. Bovine RS virus and 
human RS virus are antigenically similar (inaba et al,, 1972 and Paccaud 
and Jacquier, 1970). The RS virus staining was specific since antiserum 
absorbed with RS virus infected cells when used did not stain the 
infected cells. There was one earlier report of RS virus having some 
kind of nuclear involvement. Armstrong and his colleagues (1962) 
detected nuclear inclusions in RS virus infected HeLa cells. However, 
this finding has never been confirmed.
From temperature-shift experiments the ts defects of the ts 
mutants ts 16, ^ 1 9  and ts 15 classified in Groups I and III were found 
to occur in "early” functions. Therefore these ts mutants could be 
defective in viral nucleic acid synthesis. Since these ts mutants were 
also very thermolabile a particle-associated polymerase could be 
affected.
Since RS virus does not plaque and grow as well in primary 
cell linoo as in continuous cell lines, a continuous cell line (BS-C-1 
cells) had to be used initially to develop a good system for the 
isolation of _ts mutants. A satisfactory system, i.e. the sector-plating
method, has been developed, therefore it will now be simpler to 
isolate RS virus jts mutants in a suitable cell line for vaccine work 
e.g. BEK cells. As the growth of RS virus t^s mutants appears to be 
affected by the type of host cell used it would be valuable to 
evaluate possible ts vaccine mutants in human embryonic lung cells and 
in cultures of pieces of lung tissue.
Appendix 1
Media, Stains and Resin
1, Medium
Eagles MEM (Glasgow modification) was used (Busby et ad., 1964). 
This medium contains twice the concentration of amino acids and vitamins 
present in Eagles MEM.
Growth medium
Eagles MEM (Glasgow modification ) + 10% ECS.
Maintenance medium
Eagles MEM (Glasgow modification) + 5% PCS.
Arginine free medium
Eagles MEM (Glasgow modification) without arginine except 
that present in FCS. Normal Eagles MEM (Glasgow modification) contains 
42 ng/ml of Arginine.
Methionine free medium
Eagles M M  (Glasgow modification) without methionine.
Normal Eagles M M  (Glasgow modification) contains 15 |ig/ml methionine.
2. Phosphate buffered saline (PBS)
The PBS used unless otherwise indicated was that described 
by Dulbecco and Vogt (1954)*
Solution A To make 12 litres
NaCl
KC1
Na2HP04
kh2p°4
Solution B
CaCl2 2H20
Solution C
MgCl2 6H20
120 g
3 g  
17.25 g 
3 g
To make 1.5 litres 
1*5 g
To make 1.5 litres 
1.5 g
PBS is prepared when required by mixing 8 parts of solution A 
with 1 part of solution B and then by the addition of 1 part of solution
C. The PBS is sterilised by autoclaving for 10 mins at 10 lb/sq. in.
PBS (0.01M) pH 7.2
This PBS was used in immunofluorescent experiments.
To make 5 litres 
NaCl 42.5 g
Na2H P04 5.3 g
NaH2P04.2H20 1.9 g
The chemicals were dissolved in distilled water (5,000 ml) 
and the pH was checked using a pH meter. Then the solution was 
dispensed in 500 ml amounts and this was sterilised at 10 lbs/sq. in 
for 10 minutes.
3. Buffered, glycerol saline pH 8.3
Pure glycerine 80 ml
PBS (0.01M) pH 7.2 20 ml
The solutions were mixed thoroughly and the pH adjusted to 
8,3* Then the solution was dispensed in 4 amounts and stored at 
-4°C.
4. Trypsin
Trypsin was used at a concentration of 0.25% (w/v) in Tris 
saline for the removal of cells from glass.
5* Versene (Diaminoethanetetra-acetic acid disodium salt)
Versene (0.6 mM) was dissolved in PBS and 0.002% (v/v) phenol
red added.
6. Formal saline
The formal saline used was a solution of 4% (v/v) formaldehyde 
which also contained 85 mM NaCl and 0.1M NaoS0..
2 4
7. Giemsa
A suspension of 1*5% (v/v) of Giemsa in glycerol was heated 
at 56°C for 90-120 minutes. Then the solution was diluted with an 
equal volume of methanol. (Dacie and Lewis, 1968).
8. Agar overlay
Difco-Bacto agar (3*6%) was melted and poured into warm 1.3 
Eagles MEM (Glasgow modification) without phenol red. The final 
percentage of agar in the medium was 0.9% (w/v); the medium was 
supplemented with FCS (4%).
9. Epon
Solution A
6.2 ml Epikote resin 
10 ml Dodecenyl succinic anhydride (DDSA)
Solution B
10 ml Epikote resin 
8.9 ml Methyl nadic anhydride (MNA)
Solutions A and B were mixed in proportions 3*2 (i.e. 16.2 ml 
solution A and 10.8 ml of solution B). An accelerator BEMA was added 
to the mixture of solutions A and B. All of these products were 
obtained from Polaron Equipment Ltd., Watford, England.
Appendix 2
Preparation of samples for scanning electron microscope examination
The medium was poured off plates (50 mm) containing coverslips 
of infected and uninfected BS-C-1 cells.
Glutaraldehyde (2.5%) was added to the plates and left on the 
plates for 30 minutes to fix the cells. Then the glutaraldehyde was 
poured off and the plates washed with PBS (A, B, C). The PBS was 
removed and 1% osmic acid (l ml) added and retained for 5 minutes before 
being poured off. PBS (A, B, C) was used to wash off the osmic acid. 
Then distilled water was added and the coverslips stored at 4°C in 
distilled water until required.
The coverslips to be examined by the scanning electron 
microscope were transferred to a holder and placed in alcohol. These 
coverslips were transferred serially from low to high concentrations of 
alcohol (25%, 50%, 75%? 90%) and left 15 minutes in each concentration. 
The coverslips were left for 60 minutes in 100% alcohol. Alcohol 
treatment was used to dehydrate the cells. Prom 100% alcohol the 
coverslips were transferred to a 1:1 solution of 100% alcohol and 
iso-pentane and left for 15 minutes. Then the coverslips were dipped 
into warm isopentane for a few seconds before being attached to the 
microscope. Stubs were coated with carbon and gold. A JE0L, JSM-35 
scanning electron microscope was used with permission of JE0L Ltd., 
London.
Dr. E. Follett took the scanning EM photographs and Mrs. P. 
McSevney prepared the coverslips using the above procedure.
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